Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(1-amino-2-anilinoethyl)phosphonic acid
-
(1-amino-2-[[(4-methoxyphenyl)methyl]amino]ethyl)phosphonic acid
-
[1-amino-2-(cyclohexylamino)ethyl]phosphonic acid
-
(+)-4-hydroxypanduratin A
-
54.8% inhibition at 0.03 mM
(+)-isopanduratin A
-
29.3% inhibition at 0.03 mM
(+)-krachaizin A
-
27.9% inhibition at 0.03 mM
(+)-krachaizin B
-
76.2% inhibition at 0.03 mM
(+)-panduratin A
-
61.4% inhibition at 0.03 mM
(-)-4-hydroxypanduratin A
-
39.6% inhibition at 0.03 mM
(-)-isopanduratin A
-
95.3% inhibition at 0.03 mM
(-)-krachaizin A
-
21.7% inhibition at 0.03 mM
(-)-krachaizin B
-
51.0% inhibition at 0.03 mM
(-)-panduratin A
-
95.2% inhibition at 0.03 mM
(1-amino-2-cyclohexylethyl)phosphonic acid
-
-
(1-amino-2-cyclopentylethyl)phosphonic acid
-
-
(1-amino-2-methylpropyl)(1-hydroxy-3-phenylpropyl)phosphinic acid
-
-
(1-amino-2-phenylethyl)(1-hydroxy-3-phenylpropyl)phosphinic acid
-
-
(1-amino-3-cyclohexylpropyl)phosphonic acid
-
-
(1-amino-3-cyclopentylpropyl)phosphonic acid
-
-
(1-amino-3-methylbutyl)(1-hydroxy-3-phenylpropyl)phosphinic acid
-
-
(1-amino-3-methylbutyl)(1-hydroxypentyl)phosphinic acid
-
-
(1-amino-3-methylbutyl)(2-benzyl-3-oxo-3-phenylpropyl)phosphinic acid
-
-
(1-amino-3-methylbutyl)phosphinic acid
-
-
(1-amino-3-methylbutyl)[amino(phenyl)methyl]phosphinic acid
-
-
(1-amino-3-phenylbutyl)phosphonic acid
-
-
(1-amino-3-phenylpropyl)(2-benzyl-3-oxo-3-phenylpropyl)phosphinic acid
-
-
(1-amino-3-phenylpropyl)phosphinic acid
-
-
(1-amino-4-cyclohexylbutyl)phosphonic acid
-
-
(1-amino-5-phenylpentyl)phosphonic acid
-
-
(1-aminobutyl)(1-amino-3-methylbutyl)phosphinic acid
-
-
(1-aminobutyl)(1-hydroxy-2-phenylethyl)phosphinic acid
-
-
(1-aminobutyl)[amino(phenyl)methyl]phosphinic acid
-
-
(1-aminoethyl)(1-amino-3-methylbutyl)phosphinic acid
-
-
(1-aminoethyl)(2-benzyl-3-oxo-3-phenylpropyl)phosphinic acid
-
-
(1-aminoethyl)[amino(phenyl)methyl]phosphinic acid
-
-
(1-aminoethyl)[hydroxy[4-(propan-2-yl)phenyl]methyl]phosphinic acid
-
-
(1-aminohexyl)((2-(methoxycarbonyl)benzyl)carbamothioyl)phosphinic acid
-
-
(1-aminopentyl)(1-hydroxy-2-phenylpropyl)phosphinic acid
-
-
(1-aminopentyl)(1-hydroxy-3-phenylpropyl)phosphinic acid
-
-
(1-aminopentyl)[hydroxy(4-hydroxyphenyl)methyl]phosphinic acid
-
-
(1-aminopropyl)(1-hydroxy-3-phenylpropyl)phosphinic acid
-
-
(1-benzyl-1H-imidazol-4-yl)methyl 6-oxidanyl-6-oxidanylidene-N-[(3,4,5-trimethoxyphenyl)carbonyl]-L-norleucylalaninate
-
-
(1S)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethanaminium acetate
-
IC50: 70 nM
(1S)-2-phenyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethanaminium acetate
-
IC50: 50 nM
(1S)-3-methyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butan-1-aminium acetate
-
IC50: 74 nM
(2E)-3-[(1-aminoethyl)(hydroxy)phosphoryl]-2-methylprop-2-enoic acid
-
-
(2R)-N-[5-(4-bromophenyl)-1,3,4-thiadiazol-2-yl]-2-[(benzoyl)amino]-propanamide
-
-
(2R)-N-[5-(4-bromophenyl)-1,3,4-thiadiazol-2-yl]-2-[(phenylacetyl)-amino]-propanamide
-
-
(2R)-N-[5-(4-bromophenyl)-1,3,4-thiadiazol-2-yl]-2-[(phenylsulfonyl)-amino]-propanamide
-
-
(2R)-N-[5-(4-chlorophenyl)-1,3,4-thiadiazol-2-yl]-2-[(benzoyl)amino]-propanamide
-
-
(2R)-N-[5-(4-chlorophenyl)-1,3,4-thiadiazol-2-yl]-2-[(phenylacetyl)-amino]-propanamide
-
-
(2R)-N-[5-(4-chlorophenyl)-1,3,4-thiadiazol-2-yl]-2-[(phenylsulfonyl)-amino]-propanamide
-
-
(2R)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-2-[(benzoyl)amino]-propanamide
-
-
(2R)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-2-[(phenylacetyl)-amino]-propanamide
-
-
(2R)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-2-[(phenylsulfonyl)amino]-propanamide
-
-
(2R)-N-[5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-yl]-2-[(benzoyl)amino]-propanamide
-
-
(2R)-N-[5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-yl]-2-[(phenylacetyl)-amino]-propanamide
-
-
(2R)-N-[5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-yl]-2-[(phenylsulfonyl)amino]-propanamide
-
-
(2R)-N-[5-(4-methylphenyl)-1,3,4-thiadiazol-2-yl]-2-[(benzoyl)amino]-propanamide
-
-
(2R)-N-[5-(4-methylphenyl)-1,3,4-thiadiazol-2-yl]-2-[(phenylacetyl)-amino]-propanamide
-
-
(2R)-N-[5-(4-methylphenyl)-1,3,4-thiadiazol-2-yl]-2-[(phenylsulfonyl)-amino]-propanamide
-
-
(2R)-N-[5-(4-nitrorophenyl)-1,3,4-thiadiazol-2-yl]-2-[(benzoyl)amino]-propanamide
-
-
(2R)-N-[5-(4-nitrorophenyl)-1,3,4-thiadiazol-2-yl]-2-[(phenylacetyl)-amino]-propanamide
-
-
(2R)-N-[5-(4-nitrorophenyl)-1,3,4-thiadiazol-2-yl]-2-[(phenylsulfonyl)-amino]-propanamide
-
-
(2R)-N-[5-phenyl-1,3,4-thiadiazol-2-yl]-2-[(benzoyl)-amino]-propanamide
-
-
(2R)-N-[5-phenyl-1,3,4-thiadiazol-2-yl]-2-[(phenylacetyl)amino]-propanamide
-
-
(2R)-N-[5-phenyl-1,3,4-thiadiazol-2-yl]-2-[(phenylsulfonyl)amino]-propanamide
-
-
(2S)-2-amino-N-[(3S)-1-[2-(hydroxyamino)-2-oxoethyl]-2,6-dioxopiperidin-3-yl]-3-phenylpropanamide
-
-
(2S,3R)-3-amino-2-hydroxy-4-phenyl-N-1,3-thiazol-2-ylbutanamide
-
-
(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl-L-valine
-
-
(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl-L-valyl-L-prolyl-(trans-4-hydroxy-L-proline)
-
i.e. MR387A
(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl-L-valyl-L-prolyl-L-proline
-
i.e. MR378B
(2S,3R)-3-amino-2-hydroxy-N-1H-imidazo[4,5-c]pyridin-4-yl-4-phenylbutanamide
-
-
(2S,3R)-3-amino-N-(2,6-dihydroxypyrimidin-4-yl)-2-hydroxy-4-phenylbutanamide
-
-
(2S,3R)-3-amino-N-(5-amino-1,3-thiazol-2-yl)-2-hydroxy-4-phenylbutanamide
-
-
(2S,3R)-3-amino-N-1,3-benzothiazol-2-yl-2-hydroxy-4-phenylbutanamide
-
-
(2Z)-3-amino-3,4-dihydronaphthalen-2(1H)-one O-(2-phenylethyl)oxime hydrochloride
-
-
(2Z)-3-amino-3,4-dihydronaphthalen-2(1H)-one O-(3-phenylpropyl)oxime hydrochloride
-
-
(2Z)-3-amino-3,4-dihydronaphthalen-2(1H)-one O-(4-phenylbutyl)oxime hydrochloride
-
-
(2Z)-3-amino-3,4-dihydronaphthalen-2(1H)-one O-benzyloxime hydrochloride
-
-
(2Z)-3-amino-3,4-dihydronaphthalen-2(1H)-one O-methyloxime hydrochloride
-
-
(2Z)-3-amino-3,4-dihydronaphthalen-2(1H)-one oxime hydrochloride
-
-
(3S)-3-(D-alanylamino)-2-([[(1S)-1-aminoethyl][(3r)-tricyclo[3.3.1.13,7]dec-1-yloxy]phosphoryl]methyl)-5-methylhexanoic acid
-
-
(3S)-N-hydroxy-2-(phenylsulfonyl)-6,10-dioxa-2-azaspiro[4.5]decane-3-carboxamide
-
-
(3S)-N-hydroxy-2-(phenylsulfonyl)-6,11-dioxa-2-azaspiro[4.6]undecane-3-carboxamide
-
-
(3S)-N-hydroxy-2-(phenylsulfonyl)-6,12-dioxa-2-azaspiro[4.7]dodecane-3-carboxamide
-
-
(3S)-N-hydroxy-2-[(4-methylphenyl)sulfonyl]-6,10-dioxa-2-azaspiro[4.5]decane-3-carboxamide
-
-
(3S)-N-hydroxy-2-[(4-methylphenyl)sulfonyl]-6,11-dioxa-2-azaspiro[4.6]undecane-3-carboxamide
-
-
(3S)-N-hydroxy-2-[(4-methylphenyl)sulfonyl]-6,12-dioxa-2-azaspiro[4.7]dodecane-3-carboxamide
-
-
(4R)-4-(hexanoylamino)-N-hydroxy-1-[(3,4,5-trimethoxyphenyl)carbonyl]-L-prolinamide
(4R)-4-([(2E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino)-N-hydroxy-1-[(3,4,5-trimethoxyphenyl)carbonyl]-L-prolinamide
-
IC50: 2.1 nM
(4R)-4-[[(2E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino]-N-hydroxy-1-[(3,4,5-trimethoxyphenyl)carbonyl]-L-prolinamide
-
-
(aminomethyl)(1-amino-3-methylbutyl)phosphinic acid
-
-
(aminomethyl)[amino(phenyl)methyl]phosphinic acid
-
-
(S)-2-amino-N-((S)-1-(2-(hydroxyamino)-2-oxoethyl)-2,6-dioxopiperidin-3-yl)-3-phenylpropanamide
-
displays a substantial potential inhibitory effect on APN/CD13 activity more potently than bestatin. In the concentration range of 0.0008-0.5 mM, the mean optical density of APN/CD13 activity is reduced by 30%, 53.1%, 63.1%, 68.5%, and 70.8%, respectively, for a 30 min exposure and 37.2%, 56.7%, 66.5%, 73.8%, and 76.2%, respectively, for a 60 min exposure
1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride
-
-
1,4-dihydro-3H-isochromen-3-one
-
-
1,4-dihydro-3H-isothiochromen-3-one
-
-
1-(3-amino-1,2,3,4-tetrahydronaphthalen-2-yl)ethanone hydrochloride
-
-
1-amino-2-methylpropyl(benzylcarbamoyl)phosphinic acid
-
-
1-amino-2-methylpropyl(hexylcarbamothioyl)phosphinic acid
-
-
1-amino-2-methylpropyl(isobutylcarbamothioyl)phosphinic acid
-
-
1-amino-2-methylpropyl(methylcarbamothioyl)phosphinic acid
-
-
1-amino-2-methylpropyl(phenylcarbamoyl)phosphinic acid
-
-
1-amino-3-methylbutyl(2-(methoxycarbonyl)benzylcarbamothioyl)phosphinic acid
-
-
1-amino-3-methylbutyl(benzylcarbamothioyl)phosphinic acid
-
-
1-amino-3-methylbutyl(hexylcarbamothioyl)phosphinic acid
-
-
1-amino-3-methylbutyl(methylcarbamothioyl)phosphinic acid
-
-
1-amino-3-methylbutyl(phenethylcarbamothioyl)phosphinic acid
-
-
1-amino-3-phenylpropyl(3-(methylthio)propylcarbamothioyl)phosphinic acid
-
-
1-amino-3-phenylpropyl(4-(ethoxycarbonyl)benzylcarbamothioyl)phosphinic acid
-
-
1-amino-3-phenylpropyl(4-methoxybenzylcarbamothioyl)phosphinic acid
-
-
1-amino-3-phenylpropyl(benzylcarbamothioyl)phosphinic acid
-
-
1-amino-3-phenylpropyl(propylcarbamothioyl)phosphinic acid
-
-
1-amino-4-methylpentyl(benzylcarbamoyl)phosphinic acid
-
-
1-amino-4-methylpentyl(phenylcarbamoyl)phosphinic acid
-
-
1-aminobutyl(2-(methoxycarbonyl)phenethylcarbamothioyl)phosphinic acid
-
-
1-aminobutyl(3-(methylthio)propylcarbamothioyl)phosphinic acid
-
-
1-aminobutyl(4-(ethoxycarbonyl)phenethylcarbamothioyl)phosphinic acid
-
-
1-aminobutyl(4-methoxybenzylcarbamothioyl)phosphinic acid
-
-
1-aminobutyl(4-methoxyphenethylcarbamothioyl)phosphinic acid
-
-
1-aminobutyl(benzylcarbamothioyl)phosphinic acid
-
-
1-aminobutyl(phenethylcarbamothioyl)phosphinic acid
-
-
1-aminoethyl(3-(methylthio)propylcarbamothioyl)phosphinic acid
-
-
1-aminoethyl(4-(ethoxycarbonyl)benzylcarbamothioyl)phosphinic acid
-
-
1-aminoethyl(4-methoxybenzylcarbamothioyl)phosphinic acid
-
-
1-aminoethyl(benzylcarbamothioyl)phosphinic acid
-
-
1-aminoethyl(phenethylcarbamothioyl)phosphinic acid
-
-
1-aminopentyl(2-(methoxycarbonyl)benzylcarbamothioyl)phosphinic acid
-
-
1-aminopentyl(3-(methylthio)propylcarbamothioyl)phosphinic acid
-
-
1-aminopentyl(4-methoxybenzylcarbamothioyl)phosphinic acid
-
-
1-aminopentyl(benzylcarbamothioyl)phosphinic acid
-
-
1-aminopentyl(phenethylcarbamothioyl)phosphinic acid
-
-
1-aminopropyl(3-(methylthio)propylcarbamothioyl)phosphinic acid
-
-
1-methyl cyclohexan bestatin
-
i.e. BE15, strong inhibition
2',3-dinitro-3'-methoxy-flavone-8-acetic acid
-
75% inhibition at 1 mM
2',3-dinitro-5'-methoxy-flavone-8-acetic acid
-
80% inhibition at 1 mM
2',3-dinitroflavone-8-acetic acid
2'-nitro-flavone-8-acetic acid
-
highly cytotoxic, 83% inhibition at 1 mM
2(S)-amino-5-methylpentanal
-
-
2,2'-bipyridine
-
90% inhibition at 5 mM
2,4-dihydroxy-6-phenethylbenzoic acid methyl ester
-
22.8% inhibition at 0.03 mM
2,6-dihydroxy-4-methoxydihydrochalcone
-
14.8% inhibition at 0.03 mM
2-(1-ethylcyclopentyl)ethanamine-CO-Tyr-Ile-His-Pro-Phe-OH
-
low potency inhibitor
2-([[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]amino)propaneperoxoic acid
-
-
2-amino-1,4-dihydroisoquinolin-3(2H)-one
-
-
2-amino-1,4-dihydrophenanthren-3(2H)-one hydrochloride
-
-
2-amino-2-phenylethanethiol
-
IC50: 25 nM
2-amino-3-(benzyloxy)propane-1-thiol
-
IC50: 56 nM
2-amino-3-(methylsulfanyl)propane-1-thiol
-
IC50: 20 nM
2-amino-3-(methylsulfinyl)propane-1-thiol
-
IC50: 21 nM
2-amino-3-(tert-butylsulfanyl)propane-1-thiol
-
IC50: 40 nM
2-amino-3-cyclohexylpropane-1-thiol
-
IC50: 45 nM
2-amino-3-phenylpropane-1-thiol
-
IC50: 30 nM
2-amino-4-(methylsulfanyl)butane-1-thiol
-
IC50: 11 nM
2-amino-4-(methylsulfinyl)butane-1-thiol
-
IC50: 20 nM
2-amino-4-methylpentane-1-thiol
-
IC50: 22 nM
2-hydroxy-1,4-dihydroisoquinolin-3(2H)-one
-
-
2-mercaptoethane sulfonic acid
-
80% residual activity at 10 mM
2-[[(1-amino-3-methylbutyl)(hydroxy)phosphoryl]amino]-4-methylpentanoic acid
-
-
2-[[(1-amino-3-methylbutyl)(hydroxy)phosphoryl]methyl]-4-methylpentanoic acid
-
-
2-[[(1-amino-3-phenylpropyl)(hydroxy)phosphoryl]methyl]-4-methylpentanoic acid
-
-
2-{[(1-aminoethyl)(hydroxy)phosphoryl]methyl}decanoic acid
-
-
3,3'-dinitro-4'-methoxy-flavone-8-acetic acid
-
61% inhibition at 1 mM
3,3'-dinitroflavone-8-acetic acid
-
44% inhibition at 1 mM
3,4'-dinitroflavone-8-acetic acid
-
63% inhibition at 1 mM
3,4-dihydronaphthalen-2(1H)-one
-
-
3-(hydroperoxy(hydroxy)phosphino)-1,2,3,4-tetrahydronaphthalen-2-amine
-
-
3-amino-1-(2-phenylethyl)-3,4-dihydronaphthalen-2(1H)-one hydrochloride
-
-
3-amino-1-hydroxypropan-2-one derivatives
-
-
-
3-amino-2-(2-hydroxyphenyl)-4-oxo-4H-1-benzopyran-8-acetic acid methoxymethyl ester
-
highly cytotoxic, 19% inhibition at 1 mM
3-amino-2-hydroxypropionaldehyde derivatives
-
-
-
3-amino-2-tetralone derivatives
-
-
3-amino-3,4-dihydroquinolin-2(1H)-one hydrochloride
-
-
3-amino-flavone-8-acetic acid
-
33% inhibition at 1 mM
3-amino-N-hydroxy-1,2,3,4-tetrahydronaphthalene-2-carboxamide hydrochloride
-
-
3-nitro-2'-benzyloxy-flavone-8-acetic acid
-
cytotoxic, 76% inhibition at 1 mM
3-nitro-2'-carboxybenzyl-flavone-8-acetic acid
-
cytotoxic, 77% inhibition at 1 mM
3-nitro-2'-carboxymethyl-flavone-8-acetic acid
-
slightly cytotoxic, 66% inhibition at 1 mM
3-nitro-2'-chloro-flavone-8-acetic acid
-
slightly cytotoxic, 76% inhibition at 1 mM
3-nitro-2-(2-benzyloxyphenyl)-4-oxo-4H-1-benzopyran-8-acetic acid methoxymethyl ester
-
highly cytotoxic, 32% inhibition at 1 mM
3-nitro-2-(2-nitrophenyl)-4-oxo-4H-1-benzopyran-8-acetic acid methoxymethyl ester
-
highly cytotoxic, 48% inhibition at 1 mM
3-nitro-4'-methoxy-flavone-8-acetic acid
-
cytotoxic, 64% inhibition at 1 mM
3-nitro-flavone
-
30% inhibition at 1 mM
3-nitro-flavone-8-acetaldehyde
-
cytotoxic, 51% inhibition at 1 mM
3-nitroflavone-8-acetic acid
-
68% inhibition at 1 mM
3-[(1-amino-3-methylbutyl)(hydroxy)phosphoryl]propanoic acid
-
-
3-[(1-amino-3-phenylpropyl)(hydroxy)phosphoryl]-2-(4-hydroxybenzyl)propanoic acid
-
-
3-[(1-amino-3-phenylpropyl)(hydroxy)phosphoryl]-2-benzylpropanoic acid
-
-
3-[(1-aminoethyl)(hydroxy)phosphoryl]-2-methylpropanoic acid
-
-
4-(2-(((1-aminobutyl)(hydroxy)phosphoryl)methanethioamido)ethyl)benzoic acid
-
-
4-(2-amino-3-sulfanylpropyl)phenol
-
IC50: 45 nM
5,6-dehydrokawain
-
17.7% inhibition at 0.03 mM
5,7-dihydroxy-8-geranylflavanone
-
28.9% inhibition at 0.03 mM
6-hydroxy-6-oxo-N-1,3-thiazol-2-yl-N2-[(3,4,5-trimethoxyphenyl)carbonyl]-L-norleucinamide
-
-
6-hydroxy-N-(methoxycarbonyl)-6-oxo-N2-[(3,4,5-trimethoxyphenyl)carbonyl]-L-norleucinamide
-
-
6-hydroxy-N-(methoxycarbonyl)-N-methyl-6-oxo-N2-[(3,4,5-trimethoxyphenyl)carbonyl]-L-norleucinamide
-
-
6-oxidanyl-6-oxidanylidene-N-[(3,4,5-trimethoxyphenyl)carbonyl]-L-norleucyl-N-hydroxyglycinamide
-
-
7,4'-dihydroxy-5-methoxyflavanone
-
14.4% inhibition at 0.03 mM
7-methoxy-5-hydroxy-8-geranylflavanone
-
17.0% inhibition at 0.03 mM
adhesion/signaling-inducing antibody 452
-
-
-
alpha1-amino-3-phenylpropyl(alpha2-hydroxy-3-phenylpropyl)phosphinic acid
-
very potent inhibitor of APN
alpinetin
-
36.4% inhibition at 0.03 mM
anti-CD antibody WM15
-
-
-
anti-CD13 antibody WM15
-
anti-CD13 monoclonl antibody WM15
-
antipain
-
47% inhibition at 0.1 mM
apigenin
-
26% inhibition at 0.1 mM, 42% at 0.3 mM
arphamenine A
-
42% inhibition at 0.5 mM
baicalein
-
42% inhibition at 0.3 mM
benzo[c]phenanthridine derivatives
-
natural inhibitors
-
beta-amino-alpha-hydroxyphenylbutanoic acid
-
i.e. AHPA, or AHPA-VAl, natural inhibitor isolated from Streptomyces neyagawaensis strain SL-387, IC50: 0.0012-0.0056 mM
bis(1-amino-3-methylbutyl)phosphinic acid
-
-
bis(1-amino-3-phenylpropyl)phosphinic acid
-
-
bis[amino(phenyl)methyl]phosphinic acid
-
-
cardamonin
-
37.2% inhibition at 0.03 mM
Cd2+
-
98% inhibition at 1 mM
chymostatin
-
72% inhibition at 0.1 mM
coronavirus infection inhibitor Y2-K
-
-
-
Cu2+
-
96% inhibition at 1 mM
cyclohexylmethyl N-[(2S)-3-amino-2-hydroxy-4-phenylbutanoyl]-L-leucinate
-
-
D-Arg-L-Lys-[Hyp3, CpG5, D-Tic7, CpG8]des-Arg9-bradykinin
-
competitive to L-Ala-4-nitroanilide, additionally inhibitory to kinin B1 receptor
EC27
-
selective APN inhibitor
epsilon-amino-n-caproic acid
-
70% inhibition at 100 mM
ethyl D-cysteinate
-
strong, competitive inhibition, IC50: 350 nM
flavone
-
5% inhibition at 1 mM
flavone-8-acetic acid
-
30% inhibition at 1 mM
flavone-8-acetic acid derivatives
-
-
-
geraniol
-
7.6% inhibition at 0.03 mM
geranyl-2,4-dihydroxy-6-phenylbenzoate
-
89.4% inhibition at 0.03 mM
glycyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-cysteinamide hydrochloride
-
-
glycyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-leucinamide hydrochloride
-
-
H-(R)-beta2-homo-Val-Tyr-Ile-His-Pro-beta3-homo-Phe-OH
-
low potency inhibitor
H-(R)-beta2-homo-Val-Tyr-Ile-His-Pro-Phe-OH
-
low potency inhibitor
H-(S)-beta2-homo-Val-Tyr-Ile-His-Pro-Phe-OH
-
low potency inhibitor
H-beta2-homo-Leu-Tyr-Ile-His-Pro-beta3-homo-Phe-OH
-
low potency inhibitor
H-beta2-homo-Nle-Tyr-Ile-His-Pro-Phe-OH
-
low potency inhibitor
H-beta3-homo-Val-Tyr-Ile-His-Pro-Phe-OH
-
low potency inhibitor
H-Val-beta2-homo-Tyr-Ile-His-Pro-Phe-OH
-
low potency inhibitor
H-Val-beta3-homo-Tyr-Ile-His-Pro-Phe-OH
-
low potency inhibitor
H-Val-Tyr-beta2-homo-Leu-His-Pro-Phe-OH
-
low potency inhibitor
H-Val-Tyr-beta3-homo-Ile-His-Pro-Phe-OH
-
low potency inhibitor
H-Val-Tyr-Ile-beta3-homo-His-Pro-Phe-OH
-
low potency inhibitor
H-Val-Tyr-Ile-His-(R)-beta2-homo-Pro-Phe-OH
-
low potency inhibitor
H-Val-Tyr-Ile-His-beta3-homo-Pro-Phe-OH
-
low potency inhibitor
H-Val-Tyr-Ile-His-Pro-beta2-homo-Pro-Phe-OH
-
low potency inhibitor
H-Val-Tyr-Ile-His-Pro-beta3-homo-Phe-OH
-
low potency inhibitor
H-Val-Tyr-Ile-His-Pro-Phe-OH
-
low potency inhibitor
Hg2+
-
71% inhibition at 1 mM
iodoacetamide
-
IC50: 0.098 mM, kidney enzyme
kaempferol
-
13.7% inhibition at 0.03 mM
kaempferol 3-O-beta -D-glucopyranosyl-(1-'4)-a -L-rhamnopyranosyl-7-O-alpha -L-rhamnopyranoside
-
13.8% inhibition at 0.03 mM
kaempferol 3-O-beta-D-(3''-acetylglucopyranosyl)-7-O-alpha-L-2'''-O-[(S)-2-methylbutanoyl]rhamnopyranoside
-
16.4% inhibition at 0.03 mM
kaempferol 3-O-beta-D-(3''-O-acetylglucopyranocyl)-7-O-alpha-L-3'''-O-[(S)-2-methylbutanoyl]rhamnopyranoside
-
23.7% inhibition at 0.03 mM
kaempferol 3-O-beta-D-(3''-O-acetylglucopyranosyl)-7-O-alpha-L-(2'''-O-isobutyryl)rhamnopyranoside
-
21.7% inhibition at 0.03 mM
kaempferol 3-O-beta-D-glucopyranoside
-
31.7% inhibition at 0.03 mM
kaempferol 3-O-beta-D-glucopyranosyl-7-O-(3''-O-isobutyryl)rhamnopyranoside
-
26.9% inhibition at 0.03 mM
kaempferol 3-O-beta-D-glucopyranosyl-7-O-alpha-L-rhamnopyranoside
-
19.1% inhibition at 0.03 mM
kaempferol 7-O-alpha-L-rhamnopyranoside
-
12.5% inhibition at 0.03 mM
L-Ala
-
at micromolar concentrations
L-alanyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-leucinamide hydrochloride
-
-
L-Arg
-
at micromolar concentrations
L-cysteinyl-N-[(2R)-2-amino-3-phenylpropyl]-L-phenylalaninamide hydrochloride
-
-
L-cysteinyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-cysteinamide hydrochloride
-
-
L-Glu
-
at micromolar concentrations
L-iso-glutamine inhibitors
-
diverse derivatives, IC50 of 0.016-0.053 mM
-
L-isoleucyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-cysteinamide hydrochloride
-
-
L-isoleucyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-leucinamide hydrochloride
-
-
L-isoleucyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-phenylalaninamide hydrochloride
-
-
L-leucyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-leucinamide hydrochloride
-
-
L-leucyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-phenylalaninamide hydrochloride
-
-
L-leucyl-N1-[(2R)-2-amino-3-phenylpropyl]-Lcysteinamide hydrochloride
-
-
L-Lys-L-Lys-[Hyp3, CpG5, D-Tic7, CpG8]des-Arg9-bradykinin
-
competitive to L-Ala-4-nitroanilide
L-lysyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-cysteinamide hydrochloride
-
-
L-lysyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-phenylalaninamide hydrochloride
-
-
L-Met
-
at micromolar concentrations
L-methionyl-N-[(2R)-2-amino-3-phenylpropyl]-L-phenylalaninamide hydrochloride
-
-
L-methionyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-cysteinamide hydrochloride
-
-
L-methionyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-leucinamide hydrochloride
-
-
L-ornithyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-cysteinamide hydrochloride
-
-
L-phenylalanyl-N-[(2R)-2-amino-3-phenylpropyl]-L-phenylalaninamide
-
-
L-phenylalanyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-cysteinamide hydrochloride
-
-
L-tyrosyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-leucinamide hydrochloride
-
-
L-Val-L-Tyr-L-Ile-2-aminomethylphenylacetic acid
-
inhibits both IRAP, EC 3.4.11.2, and aminopeptidase N and induces proliferation of stem cells at low concentrations
L-valyl-N-[(2R)-2-amino-3-phenylpropyl]-L-phenylalaninamide hydrochloride
-
-
L-valyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-cysteinamide hydrochloride
-
-
Leu
-
at micromolar concentrations
leupeptin
-
24% inhibition at 0.1 mM
luteolin
-
60.2% inhibition at 0.03 mM
Methicillin
-
Ki: 4.61 mM
methyl (2S)-1-(methylsulfonyl)-4-oxopyrrolidine-2-carboxylate
-
-
methyl (2S)-1-[(4-methylphenyl)sulfonyl]-4-oxopyrrolidine-2-carboxylate
-
-
methyl (2S)-4-oxo-1-(phenylsulfonyl)pyrrolidine-2-carboxylate
-
-
methyl (2S,4R)-4-hydroxy-1-(methylsulfonyl)pyrrolidine-2-carboxylate
-
-
methyl (2S,4R)-4-hydroxy-1-(phenylsulfonyl)pyrrolidine-2-carboxylate
-
-
methyl (2S,4R)-4-hydroxy-1-[(4-methylphenyl)sulfonyl]pyrrolidine-2-carboxylate
-
-
methyl (4R)-4-([(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]amino)-1-[(3,4,5-trimethoxyphenyl)carbonyl]-L-prolinate
-
IC50: 0.9 nM
methyl (4R)-4-[[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]amino]-1-[(3,4,5-trimethoxyphenyl)carbonyl]-L-prolinate
-
-
methyl 2-([[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]amino)-4-(methylperoxy)-4-oxobutanoate
-
-
methyl 2-chloro-N-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]alaninate
-
-
methyl 6-oxidanyl-6-oxidanylidene-N-[(3,4,5-trimethoxyphenyl)carbonyl]-L-norleucyl-(4R)-4-(benzyloxy)prolinate
-
-
methyl 6-oxidanyl-6-oxidanylidene-N-[(3,4,5-trimethoxyphenyl)carbonyl]-L-norleucyl-L-methioninate
-
-
methyl 6-oxidanyl-6-oxidanylidene-N-[(3,4,5-trimethoxyphenyl)carbonyl]-L-norleucylserinate
-
-
methyl N-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]-D-phenylalaninate
-
-
methyl N-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]-L-phenylalaninate
-
-
methyl N-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]cysteinate
-
-
methyl N-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]glycinate
-
-
methyl N-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]histidinate
-
-
methyl N-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]isoleucinate
-
-
methyl N-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]leucinate
-
-
methyl N-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]methioninate
-
-
methyl N-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]threoninate
-
-
methyl N-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]tryptophanate
-
-
methyl N-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]tyrosinate
-
-
methyl N-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]valinate
-
-
methyl N2-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]-N5-(nitrocarbamimidoyl)ornithinate
-
-
methyl N2-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]lysinate
-
-
methyl [(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetate
-
-
Mg2+
-
not inhibitory at 1 mM
multiflorin B
-
32.8% inhibition at 0.03 mM
multinoside A
-
15.3% inhibition at 0.03 mM
myricetin
-
48% inhibition at 0.3 mm
N-(4-aminophenyl)-6-hydroxy-6-oxo-N2-[(3,4,5-trimethoxyphenyl)carbonyl]-L-norleucinamide
-
-
N-(4-chlorophenyl)-6-hydroxy-6-oxo-N2-[(3,4,5-trimethoxyphenyl)carbonyl]-L-norleucinamide
-
-
N-hydroxy-2-(2-methylpropyl)-N'-(4-phenylbutyl)propanediamide
-
-
N-hydroxy-2-(naphthalen-2-ylsulfanyl)-acetamide
-
-
N-hydroxy-2-(naphthalene-2-ylsulfanyl)acetamide
-
-
N-[(2S)-2-(([(1R)-1-amino-2-phenylethyl](hydroxy)phosphoryl)methyl)-4-methylpentanoyl]-L-phenylalanine
-
IC50: 2.3 nM
N-[(2S)-3-([(1R)-1-amino-2-phenylethyl](hydroxy)phosphoryl)-2-(biphenyl-4-ylmethyl)propanoyl]-L-alanine
-
IC50: 5.3 nM
N-[(2S)-3-([(1R)-1-amino-2-phenylethyl](hydroxy)phosphoryl)-2-benzylpropanoyl]phenylalanine
-
IC50: 1.5 nM
N-[(2S)-3-([(1R)-1-aminoethyl](hydroxy)phosphoryl)-2-(4-bromobenzyl)propanoyl]-L-alanine
-
IC50: 1.9 nM
N-[(2S)-3-([(1R)-1-aminoethyl](hydroxy)phosphoryl)-2-(biphenyl-4-ylmethyl)propanoyl]alanine
-
IC50: 2.9 nM
N-[(2S)-3-([(R)-amino(phenyl)methyl](hydroxy)phosphoryl)-2-(biphenyl-4-ylmethyl)propanoyl]-L-alanine
-
IC50: 4.8 nM
N-[(2S)-3-([(R)-amino(phenyl)methyl](hydroxy)phosphoryl)-2-(biphenyl-4-ylmethyl)propanoyl]-L-serine
-
IC50: 4.9 nM
N-[(2S)-3-([(R)-amino(phenyl)methyl](hydroxy)phosphoryl)-2-(biphenyl-4-ylmethyl)propanoyl]-L-threonine
-
IC50: 10.2 nM
N-[(2S)-3-([(R)-amino(phenyl)methyl](hydroxy)phosphoryl)-2-(biphenyl-4-ylmethyl)propanoyl]glycine
-
IC50: 32.8 nM
N-[(2S)-3-([(R)-amino(phenyl)methyl](hydroxy)phosphoryl)-2-benzylpropanoyl]-L-phenylalanine
-
IC50: 4.2 nM
N-[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]benzamide
-
-
N-[(3S)-1-[2-(hydroxyamino)-2-oxoethyl]-2,6-dioxopiperidin-3-yl]-3,4,5-trimethoxybenzamide
-
-
N1-[(2R)-2-amino-3-phenylpropyl]-N-(2,4-dichlorobenzoyl)-L-cysteinamide hydrochloride
-
-
N1-[(2R)-2-amino-3-phenylpropyl]-N-(2,4-dichlorobenzoyl)-L-phenylalaninamide hydrochloride
-
-
N1-[(2R)-2-amino-3-phenylpropyl]-N-(3,5-dinitrobenzoyl)-L-phenylalaninamide hydrochloride
-
-
N1-[(2R)-2-amino-3-phenylpropyl]-N-(3-phenylpropanoyl)-L-phenylalaninamide hydrochloride
-
-
N1-[(2R)-2-amino-3-phenylpropyl]-N-(4-chlorobutanoyl)-L-phenylalaninamide hydrochloride
-
-
N1-[(2R)-2-amino-3-phenylpropyl]-N-(4-methoxybenzoyl)-L-phenylalaninamide hydrochloride
-
-
N1-[(2R)-2-amino-3-phenylpropyl]-N-(4-nitrobenzoyl)-Lphenylalaninamide hydrochloride
-
-
N1-[(2R)-2-amino-3-phenylpropyl]-N-(6-aminohexanoyl)-L-cysteinamide hydrochloride
-
-
N1-[(2R)-2-amino-3-phenylpropyl]-N-(6-aminohexanoyl)-L-leucinamide hydrochloride
-
-
N1-[(2R)-2-amino-3-phenylpropyl]-N-(6-aminohexanoyl)-L-phenylalaninamide hydrochloride
-
-
N6-[(benzyloxy)carbonyl]-N-hydroxy-N2-(pyrazin-2-ylcarbonyl)-L-lysinamide
-
-
N6-[(benzyloxy)carbonyl]-N-hydroxy-N2-(pyridin-3-ylcarbonyl)-L-lysinamide
-
-
N6-[(benzyloxy)carbonyl]-N-hydroxy-N2-[(2E)-3-phenylprop-2-enoyl]-L-lysinamide
-
-
N6-[(benzyloxy)carbonyl]-N-hydroxy-N2-[(3-nitrophenyl)carbonyl]-L-lysinamide
-
-
N6-[(benzyloxy)carbonyl]-N2-(pyrazin-2-ylcarbonyl)-L-lysine
-
-
N6-[(benzyloxy)carbonyl]-N2-(pyridin-3-ylcarbonyl)-L-lysine
-
-
N6-[(benzyloxy)carbonyl]-N2-[(2,4-dichlorophenyl)carbonyl]-L-lysine
-
-
N6-[(benzyloxy)carbonyl]-N2-[(2,4-dichlorophenyl)carbonyl]-N-hydroxy-L-lysinamide
-
-
N6-[(benzyloxy)carbonyl]-N2-[(2E)-3-phenylprop-2-enoyl]-L-lysine
-
-
N6-[(benzyloxy)carbonyl]-N2-[(3-nitrophenyl)carbonyl]-L-lysine
-
-
N6-[(benzyloxy)carbonyl]-N2-[(4-bromophenyl)carbonyl]-L-lysine
-
-
N6-[(benzyloxy)carbonyl]-N2-[(4-bromophenyl)carbonyl]-N-hydroxy-L-lysinamide
-
-
pinocembrin
-
13.3% inhibition at 0.03 mM
pinostrobin
-
10.5% inhibition at 0.03 mM
PMSF
-
4.5% inhibition at 1 mM
Pro
-
at micromolar concentrations
pseudoglutamyl aminophosphinic peptides
-
-
-
quercetin
-
18.1% inhibition at 0.03 mM
quercetin 3-O-beta-D-glucopyranosyl-7-O-alpha-L-3'''-O-[(2S)-2-methylbutanoyl]-rhamnopyranoside
-
36.2% inhibition at 0.03 mM
quercetin 3-O-glucoside
-
41.8% inhibition at 0.03 mM
quercetin-3-O-beta-D-glucopyranosyl-7-O-alpha-L-rhamnopyranoside
-
12.6% inhibition at 0.03 mM
RB3014
-
IC50: 0.000025 mM, kidney enzyme
S-carboxymethyl-L-cysteine
-
33% residual activity at 10 mM
S-carboxymethyl-L-cysteinyl-glycine
-
57% residual activity at 10 mM
S-carboxymethyl-L-glutathione
-
75% residual activity at 10 mM
sinocrassoside A1
-
31.4% inhibition at 0.03 mM
sinocrassoside A10
-
28.7% inhibition at 0.03 mM
sinocrassoside A2
-
35.7% inhibition at 0.03 mM
sinocrassoside A4
-
26.9% inhibition at 0.03 mM
sinocrassoside A5
-
21.7% inhibition at 0.03 mM
sinocrassoside A6
-
16.4% inhibition at 0.03 mM
sinocrassoside A7
-
23.7% inhibition at 0.03 mM
sinocrassoside A9
-
19.9% inhibition at 0.03 mM
sinocrassoside B1
-
33.9% inhibition at 0.03 mM
sinocrassoside B2
-
39.4% inhibition at 0.03 mM
sinocrassoside B3
-
36.2% inhibition at 0.03 mM
sinocrassoside B4
-
32.1% inhibition at 0.03 mM
sinocrassoside B5
-
28.3% inhibition at 0.03 mM
sinocrassoside C1
-
12.4% inhibition at 0.03 mM
sinocrassoside D1
-
35.1% inhibition at 0.03 mM
sinocrassoside D3
-
23.2% inhibition at 0.03 mM
tert-butyl bestatin
-
i.e. BE17, the BE15 derivative has a dual inhibitory effect on invasion and motility on tumor and endothelial cells
tert-butyl N-[(2S)-3-amino-2-hydroxy-4-phenylbutanoyl]-L-leucinate
-
-
tryptophan
-
63% inhibition at 5 mM
tyrosine
-
59% inhibition at 2.25 mM
[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetic acid
-
-
[1-amino-3-(4-hydroxyphenyl)propyl]phosphonic acid
-
-
[3-nitro-2-(2-nitrophenyl)-4-oxo-4H-chromen-8-yl]acetic acid
-
IC50: 0.025 mM
[amino(cyclobutyl)methyl]phosphonic acid
-
-
[amino(cyclohexyl)methyl]phosphonic acid
-
-
[amino(cyclopropyl)methyl]phosphonic acid
-
-
[amino(phenyl)methyl](1-amino-3-phenylpropyl)phosphinic acid
-
-
[amino(phenyl)methyl](1-hydroxy-3-methylbutyl)phosphinic acid
-
-
[amino(phenyl)methyl](1-hydroxy-3-phenylpropyl)phosphinic acid
-
-
[amino(phenyl)methyl](1-hydroxyethyl)phosphinic acid
-
-
[amino(phenyl)methyl](1-hydroxypentyl)phosphinic acid
-
-
[amino(phenyl)methyl][hydroxy(phenyl)methyl]phosphinic acid
-
-
[amino[4-(1-methylethyl)phenyl]methyl]phosphonic acid
-
-
[[(1-amino-3-methylbutyl)(hydroxy)phosphoryl]amino]acetic acid
-
-
(4R)-4-(hexanoylamino)-N-hydroxy-1-[(3,4,5-trimethoxyphenyl)carbonyl]-L-prolinamide
-
-
(4R)-4-(hexanoylamino)-N-hydroxy-1-[(3,4,5-trimethoxyphenyl)carbonyl]-L-prolinamide
-
IC50: 7.7 nM
1,10-phenanthroline
-
-
1,10-phenanthroline
-
99% inhibition at 0.4 mM, Ki: 0.067 mM
1,10-phenanthroline
-
100% inhibition at 1 mM
1,10-phenanthroline
-
92.5% inhibition at 1 mM
2',3-dinitroflavone-8-acetic acid
-
-
2',3-dinitroflavone-8-acetic acid
-
reversible, competitive, selective, potent, and noncytotoxic inhibitor, 88% inhibition at 1 mM
8-hydroxyquinoline
-
-
8-hydroxyquinoline
-
91% inhibition at 3 mM
actinonin
-
-
actinonin
-
100% inhibition at 0.1 mM
actinonin
-
IC50 is 0.0031 mM
actinonin
-
competitive, moderate inhibition of keratinocyte growth
actinonin
-
IC50: 0.000075 mM, kidney enzyme
actinonin
-
natural competitive inhibitor, IC50: 0.0002 mM
actinonin
-
synthetic inhibitor, complete inhibition of plasma enzyme at 0.1 mM
actinonin
-
inhibition results in supppressed proliferation, enhanced terminal differentiation, and slightly decreased total neutral lipid production in sebocytes. In presence of inhibitor, cytokine IL-1 receptor antagonist is significantly upregulated and inhibitor suppresses proliferation and cytokine IL-2 production in Propionibacterium acnes-stimulated T-cells
actinonin
-
actinonin, an inhibitor of aminopeptidase N, may modulate chemokine secretion in the lung and thus attenuate the development of lung fibrosis
amastatin
-
-
amastatin
-
100% inhibition at 0.1 mM
amastatin
-
competitive, isolated from Streptomyces sp. strain ME98-M3, modulates blood pressure
amastatin
-
inhibits the enzyme and blocks the metabolism of brain angiotensin II and III
amastatin
-
natural competitive inhibitor from Streptomyces sp.
angiotensin IV
-
-
angiotensin IV
-
low potency inhibitor
anti-CD13 antibody WM15
-
-
-
anti-CD13 antibody WM15
-
enzyme blocking, commercial preparation
-
anti-CD13 monoclonl antibody WM15
-
-
-
anti-CD13 monoclonl antibody WM15
-
inhibits enzyme activity, but not chemotactic activity
-
bestatin
-
-
bestatin
-
96% inhibition at 0.1 mM
bestatin
-
73% inhibition at 0.005 mM
bestatin
-
strong inhibition, cytotoxic, 85% inhibition at 1 mM
bestatin
-
83.7% inhibition at 1 mM
bestatin
-
acts as an anti-tumor agent in lung squamous cell carcinoma cells and prolonged survival time of patients with completely resected stage I lung squamous cell carcinoma
bestatin
-
competitive, low inhibition of keratinocyte growth
bestatin
-
competitive, slow-binding inhibitor, from Streptomyces olivoreticuli strain MD976-C7, modulates cell growth and maturation, overview
bestatin
-
IC50 is 0.01 mM
bestatin
-
inhibits enzyme activity and cell growth, e.g. of leukocytes, overview, IC50: 0.0004 mM, kidney enzyme
bestatin
-
inhibits enzyme expression and activity
bestatin
-
inhibits the enzyme and blocks the metabolism of brain angiotensin II and III
bestatin
-
narural competitive inhibitor, inhibits enzyme activity, but not chemotactic activity, IC50: 0.007-0.0169 mM
bestatin
-
inhibition results in supppressed proliferation, enhanced terminal differentiation, and slightly decreased total neutral lipid production in sebocytes. In presence of inhibitor, cytokine IL-1 receptor antagonist is significantly upregulated and inhibitor suppresses proliferation and cytokine IL-2 production in Propionibacterium acnes-stimulated T-cells
bestatin
-
i.e. N-[(2S,3R)-3-amino-2-hydroxy-4-phenylbutyryl]-L-leucine
bestatin
-
i.e. [(2S, 3R)-3-amino-2-hydroxy-4-phenylbutanoyl]-L-leucine hydroxide, slow binding inhibitor of APN
bestatin
-
i.e. [2S, 3R]-3-amino-2-hydroxy-(4-phenylbutanoyl)-L-leucine
betulinic acid
-
-
betulinic acid
-
natural inhibitor isolated from birch tree, IC50: 0.0073 mM, a selectively apoptosis-inducing agent, overview
betulinic acid
-
pentycyclic compound, from Betula sp. and other sources, overview, modulates cell growth and maturation, overview
bradykinin
-
-
bradykinin
-
inhibition is enhanced by substance P
bradykinin
-
bradykinin is resistant to hydrolysis by CD13, acting rather as a natural inhibitor
Co2+
-
-
Co2+
-
40% inhibition at 1 mM
curcumin
-
-
curcumin
-
from Curcuma longa rhizome, inhibits the enzyme and the initiation of carcinogenesis, overview, modulates cell growth and maturation, overview
curcumin
-
natural inhibitor isolated from Curcuma longa, non-toxic, inhibits also tumor cell invasion and carcinogenesis in several organs, overview
curcumin
-
31.9% inhibition at 0.03 mM
EDTA
-
-
EDTA
-
14% inhibition at 1 mM
EDTA
-
42% inhibition at 2 mM
EDTA
-
35.5% inhibition at 5 mM
lapstatin
-
-
lapstatin
-
natural competitive inhibitor from Streptomyces sp., IC50: 0.0005 mM
leuhistin
-
-
leuhistin
-
100% inhibition at 0.1 mM
leuhistin
-
from Bacillus letraosporus strain BM156-14F1, competitive, modulates cell growth and maturation, overview
leuhistin
-
natural inhibitor isolated from Bacilus laterosporus strain BMI156-14F1, strong, competitive inhibition
methionine
-
-
methionine
-
79% inhibition at 5 mM
Mn2+
-
-
Mn2+
-
16% inhibition at 1 mM
PAQ-22
-
-
PAQ-22
-
IC50: 0.00029 mM, kidney enzyme
PC18
-
-
PC18
-
selective APN inhibitor
phebestin
-
-
phebestin
-
frpm Streptomyces sp. strain MJ716-m3
phebestin
-
IC50: 0.000015 mM, kidney enzyme
phebestin
-
natural competitive inhibitor from Streptomyces sp.
phenylalanine
-
79% inhibition at 5 mM
phenylalanine
-
Ki: 0.67 mM
probestin
-
-
probestin
-
from Streptomyces azureus strain MH663-2F6, competitive, modulates cell growth and maturation, overview
probestin
-
IC50: 0.000016 mM, kidney enzyme
probestin
-
natural competitive inhibitor from Streptomyces sp., IC50: 0.00005 mM
psammaplin A
-
from Psammaplysilla sp., Dysidea sp., and Throrectopsamma xana, non-competitive, modulates cell growth and maturation, overview
psammaplin A
-
natural inhibitor isolated from a marine sponge, non-competitive, highly cytotoxic, IC50: 0.007-0.018 mM, overview
puromycin
-
-
puromycin
-
Ki: 0.0125 mM
puromycin
-
67% inhibition at 0.1 mM
puromycin
-
93% inhibition at 1 mM
puromycin
-
78.1% inhibition at 0.05 mM
puromycin
-
IC50: 0.0031 mM, kidney enzyme
puromycin
-
natural inhibitor
Substance P
-
-
Substance P
-
competitive, high inhibition of keratinocyte growth
ubenimex
-
-
Zn2+
-
-
Zn2+
-
96% inhibition at 1 mM
additional information
-
-
-
additional information
-
enzyme inhibitors can act as anti-hypertensive drugs
-
additional information
-
enzyme inhibitors: chemistry, biological evaluations, and therapeutic prospects, behaviour in clinical trials, overview
-
additional information
-
inhibition by a CD13 blocking antibody, no inhibition by pepstatin, leupeptin, or aprotinin alone or in combination
-
additional information
-
inhibitor binding site and mechanism, the enzyme is also inhibited by hydroxamate, carboxylate, sulfhydryl, and sulfodiimide derivatives of phosphoric acid, by beta-amino-thiol reagents, and alpha-aminophosphonates, overview
-
additional information
-
inhibitory potency of bestatin and derivatives on enzyme activity, umbilical vein endothelial cell vessel formation, and cell invasion and migration, overview
-
additional information
-
no inhibition by pepstatin, phosphoramidon, and aprotinin
-
additional information
-
structural features of natural peptide hormone inhibitors, overview
-
additional information
-
the enzyme expression is down-regulated during homotypic aggregation, while the enzyme induced the homotypic aggregation, overview, CD13-mediated homotypic aggregation is inhibited by several MAP kinase inhibitors, e.g. herbimycin, phosphatidylinositol-3-kinase inhibitor LY294002, MEK1 inhibitor PD98059, p38 inhibitor SB203580, genistein, and, to a lesser extent, Ro-31-8220 and bisindolylmaleimide I, which are inhibitors of protein kinase C
-
additional information
-
inhibitory potency in decreasing order: angiotensin IV, angiotensin III, divalinal/angiotensin IV, LVV-hemorphin 7, angiotensin 4-8, angiotensin III
-
additional information
-
not inhibited by PAQ-22
-
additional information
-
not inhibited by trans-(3S,5R,6R,9S)-megastigman-7-ene-3,5,6,9-tetraol 3-O-glucoside and trans-(3S,5R,6R,9S)-megastigman-7-ene-3,5,6,9-tetraol 9-O-glucoside
-
additional information
-
the neuropeptide substance P inhibits enkephalin cleavage by CD13
-
additional information
-
there is a significant reduction of APN mRNA and protein expression, as well as enzymatic activity, in high-grade meningiomas
-
additional information
-
Tie-2 antisense (but not Tie-2 sense) treatment significantly reduces CD13 expression and abolishes angiopoieting-1-induced CD13 expression in pericytes
-
additional information
-
neither BNP7787 (i.e. disodium 2,2'-dithio-bis-ethane sulfonate, also named dimesna or Tavocept) nor S-carboxymethyl-L-cysteinyl-glutamate, nor NaCl inhibit human APN
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Acidosis
Altered intestinal and renal brush border amino-oligopeptidase structure in diabetes and metabolic acidosis: normal and biobreed (BB) rats.
Acne Vulgaris
Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation.
Acquired Immunodeficiency Syndrome
Prenatal diagnosis of cystic fibrosis by assay of amniotic fluid microvillar enzymes.
Acquired Immunodeficiency Syndrome
Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap.
Acute Kidney Injury
Differentiation of acute renal failure and chronic renal failure by 2-dimensional analysis of urinary dipeptidase versus serum creatinine.
Acute Kidney Injury
Nitric oxide inhibits the shedding of the glycosylphosphatidylinositol-anchored dipeptidase from porcine renal proximal tubules.
Acute Kidney Injury
Specimen collection time for enzyme analysis in urine.
Acute Kidney Injury
Urine proteomic analysis reveals alterations in heme/hemoglobin and aminopeptidase metabolism during Lonomia obliqua venom-induced acute kidney injury.
Acute Kidney Injury
[Experimental studies on the elevation of urinary enzyme activities and its pathogenesis in acute renal failure]
Adenocarcinoma
ACO2 and ANPEP as novel prognostic markers for gallbladder squamous cell/adenosquamous carcinomas and adenocarcinomas.
Adenocarcinoma
Enzyme activity and distribution in rat prostatic adenocarcinoma.
Adenocarcinoma
Expression and clinical significance of aminopeptidase N/CD13 in non-small cell lung cancer.
Adenocarcinoma
Intestinal differentiation and p53 gene alterations in Barrett's esophagus and esophageal adenocarcinoma.
Adenocarcinoma
Kininase I, kininase II and aminopeptidase levels in patients with gastrointestinal tumors.
Adenocarcinoma of Lung
Expression and clinical significance of aminopeptidase N/CD13 in non-small cell lung cancer.
Adenocarcinoma, Follicular
Decrease in Dipeptidyl Peptidase IV Activity is Linked to the Efficacy of Differentiating Compounds in Follicular Thyroid Carcinoma Cell Lines.
Adenoma
Brush border hydrolases in normal and neoplastic colonic epithelium.
Adenoma, Bile Duct
[Usefulness of carbohydrate antigen 19-9 (CA19-9) for the diagnosis of cholangioma. As a role of screening patients with the elevation of serum alkaline phosphatase, leucine aminopeptidase and/or gamma-glutamyl transpeptidase]
Adenomatous Polyposis Coli
Advances in the study of Lynch syndrome in China.
Adenomyosis
Expression of aminopeptidase N and neutral endopeptidase on the endometrial stromal cells in endometriosis and adenomyosis.
Albuminuria
The zinc fingers and homeoboxes 2 protein ZHX2 and its interacting proteins regulate upstream pathways in podocyte diseases.
Albuminuria
Urinary aminopeptidase activities as early and predictive biomarkers of renal dysfunction in cisplatin-treated rats.
Alveolitis, Extrinsic Allergic
The significance of cathepsins, thrombin and aminopeptidase in diffuse interstitial lung diseases.
Alzheimer Disease
Alanyl-aminopeptidase activity decrease in cerebrospinal fluid of Alzheimer patients.
Alzheimer Disease
Comparison of aminopeptidase, dipeptidyl aminopeptidase and tripeptidyl aminopeptidase activities in brain tissue from normal and Alzheimer's disease cases.
Alzheimer Disease
Comparison of major cortical aminopeptidase activity in normal brain and brain from patients with Alzheimer's disease.
Alzheimer Disease
Demonstration of puromycin-sensitive alanyl aminopeptidase in Alzheimer disease brain.
Alzheimer Disease
Insights into the molecular interactions between aminopeptidase and amyloid beta peptide using molecular modeling techniques.
Alzheimer Disease
Plasma renin-angiotensin system-regulating aminopeptidase activities are modified in early stage Alzheimer's disease and show gender differences but are not related to apolipoprotein E genotype.
Alzheimer Disease
Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease.
Alzheimer Disease
Reduction of plasma glutamyl aminopeptidase activity in sporadic Alzheimer's disease.
Anaphylaxis
Characterization of slow reacting substances (SRSs) of rat basophilic leukemia (RBL-1) cells: effect of cysteine on SRS profile.
Anaphylaxis
[Determination of the dipeptidase and tripeptidase activity in anaphylactoid shock.]
Arthritis
Expression of aminopeptidase N/CD13 in tumour-infiltrating lymphocytes from human renal cell carcinoma.
Arthritis
Neutral aminopeptidase and dipeptidyl peptidase IV in the development of collagen II-induced arthritis.
Arthritis
Review: Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice.
Arthritis
Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice.
Arthritis, Rheumatoid
Basic aminopeptidase activity is an emerging biomarker in collagen-induced rheumatoid arthritis.
Arthritis, Rheumatoid
CD13/aminopeptidase N in collagen vascular diseases.
Arthritis, Rheumatoid
Diagnostic value of brush border enzymes of the proximal renal tubules in rheumatoid arthritis.
Arthritis, Rheumatoid
Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes.
Arthritis, Rheumatoid
Expression and function of aminopeptidase N/CD13 produced by fibroblast-like synoviocytes in rheumatoid arthritis: role of CD13 in chemotaxis of cytokine-activated T cells independent of enzymatic activity.
Arthritis, Rheumatoid
Localization, Shedding, Regulation and Function of Aminopeptidase N/CD13 on Fibroblast like Synoviocytes.
Arthritis, Rheumatoid
Review: Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice.
Arthritis, Rheumatoid
Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice.
Asthenozoospermia
Enkephalin-degrading enzymes in normal and subfertile human semen.
Asthma
Comparative Study of SARS-CoV-2, SARS-CoV-1, MERS-CoV, HCoV-229E and Influenza Host Gene Expression in Asthma: Importance of Sex, Disease Severity, and Epithelial Heterogeneity.
Asthma
Dexamethasone accelerates catabolism of leukotriene C4 in bronchial epithelial cells.
Asthma
Streptococcus pneumoniae aminopeptidase N regulates dendritic cells that attenuates type-2 airway inflammation in murine allergic asthma.
Astrocytoma
Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies.
Astrocytoma
Differential Effects of Doxazosin on Renin-Angiotensin-System-Regulating Aminopeptidase Activities in Neuroblastoma and Glioma Tumoral Cells.
Atherosclerosis
Effect of BuShen JiangZhi Recipe on Atherosclerosis in ApoE-/- Mice by Regulating the Expression of Anpep via mmu_circRNA_22187.
Atrial Fibrillation
Long-range regulatory interactions at the 4q25 atrial fibrillation risk locus involve PITX2c and ENPEP.
Autoimmune Diseases
Modulation of Natural HLA-B*27:05 Ligandome by Ankylosing Spondylitis-associated Endoplasmic Reticulum Aminopeptidase 2 (ERAP2).
Autoimmune Diseases
Review: Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice.
Autoimmune Diseases
Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice.
Autoimmune Diseases
The Role of Dipeptidyl Peptidase 4 as a Therapeutic Target and Serum Biomarker in Inflammatory Bowel Disease: A Systematic Review.
Autoimmune Diseases
The role of ERAP1 in autoinflammation and autoimmunity.
Autoimmune Diseases
Transcriptional regulation of cytosol and membrane alanyl-aminopeptidase in human T cell subsets.
beta-ala-his dipeptidase deficiency
Carnosinase, diabetes mellitus and the potential relevance of carnosinase deficiency.
Biliary Atresia
Expression of aminopeptidase N in bile canaliculi: a predictor of clinical outcome in biliary atresia and a potential tool to implicate the mechanism of biliary atresia.
Biliary Tract Diseases
[Comparative studies of the activity of leucine aminopeptidase and glycyl aminopeptidase in liver and biliary tract diseases]
Biliary Tract Diseases
[Comparative study of leucyl aminopeptidase and glycyl aminopeptidase activity in liver and biliary tract diseases. I. Behavior of both enzymes in serum and liver tissue]
Blister
Supported Planar Mammalian Membranes as Models of in vivo Cell Surface Architectures.
Blister
[Histotopography of aminopeptidase in pemphigus vulgaris; with a contribution to the pathogenesis of acantholytic blister formation.]
Bowen's Disease
Aminopeptidase M and dipeptidyl peptidase IV activity in epithelial skin tumors: a histochemical study.
Brain Ischemia
Dipeptidyl peptidase IV, aminopeptidase N and DPIV/APN-like proteases in cerebral ischemia.
Brain Neoplasms
Regulation of aminopeptidase A in human brain tumor vasculature: evidence for a role of transforming growth factor-beta.
Brain Neoplasms
The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats.
Brain Neoplasms
[Cathepsin H activity in the human brain and human brain neoplasms]
Breast Neoplasms
A PAK5-DNPEP-USP4 axis dictates breast cancer growth and metastasis.
Breast Neoplasms
Aminopeptidase activities in breast cancer tissue.
Breast Neoplasms
AZGP1 and SPDEF mRNA expression differentiates breast carcinoma from ovarian serous carcinoma.
Breast Neoplasms
Circulating renin-angiotensin system-regulating specific aminopeptidase activities in pre- and post- menopausal women with breast cancer treated or not with neoadyuvant chemotherapy. A two years follow up study.
Breast Neoplasms
COVID-19 infection can cause chemotherapy resistance development in patients with breast cancer and tamoxifen may cause susceptibility to COVID-19 infection.
Breast Neoplasms
Evaluation of an Integrin ?v?3 and Aminopeptidase N Dual-Receptor Targeting Tracer for Breast Cancer Imaging.
Breast Neoplasms
Hypothalamus-pituitary-thyroid axis disruption in rats with breast cancer is related to an altered endogenous oxytocin/insulin-regulated aminopeptidase (IRAP) system.
Breast Neoplasms
Insulin-regulated aminopeptidase/placental leucil Aminopeptidase (IRAP/P-lAP) and angiotensin IV-forming activities are modified in serum of rats with breast cancer induced by N-methyl-nitrosourea.
Breast Neoplasms
Mammary renin-angiotensin system-regulating aminopeptidase activities are modified in rats with breast cancer.
Breast Neoplasms
miR-125b Acts as a Tumor Suppressor in Breast Tumorigenesis via Its Novel Direct Targets ENPEP, CK2-?, CCNJ, and MEGF9.
Breast Neoplasms
Normolipidic dietary fat modifies circulating Renin-Angiotensin system-regulating aminopeptidase activities in rat with breast cancer.
Breast Neoplasms
Prognostic value of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and aminopeptidase N/CD13 in breast cancer patients.
Breast Neoplasms
Quantification of membrane and membrane-bound proteins in normal and malignant breast cancer cells isolated from the same patient with primary breast carcinoma.
Breast Neoplasms
Renin angiotensin system-regulating aminopeptidase activities in serum of pre- and postmenopausal women with breast cancer.
Breast Neoplasms
Renin-Angiotensin system-regulating aminopeptidase activities are modified in the pineal gland of rats with breast cancer induced by N-methyl-nitrosourea.
Breast Neoplasms
Serum enkephalin-degrading aminopeptidase activity in N-methyl nitrosourea-induced rat breast cancer.
Breast Neoplasms
Specific enkephalin-degrading aminopeptidase activity in the HPT and HPO axes of rats with breast cancer induced by N-methyl nitrosourea.
Bronchitis
Feline aminopeptidase N is not a functional receptor for avian infectious bronchitis virus.
Bronchitis
The role of feline aminopeptidase N as a receptor for infectious bronchitis virus. Brief review.
Brucellosis
Purification and characterization of an immunogenic aminopeptidase of Brucella melitensis.
Candidiasis
Improved immunodiagnosis of human candidiasis by an enzyme-linked immunosorbent assay using a Candida albicans 52-kilodalton metallopeptidase.
Candidiasis, Oral
The membrane-bound intestinal enzymes of waxwings and thrushes: adaptive and functional implications of patterns of enzyme activity.
Carcinogenesis
DPEP1 is a direct target of miR-193a-5p and promotes hepatoblastoma progression by PI3K/Akt/mTOR pathway.
Carcinogenesis
Enhanced anticancer activity of 5-FU in combination with Bestatin: Evidence in human tumor-derived cell lines and an H22 tumor-bearing mouse.
Carcinogenesis
Expression and different polarity of aminopeptidase N in normal human colonic mucosa and colonic tumors.
Carcinogenesis
Histochemical observations on aminopeptidase in the mouse skin in experimental carcinogenesis.
Carcinogenesis
miR-125b Acts as a Tumor Suppressor in Breast Tumorigenesis via Its Novel Direct Targets ENPEP, CK2-?, CCNJ, and MEGF9.
Carcinogenesis
Prostate cancer gene expression signature of patients with high body mass index.
Carcinogenesis
Selective aminopeptidase-N (CD13) inhibitors with relevance to cancer chemotherapy.
Carcinoma
13F-1, a novel 5-fluorouracil prodrug containing an Asn-Gly-Arg (NO2) COOCH3 tripeptide, inhibits human colonic carcinoma growth by targeting Aminopeptidase N (APN/CD13).
Carcinoma
ACO2 and ANPEP as novel prognostic markers for gallbladder squamous cell/adenosquamous carcinomas and adenocarcinomas.
Carcinoma
Addition of an aminopeptidase N-binding sequence to human endostatin improves inhibition of ovarian carcinoma growth.
Carcinoma
Aminopeptidase M and dipeptidyl peptidase IV activity in epithelial skin tumors: a histochemical study.
Carcinoma
AZGP1 and SPDEF mRNA expression differentiates breast carcinoma from ovarian serous carcinoma.
Carcinoma
Cell cycle phases of two human lung tumor cell lines derived from squamous cell carcinoma and pulmonary metastasis of a rhabdomyosarcoma (HS 24 and HS 57) and N-acetylalanine aminopeptidase activity.
Carcinoma
Cell surface antigens in renal tumour cells: detection by immunoluminescence and enzymatic analysis.
Carcinoma
CIP-13F, a novel aminopeptidase N (APN/CD13) inhibitor, inhibits Lewis lung carcinoma growth and metastasis in mice.
Carcinoma
Clinical significance of aminopeptidase N/CD13 expression in human pancreatic carcinoma.
Carcinoma
Clinicopathological significance of aminopeptidase N/CD13 expression in human gastric carcinoma.
Carcinoma
Effect of thyroid hormone-nitric oxide interaction on tumor growth, angiogenesis, and aminopeptidase activity in mice.
Carcinoma
Enzyme activity and distribution in rat prostatic adenocarcinoma.
Carcinoma
Expression of aminopeptidase N/CD13 in tumour-infiltrating lymphocytes from human renal cell carcinoma.
Carcinoma
Expression of the COVID-19 receptor ACE2 in the human conjunctiva.
Carcinoma
Histochemical study of aminopeptidase in metaplasia and carcinoma of the stomach.
Carcinoma
Immunohistochemical expression of aminopeptidase N (CD13) in human lung squamous cell carcinomas, with special reference to Bestatin adjuvant therapy.
Carcinoma
Increased APN/CD13 and acid aminopeptidase activities in head and neck squamous cell carcinoma.
Carcinoma
Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells.
Carcinoma
Inhibitory effects of ubenimex (bestatin) on the invasion of uterine cervical carcinoma cells and their production and activation of gelatinase A.
Carcinoma
Involvement of aminopeptidase N in enhanced chemosensitivity to paclitaxel in ovarian carcinoma in vitro and in vivo.
Carcinoma
LYP, a bestatin dimethylaminoethyl ester, inhibited cancer angiogenesis both in vitro and in vivo.
Carcinoma
LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin.
Carcinoma
MicroRNA-125a attenuates the chemoresistance against ubenimex in non-small cell lung carcinoma via targeting the aminopeptidase N signaling pathway.
Carcinoma
Monoclonal antibody raised against apoprotein of C-1027: effect on biochemical and biological activities of the holoantibiotic.
Carcinoma
OF4949, new inhibitors of aminopeptidase B. I. Taxonomy, fermentation, isolation and characterization.
Carcinoma
Stimulation of the expression and the enzyme activity of aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 on human renal cell carcinoma cells and renal tubular epithelial cells by T cell-derived cytokines, such as IL-4 and IL-13.
Carcinoma
Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells.
Carcinoma
The pro-oxidant buthionine sulfoximine (BSO) reduces tumor growth of implanted Lewis lung carcinoma in mice associated with increased protein carbonyl, tubulin abundance, and aminopeptidase activity.
Carcinoma
The role of aminopeptidases in inflammatory and neoplastic tissues.
Carcinoma
Villin, intestinal brush border hydrolases and keratin polypeptides in intestinal metaplasia and gastric cancer; an immunohistologic study emphasizing the different degrees of intestinal and gastric differentiation in signet ring cell carcinomas.
Carcinoma
[Aminopeptidase activity in gastric carcinoma.]
Carcinoma
[Biological study of aminopeptidase in chemically induced carcinoma]
Carcinoma
[Do immunologic markers facilitate differentiation between histologic types of stomach cancer?]
Carcinoma
[Histochemical determination of aminopeptidase in normal skin, psoriasis, dermatitis, basaloma, spinous cell carcinoma and molluscum sebaceum.]
Carcinoma
[Placental type of aminopeptidase N from renal cell carcinoma: frequency, and biochemical and immunological studies]
Carcinoma
[Urinary excretion of glycine.prolile dipeptidile aminopeptidase, N-acetyl-beta-D-glucosaminidase, alanine aminopeptidase and low molecular protein in patients with renal cell carcinoma]
Carcinoma, Basal Cell
Aminopeptidase M and dipeptidyl peptidase IV activity in epithelial skin tumors: a histochemical study.
Carcinoma, Hepatocellular
Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma.
Carcinoma, Hepatocellular
CD13 Induces Autophagy to Promote Hepatocellular Carcinoma Cell Chemoresistance Through the P38/Hsp27/CREB/ATG7 Pathway.
Carcinoma, Hepatocellular
Designed three-in-one peptides with anchoring, antifouling and recognizing capabilities for highly sensitive and low fouling electrochemical sensing in complex biological media.
Carcinoma, Hepatocellular
Ectopeptidases are differentially expressed in hepatocellular carcinomas.
Carcinoma, Hepatocellular
Glycylproline dipeptidyl aminopeptidase isoenzyme in diagnosis of primary hepatocellular carcinoma.
Carcinoma, Hepatocellular
In situ imaging of aminopeptidase N activity in hepatocellular carcinoma: a migration model for tumour using an activatable two-photon NIR fluorescent probe.
Carcinoma, Hepatocellular
In vivo assessment of aminopeptidase N (APN/CD13) specificity of different 68Ga-labelled NGR derivatives using PET/MRI imaging.
Carcinoma, Hepatocellular
Inhibition of leukotriene D4 catabolism by D-penicillamine.
Carcinoma, Hepatocellular
Link of a ubiquitous human coronavirus to dromedary camels.
Carcinoma, Hepatocellular
Novel aminopeptidase N (APN/CD13) inhibitor 24F can suppress invasion of hepatocellular carcinoma cells as well as angiogenesis.
Carcinoma, Hepatocellular
Poly(ethylene glycol)-poly(lysine) block copolymer-ubenimex conjugate targets aminopeptidase N and exerts an antitumor effect in hepatocellular carcinoma stem cells.
Carcinoma, Hepatocellular
The value of serum GPDA-F for the diagnosis of primary hepatocellular carcinoma.
Carcinoma, Hepatocellular
[Clinical Significance of Serum GPDA-F Determined by Immunoelectrophoresis in Diagnosis of Hepatocellular Carcinoma.]
Carcinoma, Lewis Lung
CIP-13F, a novel aminopeptidase N (APN/CD13) inhibitor, inhibits Lewis lung carcinoma growth and metastasis in mice.
Carcinoma, Lewis Lung
The pro-oxidant buthionine sulfoximine (BSO) reduces tumor growth of implanted Lewis lung carcinoma in mice associated with increased protein carbonyl, tubulin abundance, and aminopeptidase activity.
Carcinoma, Non-Small-Cell Lung
Circulating aminopeptidase N/CD13 is an independent prognostic factor in patients with non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Clinical significance of aminopeptidase N in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Expression and clinical significance of aminopeptidase N/CD13 in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
MicroRNA-125a attenuates the chemoresistance against ubenimex in non-small cell lung carcinoma via targeting the aminopeptidase N signaling pathway.
Carcinoma, Non-Small-Cell Lung
Neutral endopeptidase/CD10 and aminopeptidase N/CD13 gene expression as a prognostic factor in non-small cell lung cancer.
Carcinoma, Renal Cell
A classification of tumor development based on an analysis of enzymes in tissue sections of hypernephroid carcinoma in man.
Carcinoma, Renal Cell
Cell surface antigens in renal tumour cells: detection by immunoluminescence and enzymatic analysis.
Carcinoma, Renal Cell
Expression of aminopeptidase N/CD13 in tumour-infiltrating lymphocytes from human renal cell carcinoma.
Carcinoma, Renal Cell
Reduced Activity of CD13/Aminopeptidase N (APN) in Aggressive Meningiomas Is Associated with Increased Levels of SPARC.
Carcinoma, Renal Cell
Regulation of the expression of aminopeptidase A, aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 in renal carcinoma cells and renal tubular epithelial cells by cytokines and cAMP-increasing mediators.
Carcinoma, Renal Cell
Stimulation of the expression and the enzyme activity of aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 on human renal cell carcinoma cells and renal tubular epithelial cells by T cell-derived cytokines, such as IL-4 and IL-13.
Carcinoma, Renal Cell
[Placental type of aminopeptidase N from renal cell carcinoma: frequency, and biochemical and immunological studies]
Carcinoma, Renal Cell
[Urinary excretion of glycine.prolile dipeptidile aminopeptidase, N-acetyl-beta-D-glucosaminidase, alanine aminopeptidase and low molecular protein in patients with renal cell carcinoma]
Carcinoma, Squamous Cell
Aminopeptidase M and dipeptidyl peptidase IV activity in epithelial skin tumors: a histochemical study.
Carcinoma, Squamous Cell
Cell cycle phases of two human lung tumor cell lines derived from squamous cell carcinoma and pulmonary metastasis of a rhabdomyosarcoma (HS 24 and HS 57) and N-acetylalanine aminopeptidase activity.
Carcinoma, Squamous Cell
Expression and clinical significance of aminopeptidase N/CD13 in non-small cell lung cancer.
Carcinoma, Squamous Cell
Expression of the COVID-19 receptor ACE2 in the human conjunctiva.
Carcinoma, Squamous Cell
Immunohistochemical expression of aminopeptidase N (CD13) in human lung squamous cell carcinomas, with special reference to Bestatin adjuvant therapy.
Carcinoma, Squamous Cell
Increased APN/CD13 and acid aminopeptidase activities in head and neck squamous cell carcinoma.
Cardiovascular Diseases
Role of central and peripheral aminopeptidase activities in the control of blood pressure: a working hypothesis.
Cataract
Increased lens dipeptidase activity in aging and cataract.
Celiac Disease
Evidence for a compensatory increase in synthesis of brush border enzymes in the jejunum of Irish Setters with gluten-sensitive enteropathy.
Celiac Disease
[Morphologic and histochemical study of the intestinal mucosa in celiac disease. Leucine aminopeptidase behavior in gluten intolerance]
Cholelithiasis
Biliary aminopeptidase-N and the cholesterol crystallisation defect in cholelithiasis.
Cholelithiasis
Cholesterol crystallization-promoting activity of aminopeptidase-N isolated from the vesicular carrier of biliary lipids.
Cholera
Inhibitory effect of somatostatin on cholera toxin-induced diarrhea and glycoenzyme secretion in rat intestine.
Cholestasis
Plasma endopeptidase 24.11 (enkephalinase) activity is markedly increased in cholestatic liver disease.
Cholestasis
[The activity of cholestatic enzymes in viral hepatitis B]
Cholestasis, Intrahepatic
Alanine aminopeptidase in serum: automated optimized assay, and effects of age, sex, smoking, and alcohol consumption in a selected population.
Cholesteatoma
Altered regulation of cell surface peptidases in human cholesteatoma.
Choriocarcinoma
Aminopeptidase inhibitor ubenimex (bestatin) inhibits the growth of human choriocarcinoma in nude mice through its direct cytostatic activity.
Choriocarcinoma
Expression of aminopeptidase N on human choriocarcinoma cells and cell growth suppression by the inhibition of aminopeptidase N activity.
Choriocarcinoma
Ikaros is expressed in human extravillous trophoblasts and involved in their migration and invasion.
Choriocarcinoma
Progesterone stimulates the expression of aminopeptidase A/angiotensinase in human choriocarcinoma cells.
Choriocarcinoma
SERUM AMINOPEPTIDASE IN PREGNANCY, HYDATIFORM MOLE, AND CHORIOCARCINOMA.
Choriocarcinoma
Studies of serum aminopeptidase in pregnancy, hydatidiform mole, and choriocarcinoma.
Chronic Periodontitis
Alanine aminopeptidase and dipeptidyl peptidase IV in saliva of chronic periodontitis patients.
Coccidiosis
Aminopeptidase N1 (EtAPN1), an M1 metalloprotease of the apicomplexan parasite Eimeria tenella, participates in parasite development.
Coccidiosis
Biochemical characterization of aminopeptidase N2 from Toxoplasma gondii.
Coinfection
Porcine epidemic diarrhea virus (PEDV) co-infection induced chlamydial persistence/stress does not require viral replication.
Colitis
Inhibition of alanyl-aminopeptidase on CD4+CD25+ regulatory T-cells enhances expression of FoxP3 and TGF-beta1 and ameliorates acute colitis in mice.
Colitis
Morphological and biochemical alterations in the jejunum following iodoacetamide-induced colitis in rats.
Colitis, Ulcerative
Enzymatic and morphometric evidence for Crohn's disease as a diffuse lesion of the gastrointestinal tract.
Colitis, Ulcerative
Inflammation, adenoma and cancer: objective classification of colon biopsy specimens with gene expression signature.
Colitis, Ulcerative
Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease.
Colonic Neoplasms
Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer.
Colonic Neoplasms
Cinnamic acid inhibits proliferation and modulates brush border membrane enzyme activities in Caco-2 cells.
Colonic Neoplasms
Immunohistological evidence, obtained with monoclonal antibodies, of small intestinal brush border hydrolases in human colon cancers and foetal colons.
Colonic Neoplasms
Synthesis, docking, cytotoxicity, and LTA4H inhibitory activity of new gingerol derivatives as potential colorectal cancer therapy.
Colorectal Neoplasms
Aminopeptidase N activity predicts 5-year survival in colorectal cancer patients.
Colorectal Neoplasms
Clinicopathological examination of dipeptidase 1 expression in colorectal cancer.
Colorectal Neoplasms
Dipeptidase 1 (DPEP1) is a marker for the transition from low-grade to high-grade intraepithelial neoplasia and an adverse prognostic factor in colorectal cancer.
Colorectal Neoplasms
Dipeptidase 1: a candidate tumor-specific molecular marker in colorectal carcinoma.
Colorectal Neoplasms
Distinguishing primary from secondary mucinous ovarian tumors: an algorithm using the novel marker DPEP1.
Colorectal Neoplasms
Effect of growth and sodium butyrate on brush border membrane-associated hydrolases in human colorectal cancer cell lines.
Colorectal Neoplasms
Intestinal brush-border-associated enzymes: co-ordinated expression in colorectal cancer.
Colorectal Neoplasms, Hereditary Nonpolyposis
Advances in the study of Lynch syndrome in China.
Common Cold
The SARS-CoV-2 receptor and other key components of the Renin-Angiotensin-Aldosterone System related to COVID-19 are expressed in enterocytes in larval zebrafish.
Communicable Diseases
A randomized study comparing clinical efficacy and safety of thienamycin formamidine (MK0787)/renal dipeptidase inhibitor (MK0791) and cefazolin.
Congenital Abnormalities
Effect of dietary phospholipid levels on performance, enzyme activities and fatty acid composition of pikeperch (Sander lucioperca) larvae
Coronavirus Infections
Phage displayed peptides recognizing porcine aminopeptidase N inhibit transmissible gastroenteritis coronavirus infection in vitro.
Coronavirus Infections
Role of Porcine Aminopeptidase N and Sialic Acids in Porcine Coronavirus Infections in Primary Porcine Enterocytes.
Coronavirus Infections
The SARS-CoV-2 receptor and other key components of the Renin-Angiotensin-Aldosterone System related to COVID-19 are expressed in enterocytes in larval zebrafish.
COVID-19
Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism.
COVID-19
Lung expression of genes putatively involved in SARS-CoV-2 infection is modulated in cis by germline variants.
COVID-19
Renin-angiotensin system inhibition and risk of infection and mortality in COVID-19: a systematic review and meta-analysis.
Crohn Disease
Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes.
Crohn Disease
Enzymatic and morphometric evidence for Crohn's disease as a diffuse lesion of the gastrointestinal tract.
Crohn Disease
Inflammation, adenoma and cancer: objective classification of colon biopsy specimens with gene expression signature.
Crohn Disease
Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease.
Cross Infection
Pseudomonas aeruginosa Leucine Aminopeptidase Influences Early Biofilm Composition and Structure via Vesicle-Associated Antibiofilm Activity.
Cryptogenic Organizing Pneumonia
The significance of cathepsins, thrombin and aminopeptidase in diffuse interstitial lung diseases.
Cryptorchidism
Increase of methionine aminopeptidase activity in hyperplastic Leydig cells of rat cryptorchid testis: a histochemical study.
Cryptorchidism
Increase of methionine-aminopeptidase activity in hyperplastic Leydig cells of rat cryptorchid testis.
Cystic Fibrosis
Amniotic fluid microvillar enzyme activities in the early detection of fetal abnormalities.
Cystic Fibrosis
Prenatal diagnosis in 200 pregnancies with a 1-in-4 risk of cystic fibrosis.
Cystic Fibrosis
Prenatal diagnosis of cystic fibrosis by assay of amniotic fluid microvillar enzymes.
Cystic Fibrosis
Pseudomonas aeruginosa Leucine Aminopeptidase Influences Early Biofilm Composition and Structure via Vesicle-Associated Antibiofilm Activity.
Cystic Fibrosis
Synthesis and testing of chromogenic phenoxazinone substrates for beta-alanyl aminopeptidase.
Cystic Fibrosis
Transimmortalized mouse intestinal cells (m-ICc12) that maintain a crypt phenotype.
Cystic Fibrosis
[Activity of enzymes in amniotic fluid in prenatal diagnosis of cystic fibrosis]
Cystic Fibrosis
[Prenatal diagnosis of mucoviscidosis: biochemical technics and studies of affected fetuses]
Cysts
Aminopeptidase activity in the brains of mice with chronic Toxoplasma gondii infections.
Cysts
Chymase-like angiotensin II-generating activity in end-stage human autosomal dominant polycystic kidney disease.
Cysts
Cloning and characterisation of a Heterodera glycines aminopeptidase cDNA.
Cysts
Differential effects of DNA tumor virus genes on the expression profiles, differentiation, and morphogenetic reprogramming potential of epithelial cells.
Cysts
The lysosomal aminopeptidase tripeptidyl peptidase 1 displays increased activity in malignant pancreatic cysts.
Cytomegalovirus Infections
CD13 (human aminopeptidase N) mediates human cytomegalovirus infection.
Dehydration
Effects of dehydration on renal aminopeptidase activities in adult male and female rats.
Dengue
Aminopeptidase secreted by Chromobacterium sp. Panama inhibits dengue virus infection by degrading the E protein.
Dental Caries
Aminopeptidase activity in carious dentin.
Dental Caries
Effect of a Ca(OH)2 solution and a chlorhexidine based detergent on the microbial activity of human carious teeth.
Dermatitis
[Histochemical determination of aminopeptidase in normal skin, psoriasis, dermatitis, basaloma, spinous cell carcinoma and molluscum sebaceum.]
Diabetes Complications
Protease profiling of different biofluids in type 1 diabetes mellitus.
Diabetes Insipidus
Osmoregulation, the secretion of arginine vasopressin and its metabolism during pregnancy.
Diabetes Mellitus
CLINICAL CHARACTERISTICS OF PATIENTS WITH TYPE 2 DIABETES MELLITUS CONTINUED ON ORAL ANTIDIABETES MEDICATIONS IN THE HOSPITAL.
Diabetes Mellitus
Comparison of N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase activities for evaluation of microangiopathy in diabetes mellitus.
Diabetes Mellitus
Prospective evaluation of aminopeptidase activities in plasma and peripheral organs of streptozotocin-induced diabetic rats.
Diabetes Mellitus
Studies on proteolytic activities in heart muscle of diabetic rats.
Diabetes Mellitus
[Clinical significance of urinary alanine aminopeptidase in diabetes mellitus]
Diabetes Mellitus, Experimental
Urinary excretion of alanine aminopeptidase and total proteinuria in experimental diabetes mellitus before and after islet transplantation.
Diabetes Mellitus, Type 1
Protease profiling of different biofluids in type 1 diabetes mellitus.
Diabetes Mellitus, Type 1
The putative role of proteolytic pathways in the pathogenesis of Type 1 diabetes mellitus: The 'autophagy' hypothesis.
Diabetes Mellitus, Type 1
[Urinary enzymes in insulin-dependent diabetes mellitus]
Diabetes Mellitus, Type 2
Berry and Citrus Phenolic Compounds Inhibit Dipeptidyl Peptidase IV: Implications in Diabetes Management.
Diabetes Mellitus, Type 2
CLINICAL CHARACTERISTICS OF PATIENTS WITH TYPE 2 DIABETES MELLITUS CONTINUED ON ORAL ANTIDIABETES MEDICATIONS IN THE HOSPITAL.
Diabetes Mellitus, Type 2
Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes.
Diabetes Mellitus, Type 2
Recent progress in natural products as DPP-4 inhibitors.
Diabetes Mellitus, Type 2
Reversal of increased lymphocyte PC-1 activity in patients with type 2 diabetes treated with metformin.
Diabetes Mellitus, Type 2
The influence of a single nucleotide polymorphism within CNDP1 on susceptibility to diabetic nephropathy in Japanese women with type 2 diabetes.
Diabetes Mellitus, Type 2
Urinary Lysosomal Enzyme Activities and Albuminuria in Ghanaian Patients with Type 2 Diabetes Mellitus.
Diabetic Angiopathies
Comparison of N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase activities for evaluation of microangiopathy in diabetes mellitus.
Diabetic Nephropathies
Association of CTG repeat polymorphism in carnosine dipeptidase 1 (CNDP1) gene with diabetic nephropathy in north Indians.
Diabetic Nephropathies
Diagnostic value of the aminopeptidase N, N-acetyl-beta-D-glucosaminidase and dipeptidylpeptidase IV in evaluating tubular dysfunction in patients with glomerulopathies.
Diabetic Nephropathies
The influence of a single nucleotide polymorphism within CNDP1 on susceptibility to diabetic nephropathy in Japanese women with type 2 diabetes.
Diabetic Nephropathies
Urinary Lysosomal Enzyme Activities and Albuminuria in Ghanaian Patients with Type 2 Diabetes Mellitus.
Diabetic Nephropathies
[Clinical evaluation of urinary alanine aminopeptidase in the patients with diabetes mellitus-comparison among AAP microalbumin and N-acetyl-beta-D-glucosaminidase]
Diabetic Nephropathies
[Clinical significance of urinary glycyl-prolyl dipeptidyl aminopeptidase in diabetic nephropathies]
Diabetic Nephropathies
[Urinary alanine aminopeptidase and lysozyme excretion in patients with diabetes]
Diabetic Nephropathies
[Urinary enzymes in insulin-dependent diabetes mellitus]
Digestive System Diseases
A COMPARISON OF SERUM AMINOPEPTIDASE AND ALKALINE PHOSPHATASE IN THE DETECTION OF HEPATOBILIARY DISEASE IN ANICTERIC PATIENTS.
Digestive System Diseases
The hepatobiliary disease marker serum alanine aminopeptidase predominantly comprises an isoform of the haematological myeloid differentiation antigen and leukaemia marker CD-13/gp150.
Digestive System Diseases
[Electrophoretic variants of alanine aminopeptidase in serum of patients with hepatobiliary diseases]
Digestive System Diseases
[Glycylproline dipeptidyl aminopeptidase activity in the sera from patients with hepatobiliary diseases (author's transl)]
Digestive System Diseases
[Glycylprolyl dipeptidyl aminopeptidase activity in healthy subjects and patients with hepatobiliary diseases]
Digestive System Diseases
[Studies on the specificity of alanine aminopeptidase and its variants in the serum in hepatobiliary diseases]
Digestive System Diseases
[The angiotensinase activity of -L-asparaginyl aminopeptidase in the serum of normal subjects, in patients with hepatobiliary diseases and during pregnancy]
Dirofilariasis
Evaluation of urinary enzymes in dogs with early renal disorder.
Dysgerminoma
Oxytocinase-like enzyme in an ovarian dysgerminoma: a placenta-specific protein.
Encephalomyelitis
Changes in the expression pattern of blood-brain barrier-associated pericytic aminopeptidase N (pAP N) in the course of acute experimental autoimmune encephalomyelitis.
Encephalomyelitis
DP IV/CD26, APN/CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosis.
Encephalomyelitis
PETIR-001, a dual inhibitor of dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN), ameliorates experimental autoimmune encephalomyelitis in SJL/J mice.
Encephalomyelitis
Review: Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice.
Encephalomyelitis
Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice.
Encephalomyelitis, Autoimmune, Experimental
Changes in the expression pattern of blood-brain barrier-associated pericytic aminopeptidase N (pAP N) in the course of acute experimental autoimmune encephalomyelitis.
Encephalomyelitis, Autoimmune, Experimental
PETIR-001, a dual inhibitor of dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN), ameliorates experimental autoimmune encephalomyelitis in SJL/J mice.
Encephalomyelitis, Autoimmune, Experimental
Review: Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice.
Encephalomyelitis, Autoimmune, Experimental
Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice.
Endometriosis
Expression of aminopeptidase N and neutral endopeptidase on the endometrial stromal cells in endometriosis and adenomyosis.
Enteritis
[Clinical importance of the determination of intestinal dipeptidase and enterokinase activity in patients with chronic enteritis]
Enteritis
[Dipeptidase activity in the small intestine of patients with chronic nonspecific enteritis]
Enteritis
[Disorders of dipeptidase activity of the small intestine in chronic enteritis and their treatment]
Esophageal Neoplasms
In Vitro Radiosensitization of Esophageal Cancer Cells with the Aminopeptidase Inhibitor CHR-2797.
Essential Hypertension
Circulating Aminopeptidase Activities in Men and Women with Essential Hypertension.
Essential Hypertension
Heightened pressor effect and dipsogenicity to intracerebroventricularly applied angiotensin II and III in spontaneously hypertensive rats.
Essential Hypertension
Significance of the measurement of urinary alanine aminopeptidase and N-acetyl-beta-D-glucosaminidase activity in evaluating patients with essential hypertension.
Essential Hypertension
[Determination of enzyme activity and beta 2-microglobulin concentration in the urine in chronic diffuse glomerulonephritis and hypertension]
Fanconi Syndrome
A low molecular weight alanine aminopeptidase in urine. Biochemical equivalent of tubular atrophy?
Feline Infectious Peritonitis
Analysis of the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection: aminopeptidase N is not important and a process of acidification of the endosome is necessary.
Feline Infectious Peritonitis
Characterization of determinants involved in the feline infectious peritonitis virus receptor function of feline aminopeptidase N.
Feline Infectious Peritonitis
Feline aminopeptidase N is not a functional receptor for avian infectious bronchitis virus.
Feline Infectious Peritonitis
Interspecies aminopeptidase-N chimeras reveal species-specific receptor recognition by canine coronavirus, feline infectious peritonitis virus, and transmissible gastroenteritis virus.
Feline Infectious Peritonitis
Intriguing interplay between feline infectious peritonitis virus and its receptors during entry in primary feline monocytes.
Feline Infectious Peritonitis
Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibody.
Feline Infectious Peritonitis
TNF-alpha, produced by feline infectious peritonitis virus (FIPV)-infected macrophages, upregulates expression of type II FIPV receptor feline aminopeptidase N in feline macrophages.
Fibromyalgia
Altered Serum Oxytocinase and Enkephalin-Degrading Aminopeptidase Activities in Patients With Fibromyalgia.
Fibromyalgia
Associations Among Nitric Oxide and Enkephalinases With Fibromyalgia Symptoms.
Fibrosarcoma
Bestatin analogue from Streptomyces neyagawaensis SL-387.
Fibrosarcoma
Inhibition of tumor cell invasion and matrix degradation by aminopeptidase inhibitors.
Fibrosarcoma
Synthesis and evaluation of novel Tc-99?m labeled NGR-containing hexapeptides as tumor imaging agents.
Gallstones
Biliary aminopeptidase-N and the cholesterol crystallisation defect in cholelithiasis.
Gallstones
Cholesterol saturation, not proteins or cholecystitis, is critical for crystal formation in human gallbladder bile.
Gallstones
Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: soluble pronucleating proteins in gallbladder and hepatic biles.
Gastroenteritis
A phage-displayed peptide recognizing porcine aminopeptidase N is a potent small molecule inhibitor of PEDV entry.
Gastroenteritis
Aminopeptidase N is not required for porcine epidemic diarrhea virus cell entry.
Gastroenteritis
Aminopeptidase N-null neonatal piglets are protected from transmissible gastroenteritis virus but not porcine epidemic diarrhea virus.
Gastroenteritis
Binding characterization of determinants in porcine aminopeptidase N, the cellular receptor for transmissible gastroenteritis virus.
Gastroenteritis
Binding of transmissible gastroenteritis coronavirus to cell surface sialoglycoproteins.
Gastroenteritis
Cellular receptors for transmissible gastroenteritis virus on porcine enterocytes.
Gastroenteritis
Characterization of determinants involved in the feline infectious peritonitis virus receptor function of feline aminopeptidase N.
Gastroenteritis
Characterization of functional domains in the human coronavirus HCV 229E receptor.
Gastroenteritis
Contribution of porcine aminopeptidase N to porcine deltacoronavirus infection.
Gastroenteritis
Determinants essential for the transmissible gastroenteritis virus-receptor interaction reside within a domain of aminopeptidase-N that is distinct from the enzymatic site.
Gastroenteritis
Feline aminopeptidase N is a receptor for all group I coronaviruses.
Gastroenteritis
Feline aminopeptidase N is not a functional receptor for avian infectious bronchitis virus.
Gastroenteritis
Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup I.
Gastroenteritis
Further characterization of aminopeptidase-N as a receptor for coronaviruses.
Gastroenteritis
Generation of a mouse scFv library specific for porcine aminopeptidase N using the T7 phage display system.
Gastroenteritis
Identification of a putative cellular receptor 150 kDa polypeptide for porcine epidemic diarrhea virus in porcine enterocytes.
Gastroenteritis
Interspecies aminopeptidase-N chimeras reveal species-specific receptor recognition by canine coronavirus, feline infectious peritonitis virus, and transmissible gastroenteritis virus.
Gastroenteritis
Mutational analysis of aminopeptidase N, a receptor for several group 1 coronaviruses, identifies key determinants of viral host range.
Gastroenteritis
Obtention of porcine aminopeptidase-n transgenic mice and analysis of their susceptibility to transmissible gastroenteritis virus.
Gastroenteritis
Overexpression of TGEV cell receptor impairs the production of virus particles.
Gastroenteritis
Phage displayed peptides recognizing porcine aminopeptidase N inhibit transmissible gastroenteritis coronavirus infection in vitro.
Gastroenteritis
Porcine aminopeptidase N is a functional receptor for the PEDV coronavirus.
Gastroenteritis
Porcine Deltacoronavirus Engages the Transmissible Gastroenteritis Virus Functional Receptor Porcine Aminopeptidase N for Infectious Cellular Entry.
Gastroenteritis
Role of Porcine Aminopeptidase N and Sialic Acids in Porcine Coronavirus Infections in Primary Porcine Enterocytes.
Gastroenteritis
The coronavirus transmissible gastroenteritis virus causes infection after receptor-mediated endocytosis and acid-dependent fusion with an intracellular compartment.
Gastroenteritis
[Porcine aminopeptidase N is a functional receptor for the PEDV coronavirus]
Gastroenteritis, Transmissible, of Swine
A phage-displayed peptide recognizing porcine aminopeptidase N is a potent small molecule inhibitor of PEDV entry.
Gastroenteritis, Transmissible, of Swine
Aminopeptidase N is not required for porcine epidemic diarrhea virus cell entry.
Gastroenteritis, Transmissible, of Swine
Cellular receptors for transmissible gastroenteritis virus on porcine enterocytes.
Gastroenteritis, Transmissible, of Swine
Characterization of functional domains in the human coronavirus HCV 229E receptor.
Gastroenteritis, Transmissible, of Swine
Feline aminopeptidase N is a receptor for all group I coronaviruses.
Gastroenteritis, Transmissible, of Swine
Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup I.
Gastroenteritis, Transmissible, of Swine
Generation of a mouse scFv library specific for porcine aminopeptidase N using the T7 phage display system.
Gastroenteritis, Transmissible, of Swine
Mutational analysis of aminopeptidase N, a receptor for several group 1 coronaviruses, identifies key determinants of viral host range.
Gastrointestinal Diseases
Immunoelectrophoretic studies on human small intestinal brush border proteins. A quantitative study of brush border enzymes from single small intestinal biopsies.
Gastrointestinal Neoplasms
Circulating carnosine dipeptidase 1 associates with weight loss and poor prognosis in gastrointestinal cancer.
Gingivitis
Trypsin-like, chymotrypsin-like and glycylprolyl dipeptidase activities in gingival crevicular fluid from human periodontal sites with gingivitis.
Glioblastoma
Biomarker discovery: a proteomic approach for brain cancer profiling.
Glioma
Differential Effects of Doxazosin on Renin-Angiotensin-System-Regulating Aminopeptidase Activities in Neuroblastoma and Glioma Tumoral Cells.
Glioma
Regulation of aminopeptidase A in human brain tumor vasculature: evidence for a role of transforming growth factor-beta.
Glioma
Sex differences exist in brain renin-angiotensin system-regulating aminopeptidase activities in transplacental ethyl-nitrosourea-induced gliomas.
Glomerulonephritis
Diagnostic value of the aminopeptidase N, N-acetyl-beta-D-glucosaminidase and dipeptidylpeptidase IV in evaluating tubular dysfunction in patients with glomerulopathies.
Glomerulonephritis
Diagnostic value of urinary alanine aminopeptidase and N-acetyl-beta-D-glucosaminidase in comparison to alpha 1-microglobulin as a marker in evaluating tubular dysfunction in glomerulonephritis patients.
Glomerulonephritis
Urinary trehalase activity in chronic glomerulonephritis.
Glomerulonephritis
[A method of separate determination of enzymuria associated with impairment of glomerular filtration in kidney tissue]
Glomerulonephritis
[Determination of enzyme activity and beta 2-microglobulin concentration in the urine in chronic diffuse glomerulonephritis and hypertension]
Glycosuria
Mild renal failure induced by subchronic exposure to molybdenum: urinary kallikrein excretion as a marker of distal tubular effect.
Glycosuria
Renal excretion of ascorbic acid in insulin dependent diabetes mellitus.
Granuloma
Characterization of two dipeptidases purified from hepatic schistosome egg granulomas in mice. Leukotriene D4 hydrolases of granulomatous tissue.
Granuloma
Dipeptidase activity in rat carrageenin granuloma.
Granuloma
Leucine and alanine aminopeptidase activities in experimentally induced intradermal granulomas and late stages of wound healing in the rat.
Granuloma
Morphogenesis and pathogenesis of chronic lung diseases. XI. Histoenzymatic study of the experimentally developing lung granulomas.
Granuloma
The value of modern morphological methods (histochemistry, immunopathology) in sarcoidosis.
Graves Disease
Interleukin-6 (IL-6) inhibits thyroid function in the presence of soluble IL-6 receptor in cultured human thyroid follicles.
Heart Failure
Bioinformatics identification of potential candidate blood indicators for doxorubicin-induced heart failure.
Hematologic Diseases
[Behavior of the dipeptidase (dl-alanylglycine) of the leukocytes of the peripheral blood in some blood diseases.]
Hematologic Neoplasms
Aminopeptidase-N/CD13 is a potential proapoptotic target in human myeloid tumor cells.
Hepatitis
Serum pyroglutamyl aminopeptidase activity: a promising novel biomarker candidate for liver cirrhosis.
Hepatitis
Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibody.
Hepatitis
Viral protein synthesis in mouse hepatitis virus strain A59-infected cells: effect of tunicamycin.
Hepatitis
[Effect of glucocorticoids (GCS) on the enzyme activity in viral hepatitis (VH). II. Isoenzymatic profile of leucine aminopeptidase (LAP) and glycyl aminopeptidase (GAP) of blood serum]
Hepatitis
[Effects of glucocorticoids on enzyme activity in viral hepatitis. I. Behavior of serum leucine aminopeptidase and glycine aminopeptidase]
Hepatitis
[Renal changes in viral hepatitis evaluated on the bases of gamma-glutamyltransferase and alanyl aminopeptidase activities in the urine of patients]
Hepatitis
[Suitability of "classical" leucine aminopeptidase (LAP) as indicator enzyme in hepatitis epidemica acuta. Differentiation between leucine aminopeptidase and arylamidase in hepatobiliary illnesses]
Hepatoblastoma
Prognostic significance of Aminopeptidase-N (CD13) in hepatoblastoma.
Herpes Zoster
Novel conditionally immortalized human proximal tubule cell line expressing functional influx and efflux transporters.
Histiocytoma, Malignant Fibrous
Identification of APN/CD13 as the target antigen of FU3, a human monoclonal antibody that recognizes malignant fibrous histiocytoma.
Histoplasmosis
Detection of Histoplasma capsulatum from clinical specimens by cycling probe-based real-time PCR and nested real-time PCR.
Histoplasmosis
N-acetylated ?-linked acidic dipeptidase is identified as an antigen of Histoplasma capsulatum.
Huntington Disease
Changes in nine enzyme markers for neurons, glia, and endothelial cells in agonal state and Huntington's disease caudate nucleus.
Huntington Disease
Oxidative stress and plasma aminopeptidase activity in Huntington's disease.
Hydatidiform Mole
Studies of serum aminopeptidase in pregnancy, hydatidiform mole, and choriocarcinoma.
Hyperalgesia
Inflammation Mobilizes Local Resources to Control Hyperalgesia: The Role of Endogenous Opioid Peptides.
Hypercholesterolemia
Diet-induced hypercholesterolemia impaired testicular steroidogenesis in mice through the renin-angiotensin system.
Hypersensitivity
Heightened blood pressure and drinking responsiveness to intracerebroventricularly applied angiotensins in the spontaneously hypertensive rat.
Hypersensitivity
Hypertension and angiotensin II hypersensitivity in aminopeptidase A-deficient mice.
Hypertension
A lack of coordination in the release of urinary lysosomal and brush border enzymes following renovascular surgery.
Hypertension
Acetaldehyde inhibits serum aminopeptidases.
Hypertension
Activities of aminopeptidases in a rat saline model of volume hypertension.
Hypertension
Aminopeptidase N in arterial hypertension.
Hypertension
Aminopeptidase N reduces basolateral Na+ -K+ -ATPase in proximal tubule cells.
Hypertension
An in-depth examination of the excretion of albumin and other sensitive markers of renal damage in mild hypertension.
Hypertension
Combinatorial inhibition of Angiotensin converting enzyme, Neutral endopeptidase and Aminopeptidase N by N-methylated peptides alleviates blood pressure and fibrosis in rat model of dexamethasone-induced hypertension.
Hypertension
Dietary NaCl regulates renal aminopeptidase N: relevance to hypertension in the Dahl rat.
Hypertension
Firibastat: A Novel Brain Aminopeptidase Inhibitor - A New Era of Antihypertensive therapy.
Hypertension
Functional polymorphism of the Anpep gene increases promoter activity in the Dahl salt-resistant rat.
Hypertension
Heightened pressor effect and dipsogenicity to intracerebroventricularly applied angiotensin II and III in spontaneously hypertensive rats.
Hypertension
Hypertension and angiotensin II hypersensitivity in aminopeptidase A-deficient mice.
Hypertension
Intrarenal Angiotensin III Is the Predominant Agonist for Proximal Tubule Angiotensin Type 2 Receptors.
Hypertension
Oleate, linoleate and cholesterol differently modify aspartyl- and glutamyl-aminopeptidase activities in primary cultures of rat astrocytes.
Hypertension
Relationships among alterations in renal membrane sodium transport, renin and aminopeptidase M activities in genetic hypertension.
Hypertension
Renal aminopeptidase activities in animal models of hypertension.
Hypertension
Significance of the measurement of urinary alanine aminopeptidase and N-acetyl-beta-D-glucosaminidase activity in evaluating patients with essential hypertension.
Hypertension
[Activity of aminopeptidase towards angiotensin II-amide in the serum during normal health, pregnancy, hypertension and liver disease]
Hypertension
[Renal dipeptidylpeptidase IV excretion in drug-induced kidney changes]
Hypertension, Renal
[The effect of aminopeptidase on experimental renal hypertension in rats]
Hypertension, Renovascular
Aminopeptidase activity in renovascular hypertension.
Hypertension, Renovascular
Angiotensinase activities in the kidney of renovascular hypertensive rats.
Hypertension, Renovascular
Renal aminopeptidase activities in animal models of hypertension.
Hypertension, Renovascular
Reversal of renovascular hypertension by antibodies specific for angiotensin-converting enzyme.
Hyperthyroidism
Angiotensinase activity in hypothalamus and pituitary of hypothyroid, euthyroid and hyperthyroid adult male rats.
Hyperthyroidism
Cystinyl and pyroglutamyl-beta-naphthylamide hydrolyzing activities are modified coordinately between hypothalamus, liver and plasma depending on the thyroid status of adult male rats.
Hyperthyroidism
Influence of thyroid disorders on kidney angiotensinase activity.
Hyperthyroidism
Thyroid Disorders Change the Pattern of Response of Angiotensinase Activities in the Hypothalamus-Pituitary-Adrenal Axis of Male Rats.
Hyperthyroidism
[Aminopeptidases in the serum and urine of patients with hyperthyroidism]
Hypokalemia
Tubular damage in patients with hypokalaemia.
Idiopathic Pulmonary Fibrosis
The significance of cathepsins, thrombin and aminopeptidase in diffuse interstitial lung diseases.
Immune System Diseases
Genetic Variants in ERAP1 and ERAP2 Associated With Immune-Mediated Diseases Influence Protein Expression and the Isoform Profile.
Infections
A phage-displayed peptide recognizing porcine aminopeptidase N is a potent small molecule inhibitor of PEDV entry.
Infections
Acquisition of macrophage tropism during the pathogenesis of feline infectious peritonitis is determined by mutations in the feline coronavirus spike protein.
Infections
Aminopeptidase activity in the brains of mice with chronic Toxoplasma gondii infections.
Infections
Aminopeptidase N Expression, Not Interferon Responses, Determines the Intestinal Segmental Tropism of Porcine Deltacoronavirus.
Infections
Aminopeptidase secreted by Chromobacterium sp. Panama inhibits dengue virus infection by degrading the E protein.
Infections
Aminopeptidase T of M29 Family Acts as A Novel Intracellular Virulence Factor for Listeria monocytogenes Infection.
Infections
Aminopeptidases as potential targets for the control of the Australian sheep blowfly, Lucilia cuprina.
Infections
An M29 Aminopeptidase from Listeria Monocytogenes Contributes to In Vitro Bacterial Growth but not to Intracellular Infection.
Infections
Analysis of Structures, Functions, and Epitopes of Aminopeptidase from Trichinella spiralis.
Infections
Analysis of the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection: aminopeptidase N is not important and a process of acidification of the endosome is necessary.
Infections
Binding of transmissible gastroenteritis coronavirus to cell surface sialoglycoproteins.
Infections
CD13 (human aminopeptidase N) mediates human cytomegalovirus infection.
Infections
Changes and induction of aminopeptidase activities in response to pathogen infection during germination of pigeonpea (Cajanas cajan) seeds.
Infections
Characterization of a recombinant canine coronavirus with a distinct receptor-binding (S1) domain.
Infections
Characterization of porcine epidemic diarrhea virus infectivity in human embryonic kidney cells.
Infections
Characterization of the interaction between recombinant porcine aminopeptidase N and spike glycoprotein of porcine epidemic diarrhea virus.
Infections
Contribution of porcine aminopeptidase N to porcine deltacoronavirus infection.
Infections
Control of IFN-I responses by the aminopeptidase IRAP in neonatal C57BL/6 alveolar macrophages during RSV infection.
Infections
Corrigendum: Endoplasmic Reticulum Associated Aminopeptidase 2 (ERAP2) Is Released in the Secretome of Activated MDMs and Reduces in vitro HIV-1 Infection.
Infections
Cutting edge: activation of virus-specific CD4 T cells throughout ?-herpesvirus latency.
Infections
Development of an effective fluorescence probe for discovery of aminopeptidase inhibitors to suppress biofilm formation.
Infections
Diagnostic potential of urinary enzymes and beta 2-microglobulin in acute urinary tract infection.
Infections
Differential sensitivity of bat cells to infection by enveloped RNA viruses: coronaviruses, paramyxoviruses, filoviruses, and influenza viruses.
Infections
Endoplasmic Reticulum Associated Aminopeptidase 2 (ERAP2) Is Released in the Secretome of Activated MDMs and Reduces in vitro HIV-1 Infection.
Infections
Epstein-Barr virus recombinant lacking expression of glycoprotein gp150 infects B cells normally but is enhanced for infection of epithelial cells.
Infections
Extracellular aminopeptidase modulates biofilm development of Pseudomonas aeruginosa by affecting matrix exopolysaccharide and bacterial cell death.
Infections
Factors affecting susceptibility to RNA interference in Haemonchuscontortus and in vivo silencing of an H11 aminopeptidase gene.
Infections
Genetic Control of Human Infection with SARS-CoV-2.
Infections
Human aminopeptidase N is a receptor for human coronavirus 229E.
Infections
Human cytomegalovirus infection downregulates expression of the cellular aminopeptidases CD10 and CD13.
Infections
In vivo function of a gammaherpesvirus virion glycoprotein: influence on B-cell infection and mononucleosis.
Infections
Infection of HeLa cells by avian infectious bronchitis virus is dependent on cell status.
Infections
Influence of Leishmania infection on blood-meal digestion in the sandflies Phlebotomus papatasi and P. langeroni.
Infections
Integrin ?v?3 enhances replication of porcine epidemic diarrhea virus on Vero E6 and porcine intestinal epithelial cells.
Infections
Involvement of aminopeptidase N (CD13) in infection of human neural cells by human coronavirus 229E.
Infections
Link of a ubiquitous human coronavirus to dromedary camels.
Infections
Metalloprotease ADAM17 regulates porcine epidemic diarrhea virus infection by modifying aminopeptidase N.
Infections
Molecular Characterization and Biological Function of a Novel LncRNA CRNG in Swine.
Infections
Molecular cloning and analysis of the Cryptosporidium parvum aminopeptidase N gene.
Infections
Murine gammaherpesvirus 68 lacking gp150 shows defective virion release but establishes normal latency in vivo.
Infections
Obtention of porcine aminopeptidase-n transgenic mice and analysis of their susceptibility to transmissible gastroenteritis virus.
Infections
Partial protection with a chimeric tetraspanin-leucine aminopeptidase subunit vaccine against Opisthorchis viverrini infection in hamsters.
Infections
Peptidase N encoded by Salmonella enterica serovar Typhimurium modulates systemic infection in mice.
Infections
Porcine aminopeptidase N mediated polarized infection by porcine epidemic diarrhea virus in target cells.
Infections
Porcine epidemic diarrhea virus (PEDV) co-infection induced chlamydial persistence/stress does not require viral replication.
Infections
Proteasome activator and antigen-processing aminopeptidases are regulated by virus-induced type I interferon in the hepatitis C virus-infected liver.
Infections
Pseudomonas aeruginosa Leucine Aminopeptidase Influences Early Biofilm Composition and Structure via Vesicle-Associated Antibiofilm Activity.
Infections
Resistance to coronavirus infection in amino peptidase N-deficient pigs.
Infections
Roles of Salmonella enterica serovar Typhimurium encoded Peptidase N during systemic infection of Ifn?(-/-) mice.
Infections
Sialic acid binding properties of soluble coronavirus spike (S1) proteins: differences between infectious bronchitis virus and transmissible gastroenteritis virus.
Infections
Single-cell RNA sequencing of SARS-CoV-2 cell entry factors in the preconceptional human endometrium.
Infections
The Activity of a Hexameric M17 Metallo-Aminopeptidase Is Associated With Survival of Mycobacterium tuberculosis.
Infections
The BDLF3 gene product of Epstein-Barr virus, gp150, mediates non-productive binding to heparan sulfate on epithelial cells and only the binding domain of CD21 is required for infection.
Infections
The bovine herpesvirus 4 Bo10 gene encodes a nonessential viral envelope protein that regulates viral tropism through both positive and negative effects.
Infections
The effect of Eimeria maxima infection on the expression of amino acid and sugar transporters aminopeptidase, as well as the di- and tri-peptide transporter PepT1, is not solely due to decreased feed intake.
Infections
The murine gammaherpesvirus-68 gp150 acts as an immunogenic decoy to limit virion neutralization.
Infections
The use of cells from ANPEP knockout pigs to evaluate the role of aminopeptidase N (APN) as a receptor for porcine deltacoronavirus (PDCoV).
Infections
The virus-host interface: Molecular interactions of Alphacoronavirus-1 variants from wild and domestic hosts with mammalian aminopeptidase N.
Infections
Tight junction protein occludin is a porcine epidemic diarrhea virus entry factor.
Infections
Type II Secretion-Dependent Aminopeptidase LapA and Acyltransferase PlaC Are Redundant for Nutrient Acquisition during Legionella pneumophila Intracellular Infection of Amoebas.
Infertility
Enkephalin-degrading enzymes in normal and subfertile human semen.
Infertility
Identification of the structural gene for dipeptidyl aminopeptidase yscV (DAP2) of Saccharomyces cerevisiae.
Infertility
[Changes in the enzyme level of the sperm of men with infertility]
Inflammatory Bowel Diseases
Functional Genomics and Its Bench-to-Bedside Translation Pertaining to the Identified Susceptibility Alleles and Loci in Ankylosing Spondylitis.
Inflammatory Bowel Diseases
Inflammatory bowel diseases: multiple benefits from therapy with dipeptidyl- and alanyl-aminopeptidase inhibitors.
Inflammatory Bowel Diseases
Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease.
Influenza, Human
Time-dependent viral interference between influenza virus and coronavirus in the infection of differentiated porcine airway epithelial cells.
Insulin Resistance
Effects of aerobic exercise on microalbuminuria and enzymuria in type 2 diabetic patients.
Insulin Resistance
[Obesity, inflammation and insulin resistance: role of gp 130 receptor ligands]
Intervertebral Disc Degeneration
Correlation Between Proteolytic Enzymes and Microangiogenesis in Degenerative Intervertebral Disc Nucleus.
Ischemic Attack, Transient
Dipeptidyl peptidase IV, aminopeptidase N and DPIV/APN-like proteases in cerebral ischemia.
Keratosis
Aminopeptidase M and dipeptidyl peptidase IV activity in epithelial skin tumors: a histochemical study.
Keratosis, Seborrheic
Aminopeptidase M and dipeptidyl peptidase IV activity in epithelial skin tumors: a histochemical study.
Kidney Diseases
A single genetic locus controls both expression of DPEP1/CHMP1A and kidney disease development via ferroptosis.
Kidney Diseases
Confirming the utility of four kidney biomarker tests in a longitudinal follow-up study.
Kidney Diseases
Multiple forms of alanine aminopeptidase, alkaline phosphatase and gamma-glutamyltransferase in urine of healthy persons, patients suffering from kidney diseases and patients with kidney transplants.
Kidney Diseases, Cystic
Structure of the human aminopeptidase XPNPEP3 and comparison of its in vitro activity with Icp55 orthologs: Insights into diverse cellular processes.
Kidney Failure, Chronic
Aminopeptidase activity in the livers of rats with experimental chronic renal failure.
Kidney Failure, Chronic
Behaviour of urinary dipeptidase in patients with chronic renal failure.
Kidney Failure, Chronic
Differentiation of acute renal failure and chronic renal failure by 2-dimensional analysis of urinary dipeptidase versus serum creatinine.
Kidney Failure, Chronic
Urinary trehalase activity in chronic glomerulonephritis.
Kidney Neoplasms
Arylamidase from human renal cancer tissue in comparison with normal kidney and placental enzymes.
Kidney Neoplasms
Decreases of metallothionein and aminopeptidase N in renal cancer tissues.
Latent Infection
Natural history of murine gamma-herpesvirus infection.
Leishmaniasis
Enzymuria as an index of renal damage in canine leishmaniasis.
Leishmaniasis
Structural and Functional Basis of Potent Inhibition of Leishmanial Leucine Aminopeptidase by Peptidomimetics.
Leukemia
A mutation in aminopeptidase N (CD13) isolated from a patient suffering from leukemia leads to an arrest in the endoplasmic reticulum.
Leukemia
Aminopeptidase N (CD13) is a molecular target of the cholesterol absorption inhibitor ezetimibe in the enterocyte brush border membrane.
Leukemia
Analysis of the characteristics and expression profiles of coding and noncoding RNAs of human dental pulp stem cells in hypoxic conditions.
Leukemia
Augmentation of death ligand-induced apoptosis by aminopeptidase inhibitors in human solid tumor cell lines.
Leukemia
Differential expression of metastasis-associated cell surface glycoproteins and mRNA in a murine large cell lymphoma.
Leukemia
Efficacy of tosedostat, a novel, oral agent for elderly patients with relapsed or refractory acute myeloid leukemia: a review of the Phase II OPAL trial.
Leukemia
Oncostatin M regulation of interleukin-6 expression in astrocytes: biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38.
Leukemia
Studies on aminopeptidase activity in acute non-lymphocytic leukemia. The relation to peroxidase reaction.
Leukemia
Surface aminopeptidase activity of rat natural killer cells. I. Biochemical and biological properties.
Leukemia
The Analgesic Activity of Bestatin as a Potent APN Inhibitor.
Leukemia
[Effect of aminopeptidase inhibitor on differentiation induction activity of all-trans retinoic acid in human acute promyelocytic leukemia NB4 cells and its mechanism]
Leukemia
[Experimental study of the enhancement effect of aminopeptidase N inhibitor ubenimex on the differentiation induction activity of all-trans-retinoic acid in acute promyelocytic leukemia cells and its mechanism]
Leukemia, Lymphoid
Aminopeptidase-N (CD13; gp 150): contrasting patterns of enzymatic activity in blood from patients with myeloid or lymphoid leukemia.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Purification and characterization of a ubenimex (Bestatin)-sensitive aminopeptidase B-like enzyme from K562 human chronic myeloid leukemia cells.
Leukemia, Myeloid
Multifactorial resistance to aminopeptidase inhibitor prodrug CHR2863 in myeloid leukemia cells: down-regulation of carboxylesterase 1, drug sequestration in lipid droplets and pro-survival activation ERK/Akt/mTOR.
Leukemia, Myeloid
Separate promoters control transcription of the human aminopeptidase N gene in myeloid and intestinal epithelial cells.
Leukemia, Myeloid, Acute
Aminopeptidase inhibition by the novel agent CHR-2797 (tosedostat) for the therapy of acute myeloid leukemia.
Leukemia, Myeloid, Acute
Aminopeptidase-N/CD13 is a potential proapoptotic target in human myeloid tumor cells.
Leukemia, Myeloid, Acute
In vitro and in vivo anti-leukemic activity of the peptidase-potentiated alkylator melflufen in acute myeloid leukemia.
Leukemia, Myeloid, Acute
Microfluidic chemical cytometry of peptide degradation in single drug-treated acute myeloid leukemia cells.
Leukemia, Myeloid, Acute
Multifactorial resistance to aminopeptidase inhibitor prodrug CHR2863 in myeloid leukemia cells: down-regulation of carboxylesterase 1, drug sequestration in lipid droplets and pro-survival activation ERK/Akt/mTOR.
Leukemia, Myeloid, Acute
Poly(ethylene glycol)-poly(lysine) block copolymer-ubenimex conjugate targets aminopeptidase N and exerts an antitumor effect in hepatocellular carcinoma stem cells.
Leukemia, Myeloid, Acute
Positioning of aminopeptidase inhibitors in next generation cancer therapy.
Leukemia, Promyelocytic, Acute
[Effect of aminopeptidase inhibitor on differentiation induction activity of all-trans retinoic acid in human acute promyelocytic leukemia NB4 cells and its mechanism]
Leukemia, Promyelocytic, Acute
[Experimental study of the enhancement effect of aminopeptidase N inhibitor ubenimex on the differentiation induction activity of all-trans-retinoic acid in acute promyelocytic leukemia cells and its mechanism]
Listeriosis
An M29 Aminopeptidase from Listeria Monocytogenes Contributes to In Vitro Bacterial Growth but not to Intracellular Infection.
Liver Cirrhosis
Serum pyroglutamyl aminopeptidase activity: a promising novel biomarker candidate for liver cirrhosis.
Liver Diseases
Alanine aminopeptidase in serum: automated optimized assay, and effects of age, sex, smoking, and alcohol consumption in a selected population.
Liver Diseases
Clinical significance of a new isoform of serum alanine aminopeptidase; relationship with liver disease and alcohol consumption.
Liver Diseases
Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes.
Liver Diseases
High-molecular-mass isoform of aminopeptidase N/CD13 in serum from cholestatic patients.
Liver Diseases
Intra-individual variation of analytes in serum from patients with chronic liver diseases.
Liver Diseases
Multiple forms of gamma-glutamyltransferase: a clinical study.
Liver Diseases
[Activity of aminopeptidase towards angiotensin II-amide in the serum during normal health, pregnancy, hypertension and liver disease]
Liver Diseases
[Clinical significance of glycylproline dipeptidyl aminopeptidase activity and isoenzyme patterns in the sera of patients with liver diseases]
Liver Diseases
[Clinical significance of glycylproline dipeptidyl aminopeptidase in liver diseases (author's transl)]
Liver Diseases, Alcoholic
Beta-hexosaminidase, leucine aminopeptidase, cystidyl aminopeptidase, hepatic enzymes and bilirubin in serum of chronic alcoholics with acute ethanol intoxication.
Liver Neoplasms
Aminopeptidase N inhibitor 4cc synergizes antitumor effects of 5-fluorouracil on human liver cancer cells through ROS-dependent CD13 inhibition.
Liver Neoplasms
Aminopeptidases and arylamidases in normal and cancer tissues in humans.
Liver Neoplasms
Bone morphogenetic protein-9 is a potent growth inhibitor of hepatocellular carcinoma and reduces the liver cancer stem cells population.
Liver Neoplasms
Getting to the heart of the matter in cancer: Novel approaches to targeting cancer stem cells.
Liver Neoplasms
Glycylproline dipeptidyl aminopeptidase and gamma-glutamyl transpeptidase in human hepatic cancer and embryonal tissues.
Liver Neoplasms
Serum and liver glycylproline dipeptidyl aminopeptidase activity in rats with experimental hepatic cancer.
Liver Neoplasms
Serum glycylproline dipeptidyl aminopeptidase activity in human hepatic cancer.
Liver Neoplasms
[Evaluation of serum glycylproline dipeptidyl aminopeptidase activity in the diagnosis of primary liver cancer]
Lung Diseases, Interstitial
CD13/aminopeptidase N in collagen vascular diseases.
Lung Diseases, Interstitial
The significance of cathepsins, thrombin and aminopeptidase in diffuse interstitial lung diseases.
Lung Neoplasms
Aminopeptidases and arylamidases in normal and cancer tissues in humans.
Lung Neoplasms
CD13 (aminopeptidase N) can associate with tumor-associated antigen L6 and enhance the motility of human lung cancer cells.
Lung Neoplasms
Circulating aminopeptidase N/CD13 is an independent prognostic factor in patients with non-small cell lung cancer.
Lung Neoplasms
Clinical significance of aminopeptidase N in non-small cell lung cancer.
Lung Neoplasms
Expression and clinical significance of aminopeptidase N/CD13 in non-small cell lung cancer.
Lung Neoplasms
N-acetylalanine aminopeptidase activity in normal and tumour cells.
Lung Neoplasms
Neutral endopeptidase/CD10 and aminopeptidase N/CD13 gene expression as a prognostic factor in non-small cell lung cancer.
Lung Neoplasms
Positioning of aminopeptidase inhibitors in next generation cancer therapy.
Lung Neoplasms
Stromal aminopeptidase N expression: correlation with angiogenesis in non-small-cell lung cancer.
Lupus Erythematosus, Systemic
CD13/aminopeptidase N in collagen vascular diseases.
Lupus Erythematosus, Systemic
[The value of urinary enzyme determinations in systemic lupus erythematosus (author's transl)]
Lupus Nephritis
Diagnostic value of the aminopeptidase N, N-acetyl-beta-D-glucosaminidase and dipeptidylpeptidase IV in evaluating tubular dysfunction in patients with glomerulopathies.
Lyme Disease
The thermophilic, homohexameric aminopeptidase of Borrelia burgdorferi is a member of the M29 family of metallopeptidases.
Lymphatic Metastasis
AZGP1 and SPDEF mRNA expression differentiates breast carcinoma from ovarian serous carcinoma.
Lymphatic Metastasis
Clinicopathological significance of aminopeptidase N/CD13 expression in human gastric carcinoma.
Lymphatic Metastasis
Expression and clinical significance of aminopeptidase N/CD13 in non-small cell lung cancer.
Lymphedema
Poly(ethylene glycol)-poly(lysine) block copolymer-ubenimex conjugate targets aminopeptidase N and exerts an antitumor effect in hepatocellular carcinoma stem cells.
Lymphoma
A novel mammalian high-molecular-weight aminopeptidase.
Lymphoma
Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes.
Lymphoma
Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13).
Lymphoma
Histochemistry of dipeptidyl aminopeptidase (DAP) II and IV in reactive lymphoid tissues and malignant lymphoma.
Lymphoma, B-Cell
Emerging therapies for acute myeloid leukemia.
Lymphoma, T-Cell
The aminopeptidase activity in the human T-cell lymphoma line (Jurkat) is not at the cell surface and is not aminopeptidase N (CD-13).
Malabsorption Syndromes
The activities of alanine aminopeptidase, leucine aminopeptidase, proline dipeptidase and prolyl dipeptidase in the mucosa of the small intestine. Investigations on normal children and patients with the malabsorption syndrome.
Malabsorption Syndromes
[Intestinal dipeptidase and disaccharidase activity in malabsorption syndrome in children]
Malaria
3'-RACE Amplification of Aminopeptidase N Gene from Anopheles stephensi Applicable in Transmission Blocking Vaccines.
Malaria
A comprehensive analysis of amino-peptidase N1 protein (APN) from Anopheles culicifacies for epitope design using Immuno-informatics models.
Malaria
Biochemical characterization of aminopeptidase N2 from Toxoplasma gondii.
Malaria
Chemical target validation studies of aminopeptidase in malaria parasites using alpha-aminoalkylphosphonate and phosphonopeptide inhibitors.
Malaria
Comparative proteomics and functional analysis reveal a role of P. falciparum osmiophilic bodies in malaria parasite transmission.
Malaria
Identification and Characterization of Aminopeptidase N 1 Gene of the Indian Malaria Vector Anopheles culicifacies (Diptera: Culicidae).
Malaria
Identification, molecular characterization and expression of aminopeptidase N-1 (APN-1) from Anopheles stephensi in SF9 cell line as a candidate molecule for developing a vaccine that interrupt malaria transmission.
Malaria
Plasmodium falciparum dipeptidyl aminopeptidase 3 activity is important for efficient erythrocyte invasion by the malaria parasite.
Malaria
Plasmodium falciparum neutral aminopeptidases: new targets for anti-malarials.
Malaria
Relationship of chloroquine-induced redistribution of a neutral aminopeptidase to hemoglobin accumulation in malaria parasites.
Malaria
Roles for two aminopeptidases in vacuolar hemoglobin catabolism in Plasmodium falciparum.
Malaria
Steered molecular dynamics simulations reveal critical residues for (un)binding of substrates, inhibitors and a product to the malarial M1 aminopeptidase.
Malaria
Structure-activity relationships and blood distribution of antiplasmodial aminopeptidase-1 inhibitors.
Malaria
The aminopeptidase inhibitor CHR-2863 is an orally bioavailable inhibitor of murine malaria.
Malaria
The Anopheles-midgut APN1 structure reveals a new malaria transmission-blocking vaccine epitope.
Malaria
The Plasmodium falciparum malaria M1 alanyl aminopeptidase (PfA-M1): insights of catalytic mechanism and function from MD simulations.
Malaria
Two cap residues in the S1 subsite of a Plasmodium falciparum M1-family aminopeptidase promote broad specificity and enhance catalysis.
Malaria
X-ray Crystal Structure and Specificity of the Plasmodium falciparum Malaria Aminopeptidase PfM18AAP.
Malaria, Falciparum
The Plasmodium falciparum malaria M1 alanyl aminopeptidase (PfA-M1): insights of catalytic mechanism and function from MD simulations.
Malaria, Falciparum
X-ray Crystal Structure and Specificity of the Plasmodium falciparum Malaria Aminopeptidase PfM18AAP.
Malnutrition
Effect of moderate malnutrition on concentrations of immunoglobulins and enzymes in tears and saliva of young Colombian children.
Malnutrition
Influence of malnutrition on the concentration of IgA, lysozyme, amylase and aminopeptidase in children's tears.
Medulloblastoma
[Growth promoting effect of IL-6 on medulloblastoma cells in vitro]
Melanoma
A chloride activated alanine aminopeptidase from a melanoma cell line.
Melanoma
Anchorage independence altered vasculogenic phenotype of melanoma cells through downregulation in aminopeptidase N /syndecan-1/integrin ?4 axis.
Melanoma
Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16-BL6 melanoma cells orthotopically implanted into syngeneic mice.
Melanoma
Bestatin and bacitracin inhibit porcine kidney cortex dipeptidyl peptidase IV activity and reduce human melanoma MeWo cell viability.
Melanoma
Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells.
Melanoma
Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies.
Melanoma
Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13).
Melanoma
Expression of the COVID-19 receptor ACE2 in the human conjunctiva.
Melanoma
Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13.
Melanoma
Immunoluminescent detection of intercellular adhesion molecule-1 and aminopeptidase N on human melanoma cells.
Melanoma
MT95-4, a fully humanized antibody raised against aminopeptidase N, reduces tumor progression in a mouse model.
Melanoma
New phenotypical and ultrastructural findings in spindle cell (desmoplastic/neurotropic) melanoma.
Melanoma
Promoter methylation of aminopeptidase N/CD13 in malignant melanoma.
Melanoma
Selection Signatures Analysis Reveals Genes Associated with High-Altitude Adaptation in Tibetan Goats from Nagqu, Tibet.
Melanoma
Synthesis of 5-S-L-cysteinyl-glycine-L-dopa, a natural substrate for serum and melanocyte dipeptidase.
Melanoma
[Aminopeptidase in melanoma tissue (author's transl)]
Melanoma
[Renal dipeptidylpeptidase IV excretion in drug-induced kidney changes]
membrane alanyl aminopeptidase deficiency
A patient with neurological symptoms and abnormal leukotriene metabolism: a new defect in leukotriene biosynthesis.
membrane alanyl aminopeptidase deficiency
An aminopeptidase N deficiency in dog small intestine.
membrane alanyl aminopeptidase deficiency
Dipeptidase deficiency and malabsorption of glycylglycine in disease states.
membrane alanyl aminopeptidase deficiency
Inborn errors in the metabolism of glutathione.
membrane alanyl aminopeptidase deficiency
[Dipeptidase deficiency]
Meningioma
Reduced Activity of CD13/Aminopeptidase N (APN) in Aggressive Meningiomas Is Associated with Increased Levels of SPARC.
Meningitis
Structure-guided, single-point modifications in the phosphinic dipeptide structure yield highly potent and selective inhibitors of neutral aminopeptidases.
Meningomyelocele
Fetal anal incontinence evaluated by amniotic fluid digestive enzyme assay in myelomeningocele spina bifida.
Mesothelioma
Aminopeptidase antibodies in mesothelioma: new wine deserves new sacks.
Mesothelioma
Aminopeptidase N/CD13 as a Potential Therapeutic Target in Malignant Pleural Mesothelioma.
Mesothelioma, Malignant
Aminopeptidase N/CD13 as a Potential Therapeutic Target in Malignant Pleural Mesothelioma.
Motor Neuron Disease
Lix1 knockout mouse does not exhibit spinal muscular atrophy phenotype.
Multiple Myeloma
Aminopeptidase Expression in Multiple Myeloma Associates with Disease Progression and Sensitivity to Melflufen.
Multiple Myeloma
The gp 130 family cytokines IL-6, LIF and OSM but not IL-11 can reverse the anti-proliferative effect of dexamethasone on human myeloma cells.
Multiple Sclerosis
Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes.
Multiple Sclerosis
DP IV/CD26, APN/CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosis.
Multiple Sclerosis
Expression of aminopeptidase N (APN) on peripheral blood mononuclear cells' surface as a marker of these cells' transendothelial migration properties in the course of multiple sclerosis.
Multiple Sclerosis
Increased expression of neutral endopeptidase (NEP) and aminopeptidase N (APN) on peripheral blood mononuclear cells in patients with multiple sclerosis.
Multiple Sclerosis
Review: Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice.
Multiple Sclerosis
Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice.
Multiple Sclerosis
[Increased expression of aminopeptidase N on lymphocytes in multiple sclerosis]
Muscular Atrophy, Spinal
Lix1 knockout mouse does not exhibit spinal muscular atrophy phenotype.
Muscular Dystrophies
Enzyme studies in muscular dystrophy. II. Muscle dipeptidase activity and vitamin E-deficiency.
Myocardial Infarction
AMINOPEPTIDASE ACTIVITY IN MYOCARDIAL INFARCTION OF MAN. A HISTOCHEMICAL STUDY.
Myocardial Infarction
Plasma cardiotrophin-1 following acute myocardial infarction: relationship with left ventricular systolic dysfunction.
Myocardial Infarction
[Aminopeptidases in the serum following myocardial infarct]
Neoplasm Metastasis
ACO2 and ANPEP as novel prognostic markers for gallbladder squamous cell/adenosquamous carcinomas and adenocarcinomas.
Neoplasm Metastasis
Anchorage independence altered vasculogenic phenotype of melanoma cells through downregulation in aminopeptidase N /syndecan-1/integrin ?4 axis.
Neoplasm Metastasis
APN-mediated phosphorylation of BCKDK promotes hepatocellular carcinoma metastasis and proliferation via the ERK signaling pathway.
Neoplasm Metastasis
AZGP1 and SPDEF mRNA expression differentiates breast carcinoma from ovarian serous carcinoma.
Neoplasm Metastasis
Cell cycle phases of two human lung tumor cell lines derived from squamous cell carcinoma and pulmonary metastasis of a rhabdomyosarcoma (HS 24 and HS 57) and N-acetylalanine aminopeptidase activity.
Neoplasm Metastasis
CIP-13F, a novel aminopeptidase N (APN/CD13) inhibitor, inhibits Lewis lung carcinoma growth and metastasis in mice.
Neoplasm Metastasis
Circulating aminopeptidase N/CD13 is an independent prognostic factor in patients with non-small cell lung cancer.
Neoplasm Metastasis
Clinicopathological significance of aminopeptidase N/CD13 expression in human gastric carcinoma.
Neoplasm Metastasis
Design, synthesis and biological evaluation of novel L-isoserine tripeptide derivatives as aminopeptidase N inhibitors.
Neoplasm Metastasis
Design, synthesis and biological evaluation of novel L-lysine ureido derivatives as aminopeptidase N inhibitors.
Neoplasm Metastasis
Design, synthesis and preliminary activity evaluation of novel 3-amino-2-hydroxyl-3-phenylpropanoic acid derivatives as aminopeptidase N/CD13 inhibitors.
Neoplasm Metastasis
Design, synthesis and SAR studies of tripeptide analogs with the scaffold 3-phenylpropane-1,2-diamine as aminopeptidase N/CD13 inhibitors.
Neoplasm Metastasis
Design, synthesis, and activity evaluation of a new 5-fluorouracil prodrug containing an Asn-Gly-Arg(NO2)COOCH3 tripeptide.
Neoplasm Metastasis
Development of Synthetic Aminopeptidase N/CD13 Inhibitors to Overcome Cancer Metastasis and Angiogenesis.
Neoplasm Metastasis
Distinguishing primary from secondary mucinous ovarian tumors: an algorithm using the novel marker DPEP1.
Neoplasm Metastasis
Ectopeptidases in tumour biology: a review.
Neoplasm Metastasis
Establishment of a screening protocol for identification of aminopeptidase N inhibitors.
Neoplasm Metastasis
Evaluation of (99m)Tc-probestin for imaging APN expressing tumors by SPECT.
Neoplasm Metastasis
Evaluation of an Integrin ?v?3 and Aminopeptidase N Dual-Receptor Targeting Tracer for Breast Cancer Imaging.
Neoplasm Metastasis
Expression and clinical significance of aminopeptidase N/CD13 in non-small cell lung cancer.
Neoplasm Metastasis
Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13.
Neoplasm Metastasis
In vivo imaging of Aminopeptidase N (CD13) receptors in experimental renal tumors using the novel radiotracer (68)Ga-NOTA-c(NGR).
Neoplasm Metastasis
Incadronate inhibits aminopeptidase N expression in prostatic PC-3 cells.
Neoplasm Metastasis
Inhibitory effect of anti-aminopeptidase N/CD13 antibodies on fibroblast migration.
Neoplasm Metastasis
Leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry. Part II.
Neoplasm Metastasis
LYP3, a new bestatin derivative for aminopeptidase N inhibition.
Neoplasm Metastasis
MT95-4, a fully humanized antibody raised against aminopeptidase N, reduces tumor progression in a mouse model.
Neoplasm Metastasis
Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).
Neoplasm Metastasis
Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.
Neoplasm Metastasis
Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.
Neoplasm Metastasis
Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).
Neoplasm Metastasis
Novel anticancer targets and drug discovery in post genomic age.
Neoplasm Metastasis
Novel Human Aminopeptidase N Inhibitors: Discovery and Optimization of Subsite Binding Interactions.
Neoplasm Metastasis
Novel indoline-2,3-dione derivatives as inhibitors of aminopeptidase N (APN).
Neoplasm Metastasis
Novel leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry.
Neoplasm Metastasis
Novel leucine ureido derivatives as aminopeptidase N inhibitors. Design, synthesis and activity evaluation.
Neoplasm Metastasis
Novel leucine ureido derivatives as inhibitors of aminopeptidase N (APN).
Neoplasm Metastasis
Precipitated Fluorophore-Based Molecular Probe for In Situ Imaging of Aminopeptidase N in Living Cells and Tumors.
Neoplasm Metastasis
Recent advances in the development of MMPIs and APNIs based on the pyrrolidine platforms.
Neoplasm Metastasis
Serum APN/CD13 as a novel diagnostic and prognostic biomarker of pancreatic cancer.
Neoplasm Metastasis
Synthesis and 4D-QSAR Studies of Alanine Hydroxamic Acid Derivatives as Aminopeptidase N Inhibitors.
Neoplasm Metastasis
Synthesis and activity evaluation of a new bestatin derivative LYP2 as an aminopeptidase N inhibitor.
Neoplasm Metastasis
Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells.
Neoplasm Metastasis
Ubenimex, an APN inhibitor, could serve as an anti?tumor drug in RT112 and 5637 cells by operating in an Akt?associated manner.
Neoplasm Metastasis
[Significance of the determination of alanine aminopeptidase and alkaline phosphatase in serum in the detection of osseous osteoplastic metastases]
Neoplasms
11C-MCG: synthesis, uptake selectivity, and primate PET of a probe for glutamate carboxypeptidase II (NAALADase).
Neoplasms
13F-1, a novel 5-fluorouracil prodrug containing an Asn-Gly-Arg (NO2) COOCH3 tripeptide, inhibits human colonic carcinoma growth by targeting Aminopeptidase N (APN/CD13).
Neoplasms
68Ga-DOTA-NGR as a novel molecular probe for APN-positive tumor imaging using MicroPET.
Neoplasms
A clinical evaluation of serological diagnosis for pancreatic cancer.
Neoplasms
A comparison of the monomeric [68Ga]NODAGA-NGR and dimeric [68Ga]NOTA-(NGR)2 as aminopeptidase N ligand for positron emission tomography imaging in tumor-bearing mice.
Neoplasms
A derivative of aminopeptidase inhibitor (BE15) has a dual inhibitory effect of invasion and motility on tumor and endothelial cells.
Neoplasms
A dipeptidase from Ehrlich Lettré mouse ascites tumor cells.
Neoplasms
A new class of 5-fluoro-2'-deoxyuridine prodrugs conjugated with a tumor-homing cyclic peptide CNGRC by ester linkers: synthesis, reactivity, and tumor-cell-selective cytotoxicity.
Neoplasms
A Phase Ib dose-escalation study to evaluate safety and tolerability of the addition of the aminopeptidase inhibitor tosedostat (CHR-2797) to paclitaxel in patients with advanced solid tumours.
Neoplasms
A unified mechanism for aminopeptidase N-based tumor cell motility and tumor-homing therapy.
Neoplasms
A-NGR fusion protein induces apoptosis in human cancer cells.
Neoplasms
Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes.
Neoplasms
ACO2 and ANPEP as novel prognostic markers for gallbladder squamous cell/adenosquamous carcinomas and adenocarcinomas.
Neoplasms
Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma.
Neoplasms
Activity screening and structure-activity relationship of the hit compounds targeting APN/CD13.
Neoplasms
Activity-Based Sensing and Theranostic Probes Based on Photoinduced Electron Transfer.
Neoplasms
Addition of an aminopeptidase N-binding sequence to human endostatin improves inhibition of ovarian carcinoma growth.
Neoplasms
Allosteric inhibition of aminopeptidase N functions related to tumor growth and virus infection.
Neoplasms
Altered levels of acid, basic, and neutral peptidase activity and expression in human clear cell renal cell carcinoma.
Neoplasms
Amino acid and dipeptide derivatives of daunorubicin. 1. Synthesis, physicochemical properties, and lysosomal digestion.
Neoplasms
Aminopeptidase A initiates tumorigenesis and enhances tumor cell stemness via TWIST1 upregulation in colorectal cancer.
Neoplasms
Aminopeptidase activity in cancer cells.
Neoplasms
Aminopeptidase Expression in Multiple Myeloma Associates with Disease Progression and Sensitivity to Melflufen.
Neoplasms
Aminopeptidase M and dipeptidyl peptidase IV activity in epithelial skin tumors: a histochemical study.
Neoplasms
Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer.
Neoplasms
Aminopeptidase N (APN/CD13) is selectively expressed in vascular endothelial cells and plays multiple roles in angiogenesis.
Neoplasms
Aminopeptidase N (CD13) as a target for cancer chemotherapy.
Neoplasms
Aminopeptidase N (CD13) regulates tumor necrosis factor-alpha-induced apoptosis in human neutrophils.
Neoplasms
Aminopeptidase N (CD13) targeted MR and NIRF dual-modal imaging of ovarian tumor xenograft.
Neoplasms
Aminopeptidase N (CD13): Expression, Prognostic Impact, and Use as Therapeutic Target for Tissue Factor Induced Tumor Vascular Infarction in Soft Tissue Sarcoma.
Neoplasms
Aminopeptidase N Activatable Fluorescent Probe for Tracking Metastatic Cancer and Image-Guided Surgery via in Situ Spraying.
Neoplasms
Aminopeptidase N inhibitor 4cc synergizes antitumor effects of 5-fluorouracil on human liver cancer cells through ROS-dependent CD13 inhibition.
Neoplasms
Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.
Neoplasms
Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer.
Neoplasms
Aminopeptidase N regulated by zinc in human prostate participates in tumor cell invasion.
Neoplasms
Aminopeptidase N/CD13 as a Potential Therapeutic Target in Malignant Pleural Mesothelioma.
Neoplasms
Aminopeptidase N/CD13 targeting fluorescent probes: synthesis and application to tumor cell imaging.
Neoplasms
Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.
Neoplasms
Aminopeptidase-N/CD13 is a potential proapoptotic target in human myeloid tumor cells.
Neoplasms
Aminopeptidases and angiotensin I-converting enzyme activities in primary human lung tumors and lung parenchyma.
Neoplasms
Anchorage independence altered vasculogenic phenotype of melanoma cells through downregulation in aminopeptidase N /syndecan-1/integrin ?4 axis.
Neoplasms
Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxel.
Neoplasms
Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16-BL6 melanoma cells orthotopically implanted into syngeneic mice.
Neoplasms
Antiproliferative effects of palladium(II) complexes of 5-nitrosopyrimidines and interactions with the proteolytic regulatory enzymes of the renin-angiotensin system in tumoral brain cells.
Neoplasms
Antisense-mediated inhibition of aminopeptidase N (CD13) markedly decreases growth rates of hematopoietic tumour cells.
Neoplasms
APN/CD13-targeting as a strategy to alter the tumor accumulation of liposomes.
Neoplasms
Aspartic Aminopeptidase Is a Novel Biomarker of Aggressive Chronic Lymphocytic Leukemia.
Neoplasms
Augmentation of death ligand-induced apoptosis by aminopeptidase inhibitors in human solid tumor cell lines.
Neoplasms
AZGP1 and SPDEF mRNA expression differentiates breast carcinoma from ovarian serous carcinoma.
Neoplasms
Base excision repair AP endonucleases and mismatch repair act together to induce checkpoint-mediated autophagy.
Neoplasms
Basic aminopeptidase activity is an emerging biomarker in collagen-induced rheumatoid arthritis.
Neoplasms
Bestatin as an experimental tool in mammals.
Neoplasms
Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis.
Neoplasms
Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects.
Neoplasms
Biochemical characterization of aminopeptidase N2 from Toxoplasma gondii.
Neoplasms
Biological significance of aminopeptidase N/CD13 in thyroid carcinomas.
Neoplasms
Bone marrow-derived CD13(+) cells sustain tumor progression: A potential non-malignant target for anticancer therapy.
Neoplasms
Brush border hydrolases in normal and neoplastic colonic epithelium.
Neoplasms
Carboplatin (CBDCA), iproplatin (CHIP), and high dose cisplatin in hypertonic saline evaluated for tubular nephrotoxicity.
Neoplasms
Catheptic and dipeptidase activities of ascites tumour cells.
Neoplasms
CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancer.
Neoplasms
Cell cycle phases of two human lung tumor cell lines derived from squamous cell carcinoma and pulmonary metastasis of a rhabdomyosarcoma (HS 24 and HS 57) and N-acetylalanine aminopeptidase activity.
Neoplasms
Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies.
Neoplasms
Cerenkov Luminescence Tomography of Aminopeptidase N (APN/CD13) Expression in Mice Bearing HT1080 Tumors.
Neoplasms
Changes in the dipeptidase and acid proteinase activities in blood plasma of mice carrying ascites tumors.
Neoplasms
Chlorin e6 embedded in phospholipid nanoparticles equipped with specific peptides: Interaction with tumor cells with different aminopeptidase N expression.
Neoplasms
CHR-2797: an antiproliferative aminopeptidase inhibitor that leads to amino acid deprivation in human leukemic cells.
Neoplasms
Ciliary neurotrophic factor is an endogenous pyrogen.
Neoplasms
CIP-13F, a novel aminopeptidase N (APN/CD13) inhibitor, inhibits Lewis lung carcinoma growth and metastasis in mice.
Neoplasms
Circulating aminopeptidase N/CD13 is an independent prognostic factor in patients with non-small cell lung cancer.
Neoplasms
Clinical significance of aminopeptidase N in non-small cell lung cancer.
Neoplasms
Clinical significance of aminopeptidase N/CD13 expression in human pancreatic carcinoma.
Neoplasms
Clinicopathological significance of aminopeptidase N/CD13 expression in human gastric carcinoma.
Neoplasms
Combination therapy of radiation and immunomodulators in the treatment of MM46 tumor transplanted in C3H/He mice.
Neoplasms
Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma.
Neoplasms
Cooperative effects of aminopeptidase N (CD13) expressed by nonmalignant and cancer cells within the tumor microenvironment.
Neoplasms
Correlation between adiponectin polymorphism and atherosclerotic plaque compositions under intravascular ultrasound (IVUS).
Neoplasms
Crystal structures of human procathepsin H.
Neoplasms
Cytoenzymology of benign and malignant tumours of the corpus uteri. III. Alkaline phosphatase, non-specific esterase and leucine aminopeptidase.
Neoplasms
Cytokines and feeding.
Neoplasms
Cytokines and glucocorticoids modulate human bronchial epithelial cell peptidases.
Neoplasms
Decrease in Dipeptidyl Peptidase IV Activity is Linked to the Efficacy of Differentiating Compounds in Follicular Thyroid Carcinoma Cell Lines.
Neoplasms
Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours.
Neoplasms
Design and synthesis of a novel peptide for selective detection of cancer cells.
Neoplasms
Design, Synthesis and Biological Evaluation of Ketoprofen Conjugated To RGD/NGR for Targeted Cancer Therapy.
Neoplasms
Design, synthesis and biological evaluation of novel L-isoserine tripeptide derivatives as aminopeptidase N inhibitors.
Neoplasms
Design, synthesis and biological evaluation of novel L-lysine ureido derivatives as aminopeptidase N inhibitors.
Neoplasms
Design, synthesis and biological evaluation of peptide-NSAID conjugates for targeted cancer therapy.
Neoplasms
Design, synthesis and preliminary activity evaluation of novel 3-amino-2-hydroxyl-3-phenylpropanoic acid derivatives as aminopeptidase N/CD13 inhibitors.
Neoplasms
Design, synthesis and SAR studies of tripeptide analogs with the scaffold 3-phenylpropane-1,2-diamine as aminopeptidase N/CD13 inhibitors.
Neoplasms
Design, synthesis, and activity evaluation of a new 5-fluorouracil prodrug containing an Asn-Gly-Arg(NO2)COOCH3 tripeptide.
Neoplasms
Development of NGR peptide-based agents for tumor imaging.
Neoplasms
Development of NGR-based anti-cancer agents for targeted therapeutics and imaging.
Neoplasms
Development of Synthetic Aminopeptidase N/CD13 Inhibitors to Overcome Cancer Metastasis and Angiogenesis.
Neoplasms
Diagnostic evaluation of alanine aminopeptidase as serum marker for detecting cancer.
Neoplasms
Differential Effects of Doxazosin on Renin-Angiotensin-System-Regulating Aminopeptidase Activities in Neuroblastoma and Glioma Tumoral Cells.
Neoplasms
Differential regulation of aminopeptidase N (CD13) by transendothelial migration and cytokines on human eosinophils.
Neoplasms
Dipeptidase 1 (DPEP1) is a marker for the transition from low-grade to high-grade intraepithelial neoplasia and an adverse prognostic factor in colorectal cancer.
Neoplasms
Dipeptidase 1: a candidate tumor-specific molecular marker in colorectal carcinoma.
Neoplasms
Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes.
Neoplasms
Dipeptidyl peptidase-IV inhibits glioma cell growth independent of its enzymatic activity.
Neoplasms
Direct inhibition of human acute myeloid leukemia cell growth by IL-12.
Neoplasms
Distinguishing primary from secondary mucinous ovarian tumors: an algorithm using the novel marker DPEP1.
Neoplasms
DPEP1 is a direct target of miR-193a-5p and promotes hepatoblastoma progression by PI3K/Akt/mTOR pathway.
Neoplasms
Ectopeptidases in tumour biology: a review.
Neoplasms
Effect of thyroid hormone-nitric oxide interaction on tumor growth, angiogenesis, and aminopeptidase activity in mice.
Neoplasms
Efficient inhibition of tumor angiogenesis and growth by a synthetic peptide blocking S100A4-methionine aminopeptidase 2 interaction.
Neoplasms
Elevation of glutathione in phenylalanine mustard-resistant murine L1210 leukemia cells.
Neoplasms
Engineered Peptides for Applications in Cancer Targeted Drug Delivery and Tumor Detection.
Neoplasms
Enhanced anti-tumor and anti-angiogenic efficacy of a novel liposomal fenretinide on human neuroblastoma.
Neoplasms
Enhanced Expression of CD13 in Vessels of Inflammatory and Neoplastic Tissues.
Neoplasms
Enhanced expression of CD13 in vessels of inflammatory and neoplastic tissues.
Neoplasms
Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13).
Neoplasms
Enzyme activity and distribution in rat prostatic adenocarcinoma.
Neoplasms
ERAP1 is associated with ankylosing Spondylitis in Han Chinese.
Neoplasms
ERAP1 overexpression in HPV-induced malignancies: A possible novel immune evasion mechanism.
Neoplasms
Establishment of a screening protocol for identification of aminopeptidase N inhibitors.
Neoplasms
Evaluation of (99m)Tc-probestin for imaging APN expressing tumors by SPECT.
Neoplasms
Evaluation of an Integrin ?v?3 and Aminopeptidase N Dual-Receptor Targeting Tracer for Breast Cancer Imaging.
Neoplasms
Exploration of structural and physicochemical requirements and search of virtual hits for aminopeptidase N inhibitors.
Neoplasms
Exploring ligand dissociation pathways from aminopeptidase N using random acceleration molecular dynamics simulation.
Neoplasms
Expression and clinical significance of aminopeptidase N/CD13 in non-small cell lung cancer.
Neoplasms
Expression and different polarity of aminopeptidase N in normal human colonic mucosa and colonic tumors.
Neoplasms
Expression of aminopeptidase N (CD13) in mesenchymal tumors.
Neoplasms
Expression of aminopeptidase N on human choriocarcinoma cells and cell growth suppression by the inhibition of aminopeptidase N activity.
Neoplasms
Expression of aminopeptidase N/CD13 in human ovarian cancers.
Neoplasms
Expression of aminopeptidase-n (CD 13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin.
Neoplasms
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study.
Neoplasms
Fungal lectin MpL enables entry of protein drugs into cancer cells and their subcellular targeting.
Neoplasms
Gastric and intestinal phenotypic expressions of human signet ring cell carcinomas revealed by their biochemistry, mucin histochemistry, and ultrastructure.
Neoplasms
Gastric- and intestinal-type properties of human gastric cancers transplanted into nude mice.
Neoplasms
Getting to the heart of the matter in cancer: Novel approaches to targeting cancer stem cells.
Neoplasms
Histochemical study of aminopeptidase in malignant neoplasms of the female genitals.
Neoplasms
Histochemical study of aminopeptidase in tumors of the oral region.
Neoplasms
Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13.
Neoplasms
Identification of gene signatures for invasive colorectal tumor cells.
Neoplasms
Improved biological activity of a mutant endostatin containing a single amino-acid substitution.
Neoplasms
In situ imaging of aminopeptidase N activity in hepatocellular carcinoma: a migration model for tumour using an activatable two-photon NIR fluorescent probe.
Neoplasms
In vitro assessment of the dual-targeting behavior of a peptide-based magnetic resonance imaging contrast agent.
Neoplasms
In vitro studies on CNGRC-CPG2 fusion proteins for ligand-directed enzyme prodrug therapy for targeted cancer therapy.
Neoplasms
In vivo assessment of aminopeptidase N (APN/CD13) specificity of different 68Ga-labelled NGR derivatives using PET/MRI imaging.
Neoplasms
In Vivo Coinstantaneous Identification of Hepatocellular Carcinoma Circulating Tumor Cells by Dual-Targeting Magnetic-Fluorescent Nanobeads.
Neoplasms
In vivo imaging of Aminopeptidase N (CD13) receptors in experimental renal tumors using the novel radiotracer (68)Ga-NOTA-c(NGR).
Neoplasms
In Vivo Imaging of Hypoxia and Neoangiogenesis in Experimental Syngeneic Hepatocellular Carcinoma Tumor Model Using Positron Emission Tomography.
Neoplasms
In Vivo Molecular Imaging of the Efficacy of Aminopeptidase N (APN/CD13) Receptor Inhibitor Treatment on Experimental Tumors Using 68Ga-NODAGA-c(NGR) Peptide.
Neoplasms
Increasing the activity of cell adherent cyclic NGR peptides by optimizing the peptide length and amino acid character.
Neoplasms
Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience.
Neoplasms
iNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomas.
Neoplasms
Inhibition by bestatin of a mouse ascites tumor dipeptidase. Reversal by certain substrates.
Neoplasms
Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells.
Neoplasms
Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer.
Neoplasms
Inhibition of Porcine Aminopeptidase M (pAMP) by the Pentapeptide Microginins.
Neoplasms
Inhibition of tumor cell invasion and matrix degradation by aminopeptidase inhibitors.
Neoplasms
Inhibition of tumor cell invasion by ubenimex (bestatin) in vitro.
Neoplasms
Inhibition of tumor invasion and extracellular matrix degradation by ubenimex (bestatin).
Neoplasms
Inhibitory effect of anti-aminopeptidase N/CD13 antibodies on fibroblast migration.
Neoplasms
Insulin-regulated aminopeptidase/placental leucil Aminopeptidase (IRAP/P-lAP) and angiotensin IV-forming activities are modified in serum of rats with breast cancer induced by N-methyl-nitrosourea.
Neoplasms
Intestinal brush-border-associated enzymes: co-ordinated expression in colorectal cancer.
Neoplasms
Involvement of aminopeptidase N in enhanced chemosensitivity to paclitaxel in ovarian carcinoma in vitro and in vivo.
Neoplasms
Involvement of DPPIV/CD26 in epithelial morphology and suppressed invasive ability in ovarian carcinoma cells.
Neoplasms
Isolated tumor endothelial cells maintain specific character during long-term culture.
Neoplasms
Kininase I, kininase II and aminopeptidase levels in patients with gastrointestinal tumors.
Neoplasms
Leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry. Part II.
Neoplasms
Localization of a cathepsin-like and aminopeptidase activity in various solid tumor transplants.
Neoplasms
Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast.
Neoplasms
LYP3, a new bestatin derivative for aminopeptidase N inhibition.
Neoplasms
Macrocyclisation of small peptides enabled by oxetane incorporation.
Neoplasms
Macrophage-derived interleukin-6 up-regulates MUC1, but down-regulates MUC2 expression in the human colon cancer HT-29 cell line.
Neoplasms
Melflufen - a peptidase-potentiated alkylating agent in clinical trials.
Neoplasms
Melphalan-flufenamide is cytotoxic and potentiates treatment with chemotherapy and the Src inhibitor dasatinib in urothelial carcinoma.
Neoplasms
miR-125b Acts as a Tumor Suppressor in Breast Tumorigenesis via Its Novel Direct Targets ENPEP, CK2-?, CCNJ, and MEGF9.
Neoplasms
Modification of cyclic NGR tumor neovasculature-homing motif sequence to human plasminogen kringle 5 improves inhibition of tumor growth.
Neoplasms
Molecular docking studies, biological and toxicity evaluation of dihydroisoquinoline derivatives as potential anticancer agents.
Neoplasms
Molecular Imaging of Aminopeptidase N in Cancer and Angiogenesis.
Neoplasms
MT95-4, a fully humanized antibody raised against aminopeptidase N, reduces tumor progression in a mouse model.
Neoplasms
Multiple gastric involvement by myeloid antigen CD13-positive non-secretory plasma cell leukaemia.
Neoplasms
N-acetylalanine aminopeptidase activity in normal and tumour cells.
Neoplasms
Nanocarrier-mediated targeting of tumor and tumor vascular cells improves uptake and penetration of drugs into neuroblastoma.
Neoplasms
Nanoparticles targeted with NGR motif deliver c-myc siRNA and doxorubicin for anticancer therapy.
Neoplasms
Native Chemical Ligation-Based Fluorescent Probes for Cysteine and Aminopeptidase N Using meso-thioester-BODIPY.
Neoplasms
Neutral endopeptidase/CD10 and aminopeptidase N/CD13 gene expression as a prognostic factor in non-small cell lung cancer.
Neoplasms
Neutral surface aminopeptidase activity of human tumor cell lines.
Neoplasms
New aromatic monoesters of alpha-aminoaralkylphosphonic acids as inhibitors of aminopeptidase N/CD13.
Neoplasms
NGR Tumor-Homing Peptides: Structural Requirements for Effective APN (CD13) Targeting.
Neoplasms
NGR-based strategies for targeting delivery of chemotherapeutics to tumor vasculature.
Neoplasms
NGR-modified micelles enhance their interaction with CD13-overexpressing tumor and endothelial cells.
Neoplasms
Noninvasive ratiometric fluorescence imaging of ?-glutamyltransferase activity using an activatable probe.
Neoplasms
Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.
Neoplasms
Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).
Neoplasms
Novel aminopeptidase N (APN/CD13) inhibitor 24F can suppress invasion of hepatocellular carcinoma cells as well as angiogenesis.
Neoplasms
Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.
Neoplasms
Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.
Neoplasms
Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.
Neoplasms
Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).
Neoplasms
Novel anticancer targets and drug discovery in post genomic age.
Neoplasms
Novel Human Aminopeptidase N Inhibitors: Discovery and Optimization of Subsite Binding Interactions.
Neoplasms
Novel indoline-2,3-dione derivatives as inhibitors of aminopeptidase N (APN).
Neoplasms
Novel leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry.
Neoplasms
Novel leucine ureido derivatives as aminopeptidase N inhibitors. Design, synthesis and activity evaluation.
Neoplasms
Novel leucine ureido derivatives as inhibitors of aminopeptidase N (APN).
Neoplasms
Noyes-Whitney Dissolution Model-Based pH-Sensitive Slow Release of Paclitaxel (Taxol) from Human Hair-Derived Keratin Microparticle Carriers.
Neoplasms
Peptides for cell-selective drug delivery.
Neoplasms
Pharmacokinetics of contrast agents targeted to the tumor vasculature in molecular magnetic resonance imaging.
Neoplasms
Phase I Study of NGR-hTNF, a Selective Vascular Targeting Agent, in Combination with Cisplatin in Refractory Solid Tumors.
Neoplasms
Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours.
Neoplasms
Phase II Study of Asparagine-Glycine-Arginine-Human Tumor Necrosis Factor {alpha}, a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesothelioma.
Neoplasms
Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy.
Neoplasms
Positioning of aminopeptidase inhibitors in next generation cancer therapy.
Neoplasms
Potential therapeutic impact of CD13 expression in non-small cell lung cancer.
Neoplasms
Precipitated Fluorophore-Based Molecular Probe for In Situ Imaging of Aminopeptidase N in Living Cells and Tumors.
Neoplasms
Preliminary detection of the anti?tumour activity of indoline?2,3?dione derivative DH?12a targeting aminopeptidase N.
Neoplasms
Preparation and comparative evaluation of
Neoplasms
Probing the structural and molecular diversity of tumor vasculature.
Neoplasms
Prognostic value of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and aminopeptidase N/CD13 in breast cancer patients.
Neoplasms
Protein phosphatase type 2A, PP2A, is involved in degradation of gp130.
Neoplasms
Proteomic Characterization of Two Medically Important Malaysian Snake Venoms, Calloselasma rhodostoma (Malayan Pit Viper) and Ophiophagus hannah (King Cobra).
Neoplasms
Proteomic profiling of the retinal dysplasia and degeneration chick retina.
Neoplasms
Proximal CD13 Versus Distal GATA-3 Expression in Renal Neoplasia According to WHO 2016 Classification.
Neoplasms
Psammaplin A, a marine natural product, inhibits aminopeptidase N and suppresses angiogenesis in vitro.
Neoplasms
Purification and properties of a mouse ascites tumor dipeptidase, a metalloenzyme.
Neoplasms
Pyruvate kinase is a dosage-dependent regulator of cellular amino acid homeostasis.
Neoplasms
Quantitative molecular magnetic resonance imaging of tumor angiogenesis using cNGR-labeled paramagnetic quantum dots.
Neoplasms
Radiation synergizes with antitumor activity of CD13-targeted tissue factor in a HT1080 xenograft model of human soft tissue sarcoma.
Neoplasms
Rapid and Sensitive Detection of Cancer Cells with Activatable Fluorescent Probes for Enzyme Activity.
Neoplasms
Rapid and sensitive detection of early esophageal squamous cell carcinoma with fluorescence probe targeting dipeptidylpeptidase IV.
Neoplasms
Rapid screening of peptide probes through in situ single-bead sequencing microarray.
Neoplasms
Recent advances in the development of MMPIs and APNIs based on the pyrrolidine platforms.
Neoplasms
Reduced Activity of CD13/Aminopeptidase N (APN) in Aggressive Meningiomas Is Associated with Increased Levels of SPARC.
Neoplasms
Reduced growth, increased vascular area, and reduced response to cisplatin in CD13-overexpressing human ovarian cancer xenografts.
Neoplasms
Regulation of aminopeptidase A in human brain tumor vasculature: evidence for a role of transforming growth factor-beta.
Neoplasms
Renal Carcinoma Is Associated With Increased Risk of Coronavirus Infections.
Neoplasms
Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature.
Neoplasms
Research Progress of Radiolabeled Asn-Gly-Arg (NGR) Peptides for Imaging and Therapy.
Neoplasms
Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation.
Neoplasms
Role of ubenimex as an anticancer drug and its synergistic effect with Akt inhibitor in human A375 and A2058 cells.
Neoplasms
Selective aminopeptidase-N (CD13) inhibitors with relevance to cancer chemotherapy.
Neoplasms
Serum APN/CD13 as a novel diagnostic and prognostic biomarker of pancreatic cancer.
Neoplasms
Sex differences exist in brain renin-angiotensin system-regulating aminopeptidase activities in transplacental ethyl-nitrosourea-induced gliomas.
Neoplasms
Silver(I)/6-hydroxyiminolumazine compounds differently modify renin-angiotensin system-regulating aminopeptidases A and N in human neuroblastoma and glioma cells.
Neoplasms
Soluble aminopeptidase N/CD13 in malignant and nonmalignant effusions and intratumoral fluid.
Neoplasms
Solute carrier transporters as targets for drug delivery and pharmacological intervention for chemotherapy.
Neoplasms
Studies on the mouse mammary tumour agent (MTA). II. Cytochemistry of aminopeptidase in normal mammary gland of C57BL, spontaneous and virus-induced mammary tumours in R3 and C57BL mouse strains, respectively, and in cell lines producing the mammary tumour virus.
Neoplasms
Sucrase-isomaltase expression and enterocytic ultrastructure of human colorectal tumors.
Neoplasms
Synthesis and 4D-QSAR Studies of Alanine Hydroxamic Acid Derivatives as Aminopeptidase N Inhibitors.
Neoplasms
Synthesis and activity evaluation of a new bestatin derivative LYP2 as an aminopeptidase N inhibitor.
Neoplasms
Synthesis and biological evaluation of novel flavone-8-acetic acid derivatives as reversible inhibitors of aminopeptidase N/CD13.
Neoplasms
Synthesis and evaluation of novel Tc-99?m labeled NGR-containing hexapeptides as tumor imaging agents.
Neoplasms
Synthesis and evaluation of novel Tc-99m labeled probestin conjugates for imaging APN/CD13 expression in vivo.
Neoplasms
Synthesis and Molecular Simulation Studies of Mandelic Acid Peptidomimetic Derivatives as Aminopeptidase N Inhibitors.
Neoplasms
Synthesis and molecular simulation study of furoic peptidomimetic derivatives as potent aminopeptodase N inhibitors.
Neoplasms
Synthesis of 1,3,4-thiadiazole derivatives as aminopeptidase N inhibitors.
Neoplasms
Synthesis of 5-(4'-carboxyphenyl)-10,15,20-tris-(4 pyridyl)-porphyrin and its peptidyl phosphonate derivatives.
Neoplasms
Tamm Horsfall protein expression by a small renal cell carcinoma presenting with metastases.
Neoplasms
Targeted antitumor prodrug therapy using CNGRC-yCD fusion protein in combination with 5-fluorocytosine.
Neoplasms
Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells.
Neoplasms
Targeting inhibition of fibroblast activation protein-? and prolyl oligopeptidase activities on cells common to metastatic tumor microenvironments.
Neoplasms
Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy.
Neoplasms
Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibody.
Neoplasms
Targeting peptide functionalized liposomes towards aminopeptidase N for precise tumor diagnosis and therapy.
Neoplasms
Targeting Tissue Factor to Tumor Vasculature to Induce Tumor Infarction.
Neoplasms
The Aminopeptidase CD13 Induces Homotypic Aggregation in Neutrophils and Impairs Collagen Invasion.
Neoplasms
The Analgesic Activity of Bestatin as a Potent APN Inhibitor.
Neoplasms
The CNGRCLLII(KLAKLAK)2 peptide shows cytotoxicity against HUVECs by inducing apoptosis: An in vitro and in vivo study.
Neoplasms
The effect of different species aminopeptidase N structure on the activity screening of aminopeptidase N inhibitor.
Neoplasms
The effect of Mn2+ and Co2+ on the activities of a zinc metallodipeptidase from a mouse ascites tumor.
Neoplasms
The enzymes of the hepatobiliary tract: a biochemical and clinical comparison.
Neoplasms
The Involvement of the Mammalian Target of Rapamycin, Protein Tyrosine Phosphatase 1b and Dipeptidase 4 Signaling Pathways in Cancer and Diabetes: A Narrative Review.
Neoplasms
The main neutral aminopeptidase activity of human lymphoid tumour cell lines does not originate from the aminopeptidase N-(APN; CD13) gene.
Neoplasms
The neovasculature homing motif NGR: more than meets the eye.
Neoplasms
The novel alkylating prodrug melflufen (J1) inhibits angiogenesis in vitro and in vivo.
Neoplasms
The pro-oxidant buthionine sulfoximine (BSO) reduces tumor growth of implanted Lewis lung carcinoma in mice associated with increased protein carbonyl, tubulin abundance, and aminopeptidase activity.
Neoplasms
The synthesis and preliminary activity assay in vitro of peptide-like derivatives as APN inhibitors.
Neoplasms
Tissue-factor fusion proteins induce occlusion of tumor vessels.
Neoplasms
Tumor Growth Inhibition via Occlusion of Tumor Vasculature Induced by N-Terminally PEGylated Retargeted Tissue Factor tTF-NGR.
Neoplasms
Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma.
Neoplasms
Tumor vascular targeting with tumor necrosis factor alpha and chemotherapeutic drugs.
Neoplasms
Ubenimex induces apoptotic and autophagic cell death in rat GH3 and MMQ cells through the ROS/ERK pathway.
Neoplasms
XPNPEP2 is associated with lymph node metastasis in prostate cancer patients.
Neoplasms
[Alanine aminopeptidase and gamma-glutamyltransferase in tumors of the human]
Neoplasms
[Aldolase, dipeptidase, tripeptidase, tributyrinase, phosphatase, amylase, proteins and protein polysaccharides in the blood serum and ascites fluid in the mouse ascites tumor.]
Neoplasms
[Cancer and aminopeptidase N]
Neoplasms
[Cathepsin H activity in the human brain and human brain neoplasms]
Neoplasms
[Comparative study on urinary parameters reflecting renal damage during chemotherapy for urological cancer]
Neoplasms
[Detection of gene expression alteration of myeloma cells treated with arsenic trioxide]
Neoplasms
[Do immunologic markers facilitate differentiation between histologic types of stomach cancer?]
Neoplasms
[Enzyme cytochemical investigations on pleural effusions (author's transl)]
Neoplasms
[Enzymological study of prostatic cancer. I. Changes of serum lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase, prostatic acid phosphatase, glutamic pyruvic transaminase, glutamic oxalacetic transaminase activity and lactic dehydrogenase isoenzymes in prostatic cancer under anti-androgenic treatment, with special reference to prognosis]
Neoplasms
[Enzymological study of prostatic cancer. II. Serum lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase, prostatic acid phosphatase activity and lactic dehydrogenase isoenzymes in prostatic cancer, with special reference to relation with stage and histological malignancy]
Neoplasms
[Growth promoting effect of IL-6 on medulloblastoma cells in vitro]
Neoplasms
[Histochemical studies of human stomach biopsies with special reference to hydrolases]
Neoplasms
[Inhibition of tumor cell invasion and induction of apoptosis by ubenimex].
Neoplasms
[MnSOD gene regulated by aminopeptidase N promoter specifically protects bone marrow from radiation]
Neoplasms
[On relations between aminopeptidase (LAP) and destructive tumor growth]
Neoplasms
[The significance of serum leucine aminopeptidase (P-LAP) determination in the gynecological malignancies]
Neoplasms
[Tumor markers in the cytodiagnosis of thyroid nodules. Detection of dipeptidyl aminopeptidase IV (DAP IV) activity]
Neoplasms
[Urological neoplasms and enzyme. IV. Studies on the alteration of lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, and total acid phosphatase activities and LDH isozymes in experimentally induced renal tumors with dimethylnitrosamine]
Neoplasms
[Urological neoplasms and enzymes. V. Studies on the alteration of lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase activities and LDH isozymes in experimentally induced renal tumors with lead acetate]
Nephritis
A fluorometric method for dipeptidase activity measurement in urine, using L-alanyl-L-alanine as substrate.
Nephritis
Urinary alanine aminopeptidase activity in various urinary tract diseases.
Nephroma, Mesoblastic
In vivo assessment of aminopeptidase N (APN/CD13) specificity of different 68Ga-labelled NGR derivatives using PET/MRI imaging.
Nephrosclerosis
Urinary Lysosomal Enzyme Activities and Albuminuria in Ghanaian Patients with Type 2 Diabetes Mellitus.
Nephrotic Syndrome
Urinary trehalase activity in chronic glomerulonephritis.
Nephrotic Syndrome
[A method of separate determination of enzymuria associated with impairment of glomerular filtration in kidney tissue]
Nephrotic Syndrome
[Activity of alanine aminopeptidase, beta-glucuronidase and N-acetyl-beta-d-glucosaminidase in urine of children with nephrotic syndrome]
Neuralgia
Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain.
Neuroblastoma
Characterization of the enkephalin-degrading aminopeptidase of neuroblastoma (N1E-115) cell membranes.
Neuroblastoma
Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma.
Neuroblastoma
Differential Effects of Doxazosin on Renin-Angiotensin-System-Regulating Aminopeptidase Activities in Neuroblastoma and Glioma Tumoral Cells.
Neuroblastoma
Enkephalin degradation by enkephalinergic neuroblastoma cells. Involvement of angiotensin-converting-enzyme.
Neuroblastoma
Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy.
Neuroblastoma
Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.
Neuronal Ceroid-Lipofuscinoses
Functional consequences and rescue potential of pathogenic missense mutations in tripeptidyl peptidase I.
Neuronal Ceroid-Lipofuscinoses
Tripeptidyl-peptidase I in neuronal ceroid lipofuscinoses and other lysosomal storage disorders.
Non-alcoholic Fatty Liver Disease
Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
[Serum dipeptidyl peptidase N levels in obese children with nonalcoholic fatty liver disease].
Obesity
Klotho and Aminopeptidases as Early Biomarkers of Renal Injury in Zucker Obese Rats.
Obesity
[Obesity, inflammation and insulin resistance: role of gp 130 receptor ligands]
Obstetric Labor, Premature
Placental leucine aminopeptidase- and aminopeptidase A- deficient mice offer insight concerning the mechanisms underlying preterm labor and preeclampsia.
Oligohydramnios
Effects of exposure to tobacco smoke in pregnancies complicted by oligohydramnios and premature rupture of the membranes. II. Activity of brush border enzymes in human amniotic fluid.
Opisthorchiasis
Partial protection with a chimeric tetraspanin-leucine aminopeptidase subunit vaccine against Opisthorchis viverrini infection in hamsters.
Osteoarthritis
CD13/aminopeptidase N in collagen vascular diseases.
Osteoporosis
Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes.
Osteosarcoma
Enhancement of methotrexate nephrotoxicity after cisplatin therapy.
Osteosarcoma
Inhibitory effect of antisense aminopeptidase N (APN/CD13) cDNA transfection on the invasive potential of osteosarcoma cells.
Osteosarcoma
Possible contribution of aminopeptidase N (APN/CD13) to invasive potential enhanced by interleukin-6 and soluble interleukin-6 receptor in human osteosarcoma cell lines.
Osteosarcoma
Possible contribution of aminopeptidase N (APN/CD13) to migration and invasion of human osteosarcoma cell lines.
Ototoxicity
Pharmacokinetic and toxicity evaluation of five-day continuous infusion versus intermittent bolus cis-diamminedichloroplatinum(II) in head and neck cancer patients.
Ovarian Neoplasms
Distinguishing primary from secondary mucinous ovarian tumors: an algorithm using the novel marker DPEP1.
Ovarian Neoplasms
Expression of aminopeptidase N/CD13 in human ovarian cancers.
Ovarian Neoplasms
Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: a possible target for combination therapy with anti-proliferative aminopeptidase inhibitors.
Pancreatic Cyst
The lysosomal aminopeptidase tripeptidyl peptidase 1 displays increased activity in malignant pancreatic cysts.
Pancreatic Diseases
[Critical studies on the diagnostic significance of alanine aminopeptidase and its isoenzymes in pancreatic diseases]
Pancreatic Diseases
[Isoenzymes of alanine aminopeptidase as specific parameters in the diagnosis of biliary and pancreatic diseases]
Pancreatic Neoplasms
A clinical evaluation of serological diagnosis for pancreatic cancer.
Pancreatic Neoplasms
Phase Ib/II study combining tosedostat with capecitabine in patients with advanced pancreatic adenocarcinoma.
Pancreatic Neoplasms
Serum APN/CD13 as a novel diagnostic and prognostic biomarker of pancreatic cancer.
Pancreatic Neoplasms
[Isoenzymes of alanine arylamidase (AAP, EC 3.4.11.2) and gamma-glutamyltranspeptidase (GGTP, EC 2.3.2.2) in chronic pancreatitis and pancreas neoplasm (author's transl)]
Pancreatitis
Serum pyroglutamyl aminopeptidase activity: a promising novel biomarker candidate for liver cirrhosis.
Pancreatitis, Chronic
Serum APN/CD13 as a novel diagnostic and prognostic biomarker of pancreatic cancer.
Pancreatitis, Chronic
[Isoenzymes of alanine arylamidase (AAP, EC 3.4.11.2) and gamma-glutamyltranspeptidase (GGTP, EC 2.3.2.2) in chronic pancreatitis and pancreas neoplasm (author's transl)]
Papilloma
Expression of the COVID-19 receptor ACE2 in the human conjunctiva.
Paralysis
The Drosophila slamdance gene: a mutation in an aminopeptidase can cause seizure, paralysis and neuronal failure.
Parasitic Diseases
Induction of some digestive enzymes in the midgut of the sandfly Phlebotomus langeroni after sugar and blood meals.
Parkinson Disease
Plasma aminopeptidase activities in Parkinson's disease.
Parkinson Disease
The Human Coronavirus Receptor ANPEP (CD13) Is Overexpressed in Parkinson's Disease.
Pemphigus
[Histotopography of aminopeptidase in pemphigus vulgaris; with a contribution to the pathogenesis of acantholytic blister formation.]
Periodontal Diseases
Alanine aminopeptidase and dipeptidylpeptidase IV in saliva: the possible role in periodontal disease.
Periodontal Diseases
An aminopeptidase nutritionally important to Fusobacterium nucleatum.
Periodontal Diseases
Serum levels of oncostatin M (a gp 130 cytokine): an inflammatory biomarker in periodontal disease.
Periodontitis
Salivary proteolytic activities in periodontitis, gingivitis and diabetes mellitus.
Peritonitis
Analysis of the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection: aminopeptidase N is not important and a process of acidification of the endosome is necessary.
Peritonitis
Characterization of determinants involved in the feline infectious peritonitis virus receptor function of feline aminopeptidase N.
Peritonitis
Feline aminopeptidase N is not a functional receptor for avian infectious bronchitis virus.
Peritonitis
Interspecies aminopeptidase-N chimeras reveal species-specific receptor recognition by canine coronavirus, feline infectious peritonitis virus, and transmissible gastroenteritis virus.
Peritonitis
Intriguing interplay between feline infectious peritonitis virus and its receptors during entry in primary feline monocytes.
Peritonitis
Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibody.
Peritonitis
TNF-alpha, produced by feline infectious peritonitis virus (FIPV)-infected macrophages, upregulates expression of type II FIPV receptor feline aminopeptidase N in feline macrophages.
Pituitary Neoplasms
Expression of interleukin-6, interleukin-6 receptor (gp80), and the receptor's signal-transducing subunit (gp130) in human normal pituitary glands and pituitary adenomas.
Pleural Effusion
CD13/aminopeptidase N in collagen vascular diseases.
Pneumonia
Structural and kinetic bases for the metal preference of the M18 aminopeptidase from Pseudomonas aeruginosa.
Pneumonia
The significance of cathepsins, thrombin and aminopeptidase in diffuse interstitial lung diseases.
Pneumonia, Progressive Interstitial, of Sheep
Expression of the gp150 maedi visna virus envelope precursor protein by mammalian expression vectors.
Polycystic Kidney, Autosomal Dominant
Chymase-like angiotensin II-generating activity in end-stage human autosomal dominant polycystic kidney disease.
Polyuria
Reversibility of renal tubular dysfunction in streptozotocin-induced diabetes in the rat.
Pre-Eclampsia
Aminopeptidase A (ENPEP) gene polymorphisms and preeclampsia: Descriptive analysis.
Pre-Eclampsia
Increased tubular enzyme excretion in preeclampsia.
Pre-Eclampsia
Physiological and pathophysiological roles of placental aminopeptidase in maternal sera: possible relation to preeclampsia and preterm delivery.
Pre-Eclampsia
Placental leucine aminopeptidase- and aminopeptidase A- deficient mice offer insight concerning the mechanisms underlying preterm labor and preeclampsia.
Pre-Eclampsia
Relationship between the changes in placental blood flow resistance assessed by Doppler technique and maternal serum placental aminopeptidases, which degrade vaso-active peptides, in pre-eclampsia.
Pre-Eclampsia
The role of LNPEP and ANPEP gene polymorphisms in the pathogenesis of pre-eclampsia.
Primary Immunodeficiency Diseases
Flavivirus Antagonism of Type I Interferon Signaling Reveals Prolidase as a Regulator of IFNAR1 Surface Expression.
Prostatic Hyperplasia
[Enzymatic activities in human prostatic adenoma (leucine aminopeptidase, 5-nucleotidase, adenosine triphosphatase, lactic dehydrogenase, phosphohexoisomerase).]
Prostatic Neoplasms
11C-MCG: synthesis, uptake selectivity, and primate PET of a probe for glutamate carboxypeptidase II (NAALADase).
Prostatic Neoplasms
Angiotensin II and its fragments (angiotensins III and IV) decrease the growth of DU-145 prostate cancer in vitro.
Prostatic Neoplasms
Incadronate inhibits aminopeptidase N expression in prostatic PC-3 cells.
Prostatic Neoplasms
Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer.
Prostatic Neoplasms
Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast.
Prostatic Neoplasms
Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer.
Prostatic Neoplasms
[Comparative study on urinary parameters reflecting renal damage during chemotherapy for urological cancer]
Prostatic Neoplasms
[Enzymological study of prostatic cancer. I. Changes of serum lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase, prostatic acid phosphatase, glutamic pyruvic transaminase, glutamic oxalacetic transaminase activity and lactic dehydrogenase isoenzymes in prostatic cancer under anti-androgenic treatment, with special reference to prognosis]
Prostatic Neoplasms
[Enzymological study of prostatic cancer. II. Serum lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase, prostatic acid phosphatase activity and lactic dehydrogenase isoenzymes in prostatic cancer, with special reference to relation with stage and histological malignancy]
Prostatic Neoplasms
[Enzymological study of prostatic cancer. V. Alterations in the serum acid and alkaline phosphatase and leucine aminopeptidase activities following massage of the prostate]
Proteinuria
Cancer chemotherapy-induced tubular nephrotoxicity evaluated by immunochemical determination of urinary adenosine deaminase binding protein.
Proteinuria
Cisplatin nephrotoxicity and protection by silibinin.
Proteinuria
Neomycin toxicosis in calves.
Proteinuria
Tubulopathy with macroalbuminuria due to diabetic nephropathy and primary glomerulonephritis.
Proteinuria
Urinary excretion of alanine aminopeptidase and total proteinuria in experimental diabetes mellitus before and after islet transplantation.
Proteinuria
Vancomycin does not enhance amikacin-induced tubular nephrotoxicity in children.
Psoriasis
APN/CD13 is over-expressed by Psoriatic fibroblasts and is modulated by CGRP and IL-4 but not by retinoic acid treatment.
Psoriasis
Functional Genomics and Its Bench-to-Bedside Translation Pertaining to the Identified Susceptibility Alleles and Loci in Ankylosing Spondylitis.
Psoriasis
[Histochemical determination of aminopeptidase in normal skin, psoriasis, dermatitis, basaloma, spinous cell carcinoma and molluscum sebaceum.]
Pulmonary Disease, Chronic Obstructive
A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation.
Pulmonary Disease, Chronic Obstructive
Development and Clinical Validation of a Novel 4-Gene Prognostic Signature Predicting Survival in Colorectal Cancer.
Pulmonary Disease, Chronic Obstructive
Effect of Modifier Structure on the Activation of Leukotriene A4 Hydrolase Aminopeptidase Activity.
Pulmonary Emphysema
Effect of the leukotriene A4 hydrolase aminopeptidase augmentor 4-methoxydiphenylmethane in a pre-clinical model of pulmonary emphysema.
Pulmonary Eosinophilia
The significance of cathepsins, thrombin and aminopeptidase in diffuse interstitial lung diseases.
Pulmonary Heart Disease
[Urinary alanine aminopeptidase and lysozyme excretion in patients with diabetes]
Pyelonephritis
Efficacy and safety of once daily versus intermittent dosing of tobramycin in rabbits with acute pyelonephritis.
Pyelonephritis
Urinary alanine aminopeptidase activity in various urinary tract diseases.
Pyelonephritis
[Excretion of alanine aminopeptidase in the urine after administration of lysosomotrophic substances in patients with latent or florid pyelonephritis]
Pyelonephritis
[Renal dipeptidylpeptidase IV excretion in drug-induced kidney changes]
Renal Insufficiency
A low molecular weight alanine aminopeptidase in urine. Biochemical equivalent of tubular atrophy?
Renal Insufficiency
Alanine aminopeptidase excretion after mercuric chloride renal failure.
Renal Insufficiency
Aminopeptidase activity in the livers of rats with experimental chronic renal failure.
Renal Insufficiency
Evaluation of urinary enzymes in dogs with early renal disorder.
Renal Insufficiency, Chronic
Diagnostic significance of different urinary enzymes in patients suffering from chronic renal diseases.
Rhabdomyolysis
Lipoic acid effects on renal function, aminopeptidase activities and oxidative stress in Crotalus durissus terrificus envenomation in mice.
Rhabdomyosarcoma
Cell cycle phases of two human lung tumor cell lines derived from squamous cell carcinoma and pulmonary metastasis of a rhabdomyosarcoma (HS 24 and HS 57) and N-acetylalanine aminopeptidase activity.
Sarcoidosis
CD13/aminopeptidase N, a novel chemoattractant for T lymphocytes in pulmonary sarcoidosis.
Sarcoidosis, Pulmonary
CD13/aminopeptidase N, a novel chemoattractant for T lymphocytes in pulmonary sarcoidosis.
Sarcoma
Aminopeptidase N (CD13): Expression, Prognostic Impact, and Use as Therapeutic Target for Tissue Factor Induced Tumor Vascular Infarction in Soft Tissue Sarcoma.
Sarcoma
Identification of APN/CD13 as the target antigen of FU3, a human monoclonal antibody that recognizes malignant fibrous histiocytoma.
Schistosomiasis
Antigenic properties of Schistosoma mansoni aminopeptidases: evolution during the development in mammalian hosts.
Scleroderma, Systemic
CD13/aminopeptidase N in collagen vascular diseases.
Seizures
The Drosophila slamdance gene: a mutation in an aminopeptidase can cause seizure, paralysis and neuronal failure.
Severe Acute Respiratory Syndrome
Renin-angiotensin system inhibition and risk of infection and mortality in COVID-19: a systematic review and meta-analysis.
Shock, Cardiogenic
Circulating plasma dipeptidyl dipeptidase 3 and the prognosis of cardiogenic shock.
Shock, Septic
Leucyl/cystinyl aminopeptidase (LNPEP) gene variants in septic shock.
Silicosis
[Kinin aminopeptidase in lung tissue and activity of kininase II in the serum of patients with silicosis]
Sjogren's Syndrome
[Activity of the esterase, alkaline phosphatase and aminopeptidase in the gastric mucosa in patients with Sjogren syndrome.]
Skin Diseases
The ectopeptidases dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN) and their related enzymes as possible targets in the treatment of skin diseases.
Skin Diseases, Vesiculobullous
Histochemical study of bullous dermatoses. II. Leucine aminopeptidase.
Spinal Dysraphism
Fetal anal incontinence evaluated by amniotic fluid digestive enzyme assay in myelomeningocele spina bifida.
Spondylitis, Ankylosing
ERAP1 and ankylosing spondylitis.
Spondylitis, Ankylosing
Expression of MHC class I dimers and ERAP1 in an ankylosing spondylitis patient cohort.
Squamous Cell Carcinoma of Head and Neck
Increased APN/CD13 and acid aminopeptidase activities in head and neck squamous cell carcinoma.
Starvation
Adaptation of intestinal enzymes to seasonal and dietary changes in a hibernator: the European hamster (Cricetus cricetus).
Starvation
Adaptation of intestinal hydrolases to starvation in rats: effect of thyroid function.
Starvation
Alterations in the DNA binding activity of transcriptional factors activator protein-1, Sp1, and hepatocyte nuclear factor-1 in rat jejunum during starvation and refeeding.
Starvation
Deletion analysis of the promoter region of the Escherichia coli pepN gene, a gene subject in vivo to multiple global controls.
Starvation
Dietary whey proteins and their peptides or amino acids: effects on the jejunal mucosa of starved rats.
Starvation
Effect of early postnatal long-term fasting on the development of peptide hydrolysis in chicks.
Starvation
Effect of fasting on the structure and function of the gastrointestinal tract of house sparrows (Passer domesticus).
Starvation
Evidence for a potential common T-cell epitope between human thyroid peroxidase and human thyroglobulin with implications for the pathogenesis of autoimmune thyroid disease.
Starvation
Modifications of brush border enzyme activities during starvation in the jejunum and ileum of adult rats.
Starvation
PtdIns4P restriction by hydrolase SAC1 decides specific fusion of autophagosomes with lysosomes.
Starvation
The cellular location of proteases in Candida albicans.
Stomach Neoplasms
Aminopeptidase N (APN/CD13) as a target molecule for scirrhous gastric cancer.
Stomach Neoplasms
Aminopeptidases and arylamidases in normal and cancer tissues in humans.
Stomach Neoplasms
Clinicopathological significance of aminopeptidase N/CD13 expression in human gastric carcinoma.
Stomatitis, Denture
Activity of arginine aminopeptidases and phosphatases in inflamed palatal mucosa in denture stomatitis: a histochemical and biochemical study.
Stroke
Bioinformatics Gene Analysis of Potential Biomarkers and Therapeutic Targets for Unstable Atherosclerotic Plaque-Related Stroke.
Testicular Neoplasms
Urinary excretion of alanine-aminopeptidase and N-acetyl-beta-D-glucosaminidase during sequential combination chemotherapy.
Tetanus
Evidence for a link between specific proteolysis and inhibition of [3H]-noradrenaline release by the light chain of tetanus toxin.
Tetanus
Families of zinc metalloproteases.
Thromboembolism
Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism.
Thrombosis
Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience.
Thymoma
Characterization of the neutral aminopeptidase activity associated to the mouse thymocyte-activating molecule.
Thymoma
Murine thymocytes possess specific cell surface-associated exoaminopeptidase activities: preferential expression by immature CD4-CD8- subpopulation.
Thyroid Carcinoma, Anaplastic
Biological significance of aminopeptidase N/CD13 in thyroid carcinomas.
Thyroid Neoplasms
Biological significance of aminopeptidase N/CD13 in thyroid carcinomas.
Thyroid Neoplasms
Decrease in Dipeptidyl Peptidase IV Activity is Linked to the Efficacy of Differentiating Compounds in Follicular Thyroid Carcinoma Cell Lines.
Thyroid Neoplasms
Diagnostic evaluation of alanine aminopeptidase as serum marker for detecting cancer.
Thyroid Nodule
[Tumor markers in the cytodiagnosis of thyroid nodules. Detection of dipeptidyl aminopeptidase IV (DAP IV) activity]
Toxoplasmosis
Aminopeptidase activity in the brains of mice with chronic Toxoplasma gondii infections.
Toxoplasmosis, Congenital
Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans.
Trichinellosis
Molecular characterization of Trichinella spiralis aminopeptidase and its potential as a novel vaccine candidate antigen against trichinellosis in BALB/c mice.
Tuberculosis
Aminopeptidase N Facilitates Entry and Intracellular Survival of Mycobacterium Tuberculosis in Monocytes.
Tuberculosis
Characterization and comparison of aminopeptidase activity of various strains of Mycobacterium tuberculosis.
Tuberculosis
Mycobacterium tuberculosis puromycin hydrolase displays a prolyl oligopeptidase fold and an acyl aminopeptidase activity.
Tuberculosis
The Activity of a Hexameric M17 Metallo-Aminopeptidase Is Associated With Survival of Mycobacterium tuberculosis.
Tuberculosis
Transposition of IS117 of Streptomyces coelicolor A3(2) in Mycobacterium smegmatis.
Urinary Bladder Neoplasms
Aminopeptidase activities as prospective urinary biomarkers for bladder cancer.
Urinary Bladder Neoplasms
[Activity of aminopeptidase in blood and urine in patients with bladder neoplasms]
Urinary Bladder Neoplasms
[Enzymological study of bladder tumor. I. Serum lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase, prostatic acid phosphatase, glutamic pyruvic transaminase, glutamic oxalacetic transaminase activities and LDH isoenzymes: the relations with stage and histological grade]
Urinary Bladder Neoplasms
[Mechanisms for effect of osthole on inhibiting the growth and invasion of bladder cancer cells].
Urinary Tract Infections
Diagnostic potential of urinary enzymes and beta 2-microglobulin in acute urinary tract infection.
Urologic Diseases
Urinary alanine aminopeptidase activity in various urinary tract diseases.
Urologic Diseases
[Clinical evaluation of urinary glycyl-prolyl dipeptidyl aminopeptidase in patients with urological disease]
Urologic Neoplasms
Inhibition of aminopeptidase N (AP-N) and urokinase-type plasminogen activator (uPA) by zinc suppresses the invasion activity in human urological cancer cells.
Urologic Neoplasms
[Urological neoplasms and enzyme. IV. Studies on the alteration of lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, and total acid phosphatase activities and LDH isozymes in experimentally induced renal tumors with dimethylnitrosamine]
Urologic Neoplasms
[Urological neoplasms and enzymes. V. Studies on the alteration of lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase activities and LDH isozymes in experimentally induced renal tumors with lead acetate]
Uterine Cervical Neoplasms
Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer.
Vaccinia
Envelope-Specific Recognition Patterns of HIV Vaccine-Induced IgG Antibodies Are Linked to Immunogen Structure and Sequence.
Vaccinia
Immunogenicity of HIV-1 Vaccines Expressing Chimeric Envelope Glycoproteins on the Surface of Pr55 Gag Virus-Like Particles.
Vaccinia
Murine gamma-herpesvirus 68 glycoprotein 150 protects against virus-induced mononucleosis: a model system for gamma-herpesvirus vaccination.
Vaccinia
Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap.
Vesicular Stomatitis
A novel type of detergent-resistant membranes may contribute to an early protein sorting event in epithelial cells.
Viremia
Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism.
Virus Diseases
Allosteric inhibition of aminopeptidase N functions related to tumor growth and virus infection.
Virus Diseases
Aminopeptidase N Knockout Pigs Are Not Resistant to Porcine Epidemic Diarrhea Virus Infection.
Virus Diseases
Aminopeptidase secreted by Chromobacterium sp. Panama inhibits dengue virus infection by degrading the E protein.
Virus Diseases
Analysis of the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection: aminopeptidase N is not important and a process of acidification of the endosome is necessary.
Virus Diseases
Contribution of the porcine aminopeptidase N (CD13) receptor density to porcine epidemic diarrhea virus infection.
Virus Diseases
Human aminopeptidase N is a receptor for human coronavirus 229E.
Virus Diseases
Metalloprotease ADAM17 regulates porcine epidemic diarrhea virus infection by modifying aminopeptidase N.
Virus Diseases
Time-dependent viral interference between influenza virus and coronavirus in the infection of differentiated porcine airway epithelial cells.
Visna
Expression of the gp150 maedi visna virus envelope precursor protein by mammalian expression vectors.
Visna
Visna/maedi virus Env protein expressed by a vaccinia virus recombinant induces cell-to-cell fusion in cells of different origins in the apparent absence of Env cleavage: role of glycosylation and of proteoglycans.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.00025 - 0.0005
(1-amino-2-methylpropyl)(1-hydroxy-3-phenylpropyl)phosphinic acid
0.00093
(1-amino-2-phenylethyl)(1-hydroxy-3-phenylpropyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.00042 - 0.001
(1-amino-3-methylbutyl)(1-hydroxy-3-phenylpropyl)phosphinic acid
0.003
(1-amino-3-methylbutyl)(1-hydroxypentyl)phosphinic acid
Homo sapiens
-
-
0.004
(1-amino-3-methylbutyl)[amino(phenyl)methyl]phosphinic acid
Homo sapiens
-
-
0.05
(1-aminobutyl)(1-amino-3-methylbutyl)phosphinic acid
Homo sapiens
-
-
0.002
(1-aminobutyl)(1-hydroxy-2-phenylethyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.017
(1-aminobutyl)[amino(phenyl)methyl]phosphinic acid
Homo sapiens
-
-
0.155
(1-aminoethyl)(1-amino-3-methylbutyl)phosphinic acid
Homo sapiens
-
-
0.046
(1-aminoethyl)[amino(phenyl)methyl]phosphinic acid
Homo sapiens
-
-
0.00087
(1-aminoethyl)[hydroxy[4-(propan-2-yl)phenyl]methyl]phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.02
(1-aminohexyl)((2-(methoxycarbonyl)benzyl)carbamothioyl)phosphinic acid
Homo sapiens
-
IC50 above 0.02 mM, at 37°C in 100 mM Tris-HCl, pH 7.5
0.00086
(1-aminopentyl)(1-hydroxy-2-phenylpropyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.00022
(1-aminopentyl)(1-hydroxy-3-phenylpropyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.0093
(1-aminopentyl)[hydroxy(4-hydroxyphenyl)methyl]phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.0006
(1-aminopropyl)(1-hydroxy-3-phenylpropyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.0297
(1-benzyl-1H-imidazol-4-yl)methyl 6-oxidanyl-6-oxidanylidene-N-[(3,4,5-trimethoxyphenyl)carbonyl]-L-norleucylalaninate
Homo sapiens
-
-
0.00007
(1S)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethanaminium acetate
Homo sapiens
-
IC50: 70 nM
0.00005
(1S)-2-phenyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethanaminium acetate
Homo sapiens
-
IC50: 50 nM
0.000074
(1S)-3-methyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butan-1-aminium acetate
Homo sapiens
-
IC50: 74 nM
0.3089
(2R)-N-[5-(4-bromophenyl)-1,3,4-thiadiazol-2-yl]-2-[(benzoyl)amino]-propanamide
Homo sapiens
-
in phosphate sodium buffer (pH 7.2, 50 mM), at 37°C
0.2966
(2R)-N-[5-(4-bromophenyl)-1,3,4-thiadiazol-2-yl]-2-[(phenylacetyl)-amino]-propanamide
Homo sapiens
-
in phosphate sodium buffer (pH 7.2, 50 mM), at 37°C
0.1073
(2R)-N-[5-(4-bromophenyl)-1,3,4-thiadiazol-2-yl]-2-[(phenylsulfonyl)-amino]-propanamide
Homo sapiens
-
in phosphate sodium buffer (pH 7.2, 50 mM), at 37°C
0.2875
(2R)-N-[5-(4-chlorophenyl)-1,3,4-thiadiazol-2-yl]-2-[(benzoyl)amino]-propanamide
Homo sapiens
-
in phosphate sodium buffer (pH 7.2, 50 mM), at 37°C
0.2058
(2R)-N-[5-(4-chlorophenyl)-1,3,4-thiadiazol-2-yl]-2-[(phenylacetyl)-amino]-propanamide
Homo sapiens
-
in phosphate sodium buffer (pH 7.2, 50 mM), at 37°C
0.0964
(2R)-N-[5-(4-chlorophenyl)-1,3,4-thiadiazol-2-yl]-2-[(phenylsulfonyl)-amino]-propanamide
Homo sapiens
-
in phosphate sodium buffer (pH 7.2, 50 mM), at 37°C
0.1905
(2R)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-2-[(benzoyl)amino]-propanamide
Homo sapiens
-
in phosphate sodium buffer (pH 7.2, 50 mM), at 37°C
0.169
(2R)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-2-[(phenylacetyl)-amino]-propanamide
Homo sapiens
-
in phosphate sodium buffer (pH 7.2, 50 mM), at 37°C
0.1153
(2R)-N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-2-[(phenylsulfonyl)amino]-propanamide
Homo sapiens
-
in phosphate sodium buffer (pH 7.2, 50 mM), at 37°C
0.0698
(2R)-N-[5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-yl]-2-[(benzoyl)amino]-propanamide
Homo sapiens
-
in phosphate sodium buffer (pH 7.2, 50 mM), at 37°C
0.0399
(2R)-N-[5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-yl]-2-[(phenylacetyl)-amino]-propanamide
Homo sapiens
-
in phosphate sodium buffer (pH 7.2, 50 mM), at 37°C
0.0488
(2R)-N-[5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-yl]-2-[(phenylsulfonyl)amino]-propanamide
Homo sapiens
-
in phosphate sodium buffer (pH 7.2, 50 mM), at 37°C
0.1178
(2R)-N-[5-(4-methylphenyl)-1,3,4-thiadiazol-2-yl]-2-[(benzoyl)amino]-propanamide
Homo sapiens
-
in phosphate sodium buffer (pH 7.2, 50 mM), at 37°C
0.107
(2R)-N-[5-(4-methylphenyl)-1,3,4-thiadiazol-2-yl]-2-[(phenylacetyl)-amino]-propanamide
Homo sapiens
-
in phosphate sodium buffer (pH 7.2, 50 mM), at 37°C
0.3378
(2R)-N-[5-(4-methylphenyl)-1,3,4-thiadiazol-2-yl]-2-[(phenylsulfonyl)-amino]-propanamide
Homo sapiens
-
in phosphate sodium buffer (pH 7.2, 50 mM), at 37°C
0.3178
(2R)-N-[5-(4-nitrorophenyl)-1,3,4-thiadiazol-2-yl]-2-[(benzoyl)amino]-propanamide
Homo sapiens
-
in phosphate sodium buffer (pH 7.2, 50 mM), at 37°C
0.3091
(2R)-N-[5-(4-nitrorophenyl)-1,3,4-thiadiazol-2-yl]-2-[(phenylacetyl)-amino]-propanamide
Homo sapiens
-
in phosphate sodium buffer (pH 7.2, 50 mM), at 37°C
0.1678
(2R)-N-[5-(4-nitrorophenyl)-1,3,4-thiadiazol-2-yl]-2-[(phenylsulfonyl)-amino]-propanamide
Homo sapiens
-
in phosphate sodium buffer (pH 7.2, 50 mM), at 37°C
0.1701
(2R)-N-[5-phenyl-1,3,4-thiadiazol-2-yl]-2-[(benzoyl)-amino]-propanamide
Homo sapiens
-
in phosphate sodium buffer (pH 7.2, 50 mM), at 37°C
0.1416
(2R)-N-[5-phenyl-1,3,4-thiadiazol-2-yl]-2-[(phenylacetyl)amino]-propanamide
Homo sapiens
-
in phosphate sodium buffer (pH 7.2, 50 mM), at 37°C
0.3732
(2R)-N-[5-phenyl-1,3,4-thiadiazol-2-yl]-2-[(phenylsulfonyl)amino]-propanamide
Homo sapiens
-
in phosphate sodium buffer (pH 7.2, 50 mM), at 37°C
1.88
(2S)-2-amino-N-[(3S)-1-[2-(hydroxyamino)-2-oxoethyl]-2,6-dioxopiperidin-3-yl]-3-phenylpropanamide
Homo sapiens
-
in PBS buffer, at 37°C
0.0578
(3S)-N-hydroxy-2-(phenylsulfonyl)-6,10-dioxa-2-azaspiro[4.5]decane-3-carboxamide
Homo sapiens
-
-
0.0827
(3S)-N-hydroxy-2-(phenylsulfonyl)-6,11-dioxa-2-azaspiro[4.6]undecane-3-carboxamide
Homo sapiens
-
-
0.1067
(3S)-N-hydroxy-2-(phenylsulfonyl)-6,12-dioxa-2-azaspiro[4.7]dodecane-3-carboxamide
Homo sapiens
-
-
0.0485
(3S)-N-hydroxy-2-[(4-methylphenyl)sulfonyl]-6,10-dioxa-2-azaspiro[4.5]decane-3-carboxamide
Homo sapiens
-
-
0.0618
(3S)-N-hydroxy-2-[(4-methylphenyl)sulfonyl]-6,11-dioxa-2-azaspiro[4.6]undecane-3-carboxamide
Homo sapiens
-
-
0.0732
(3S)-N-hydroxy-2-[(4-methylphenyl)sulfonyl]-6,12-dioxa-2-azaspiro[4.7]dodecane-3-carboxamide
Homo sapiens
-
-
0.05
(4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-1,2,3,4-tetrahydro-1lambda~6~-thieno[3,2-e][1,2]thiazine-6-sulfonamide
Homo sapiens
-
IC50 is 0.05 mM
0.0000077
(4R)-4-(hexanoylamino)-N-hydroxy-1-[(3,4,5-trimethoxyphenyl)carbonyl]-L-prolinamide
0.0000021
(4R)-4-([(2E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino)-N-hydroxy-1-[(3,4,5-trimethoxyphenyl)carbonyl]-L-prolinamide
Homo sapiens
-
IC50: 2.1 nM
0.0000021
(4R)-4-[[(2E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino]-N-hydroxy-1-[(3,4,5-trimethoxyphenyl)carbonyl]-L-prolinamide
Homo sapiens
-
-
0.076
(aminomethyl)(1-amino-3-methylbutyl)phosphinic acid
Homo sapiens
-
-
0.042
(aminomethyl)[amino(phenyl)methyl]phosphinic acid
Homo sapiens
-
-
0.012 - 0.179
1,10-phenanthroline
0.00093
1-amino-2-methylpropyl(benzylcarbamoyl)phosphinic acid
Homo sapiens
-
-
0.00118 - 0.0012
1-amino-2-methylpropyl(hexylcarbamothioyl)phosphinic acid
0.0019 - 0.01535
1-amino-2-methylpropyl(isobutylcarbamothioyl)phosphinic acid
0.0146
1-amino-2-methylpropyl(methylcarbamothioyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.16
1-amino-2-methylpropyl(phenylcarbamoyl)phosphinic acid
Homo sapiens
-
-
0.02
1-amino-3-methylbutyl(2-(methoxycarbonyl)benzylcarbamothioyl)phosphinic acid
Homo sapiens
-
IC50 above 0.02 mM, at 37°C in 100 mM Tris-HCl, pH 7.5
0.0082
1-amino-3-methylbutyl(benzylcarbamothioyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.0005 - 0.00096
1-amino-3-methylbutyl(hexylcarbamothioyl)phosphinic acid
0.01056 - 0.02
1-amino-3-methylbutyl(methylcarbamothioyl)phosphinic acid
0.02
1-amino-3-methylbutyl(phenethylcarbamothioyl)phosphinic acid
Homo sapiens
-
IC50 above 0.02 mM, at 37°C in 100 mM Tris-HCl, pH 7.5
0.00047
1-amino-3-phenylpropyl(3-(methylthio)propylcarbamothioyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.0114
1-amino-3-phenylpropyl(4-(ethoxycarbonyl)benzylcarbamothioyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.00038 - 0.00064
1-amino-3-phenylpropyl(4-methoxybenzylcarbamothioyl)phosphinic acid
0.0013
1-amino-3-phenylpropyl(benzylcarbamothioyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.00056
1-amino-3-phenylpropyl(propylcarbamothioyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.00053
1-amino-4-methylpentyl(benzylcarbamoyl)phosphinic acid
Homo sapiens
-
-
0.035
1-amino-4-methylpentyl(phenylcarbamoyl)phosphinic acid
Homo sapiens
-
-
0.02
1-aminobutyl(2-(methoxycarbonyl)phenethylcarbamothioyl)phosphinic acid
Homo sapiens
-
IC50 above 0.02 mM, at 37°C in 100 mM Tris-HCl, pH 7.5
0.00145
1-aminobutyl(3-(methylthio)propylcarbamothioyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.02
1-aminobutyl(4-(ethoxycarbonyl)phenethylcarbamothioyl)phosphinic acid
Homo sapiens
-
IC50 above 0.02 mM, at 37°C in 100 mM Tris-HCl, pH 7.5
0.00068
1-aminobutyl(4-methoxybenzylcarbamothioyl)phosphinic acid
Homo sapiens
-
-
0.00215
1-aminobutyl(4-methoxyphenethylcarbamothioyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.00125
1-aminobutyl(benzylcarbamothioyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.00228 - 0.0036
1-aminobutyl(phenethylcarbamothioyl)phosphinic acid
0.00252
1-aminoethyl(3-(methylthio)propylcarbamothioyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.02
1-aminoethyl(4-(ethoxycarbonyl)benzylcarbamothioyl)phosphinic acid
Homo sapiens
-
IC50 above 0.02 mM, at 37°C in 100 mM Tris-HCl, pH 7.5
0.00112 - 0.02
1-aminoethyl(4-methoxybenzylcarbamothioyl)phosphinic acid
0.0022
1-aminoethyl(benzylcarbamothioyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.0042 - 0.0058
1-aminoethyl(phenethylcarbamothioyl)phosphinic acid
0.02
1-aminopentyl(2-(methoxycarbonyl)benzylcarbamothioyl)phosphinic acid
Homo sapiens
-
IC50 above 0.02 mM, at 37°C in 100 mM Tris-HCl, pH 7.5
0.00077
1-aminopentyl(3-(methylthio)propylcarbamothioyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.00025 - 0.00064
1-aminopentyl(4-methoxybenzylcarbamothioyl)phosphinic acid
0.0015
1-aminopentyl(benzylcarbamothioyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.00071 - 0.00073
1-aminopentyl(phenethylcarbamothioyl)phosphinic acid
0.0016
1-aminopropyl(3-(methylthio)propylcarbamothioyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.0189
2-([[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]amino)propaneperoxoic acid
Homo sapiens
-
-
0.00002
2-amino-1,4-dihydrophenanthren-3(2H)-one hydrochloride
Homo sapiens
-
-
0.000025
2-amino-2-phenylethanethiol
Homo sapiens
-
IC50: 25 nM
0.000056
2-amino-3-(benzyloxy)propane-1-thiol
Homo sapiens
-
IC50: 56 nM
0.00002
2-amino-3-(methylsulfanyl)propane-1-thiol
Homo sapiens
-
IC50: 20 nM
0.000021
2-amino-3-(methylsulfinyl)propane-1-thiol
Homo sapiens
-
IC50: 21 nM
0.00004
2-amino-3-(tert-butylsulfanyl)propane-1-thiol
Homo sapiens
-
IC50: 40 nM
0.000045
2-amino-3-cyclohexylpropane-1-thiol
Homo sapiens
-
IC50: 45 nM
0.00003
2-amino-3-phenylpropane-1-thiol
Homo sapiens
-
IC50: 30 nM
0.000011
2-amino-4-(methylsulfanyl)butane-1-thiol
Homo sapiens
-
IC50: 11 nM
0.00002
2-amino-4-(methylsulfinyl)butane-1-thiol
Homo sapiens
-
IC50: 20 nM
0.000022
2-amino-4-methylpentane-1-thiol
Homo sapiens
-
IC50: 22 nM
0.00008
3-amino-1-(2-phenylethyl)-3,4-dihydronaphthalen-2(1H)-one hydrochloride
Homo sapiens
-
-
0.02
4-(2-(((1-aminobutyl)(hydroxy)phosphoryl)methanethioamido)ethyl)benzoic acid
Homo sapiens
-
IC50 above 0.02 mM, at 37°C in 100 mM Tris-HCl, pH 7.5
0.000045
4-(2-amino-3-sulfanylpropyl)phenol
Homo sapiens
-
IC50: 45 nM
0.0228
6-hydroxy-6-oxo-N-1,3-thiazol-2-yl-N2-[(3,4,5-trimethoxyphenyl)carbonyl]-L-norleucinamide
Homo sapiens
-
-
0.0532
6-hydroxy-N-(methoxycarbonyl)-6-oxo-N2-[(3,4,5-trimethoxyphenyl)carbonyl]-L-norleucinamide
Homo sapiens
-
-
0.0414
6-hydroxy-N-(methoxycarbonyl)-N-methyl-6-oxo-N2-[(3,4,5-trimethoxyphenyl)carbonyl]-L-norleucinamide
Homo sapiens
-
-
0.0161
6-oxidanyl-6-oxidanylidene-N-[(3,4,5-trimethoxyphenyl)carbonyl]-L-norleucyl-N-hydroxyglycinamide
Homo sapiens
-
-
0.000075 - 0.0031
actinonin
0.00006
alpha1-amino-3-phenylpropyl(alpha2-hydroxy-3-phenylpropyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.0012 - 0.0056
beta-amino-alpha-hydroxyphenylbutanoic acid
Homo sapiens
-
i.e. AHPA, or AHPA-VAl, natural inhibitor isolated from Streptomyces neyagawaensis strain SL-387, IC50: 0.0012-0.0056 mM
0.0073
betulinic acid
Homo sapiens
-
natural inhibitor isolated from birch tree, IC50: 0.0073 mM, a selectively apoptosis-inducing agent, overview
0.05
bis(1-amino-3-methylbutyl)phosphinic acid
Homo sapiens
-
-
0.00083
bis(1-amino-3-phenylpropyl)phosphinic acid
Homo sapiens
-
-
0.0006
bis[amino(phenyl)methyl]phosphinic acid
Homo sapiens
-
-
0.00035
ethyl D-cysteinate
Homo sapiens
-
strong, competitive inhibition, IC50: 350 nM
0.1737
glycyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-cysteinamide hydrochloride
Homo sapiens
-
-
3.244
glycyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-leucinamide hydrochloride
Homo sapiens
-
-
0.098
iodoacetamide
Homo sapiens
-
IC50: 0.098 mM, kidney enzyme
0.5215
L-alanyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-leucinamide hydrochloride
Homo sapiens
-
-
0.0492
L-cysteinyl-N-[(2R)-2-amino-3-phenylpropyl]-L-phenylalaninamide hydrochloride
Homo sapiens
-
-
0.0103
L-cysteinyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-cysteinamide hydrochloride
Homo sapiens
-
-
0.016 - 0.053
L-iso-glutamine inhibitors
Homo sapiens
-
diverse derivatives, IC50 of 0.016-0.053 mM
-
0.0148
L-isoleucyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-cysteinamide hydrochloride
Homo sapiens
-
-
0.1476
L-isoleucyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-leucinamide hydrochloride
Homo sapiens
-
-
0.1579
L-isoleucyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-phenylalaninamide hydrochloride
Homo sapiens
-
-
0.1421
L-leucyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-leucinamide hydrochloride
Homo sapiens
-
-
0.1809
L-leucyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-phenylalaninamide hydrochloride
Homo sapiens
-
-
0.045
L-leucyl-N1-[(2R)-2-amino-3-phenylpropyl]-Lcysteinamide hydrochloride
Homo sapiens
-
-
0.0086
L-lysyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-cysteinamide hydrochloride
Homo sapiens
-
-
0.0895
L-lysyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-phenylalaninamide hydrochloride
Homo sapiens
-
-
0.0088
L-methionyl-N-[(2R)-2-amino-3-phenylpropyl]-L-phenylalaninamide hydrochloride
Homo sapiens
-
-
0.0165
L-methionyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-cysteinamide hydrochloride
Homo sapiens
-
-
0.0304
L-methionyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-leucinamide hydrochloride
Homo sapiens
-
-
0.0332
L-ornithyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-cysteinamide hydrochloride
Homo sapiens
-
-
0.0155
L-phenylalanyl-N-[(2R)-2-amino-3-phenylpropyl]-L-phenylalaninamide
Homo sapiens
-
-
0.0098
L-phenylalanyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-cysteinamide hydrochloride
Homo sapiens
-
-
0.1969
L-tyrosyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-leucinamide hydrochloride
Homo sapiens
-
-
0.0585
L-valyl-N-[(2R)-2-amino-3-phenylpropyl]-L-phenylalaninamide hydrochloride
Homo sapiens
-
-
0.0588
L-valyl-N1-[(2R)-2-amino-3-phenylpropyl]-L-cysteinamide hydrochloride
Homo sapiens
-
-
0.0005
lapstatin
Homo sapiens
-
natural competitive inhibitor from Streptomyces sp., IC50: 0.0005 mM
0.0926
methyl (2S)-1-(methylsulfonyl)-4-oxopyrrolidine-2-carboxylate
Homo sapiens
-
-
0.0549
methyl (2S)-1-[(4-methylphenyl)sulfonyl]-4-oxopyrrolidine-2-carboxylate
Homo sapiens
-
-
0.0758
methyl (2S)-4-oxo-1-(phenylsulfonyl)pyrrolidine-2-carboxylate
Homo sapiens
-
-
0.0416
methyl (2S,4R)-4-hydroxy-1-(methylsulfonyl)pyrrolidine-2-carboxylate
Homo sapiens
-
-
0.0538
methyl (2S,4R)-4-hydroxy-1-(phenylsulfonyl)pyrrolidine-2-carboxylate
Homo sapiens
-
-
0.0384
methyl (2S,4R)-4-hydroxy-1-[(4-methylphenyl)sulfonyl]pyrrolidine-2-carboxylate
Homo sapiens
-
-
0.0000009
methyl (4R)-4-([(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]amino)-1-[(3,4,5-trimethoxyphenyl)carbonyl]-L-prolinate
Homo sapiens
-
IC50: 0.9 nM
0.0000009
methyl (4R)-4-[[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]amino]-1-[(3,4,5-trimethoxyphenyl)carbonyl]-L-prolinate
Homo sapiens
-
-
0.0217
methyl 2-([[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]amino)-4-(methylperoxy)-4-oxobutanoate
Homo sapiens
-
-
0.05
methyl 2-chloro-N-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]alaninate
Homo sapiens
-
-
0.0302
methyl 6-oxidanyl-6-oxidanylidene-N-[(3,4,5-trimethoxyphenyl)carbonyl]-L-norleucyl-(4R)-4-(benzyloxy)prolinate
Homo sapiens
-
-
0.0507
methyl 6-oxidanyl-6-oxidanylidene-N-[(3,4,5-trimethoxyphenyl)carbonyl]-L-norleucyl-L-methioninate
Homo sapiens
-
-
0.0368
methyl 6-oxidanyl-6-oxidanylidene-N-[(3,4,5-trimethoxyphenyl)carbonyl]-L-norleucylserinate
Homo sapiens
-
-
0.011
methyl N-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]-D-phenylalaninate
Homo sapiens
-
-
0.0462
methyl N-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]-L-phenylalaninate
Homo sapiens
-
-
0.0503
methyl N-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]cysteinate
Homo sapiens
-
-
0.0554
methyl N-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]glycinate
Homo sapiens
-
-
0.0052
methyl N-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]histidinate
Homo sapiens
-
-
0.0493
methyl N-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]isoleucinate
Homo sapiens
-
-
0.0462
methyl N-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]leucinate
Homo sapiens
-
-
0.0207
methyl N-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]methioninate
Homo sapiens
-
-
0.0519
methyl N-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]threoninate
Homo sapiens
-
-
0.0431
methyl N-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]tryptophanate
Homo sapiens
-
-
0.0448
methyl N-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]tyrosinate
Homo sapiens
-
-
0.0214
methyl N-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]valinate
Homo sapiens
-
-
0.042
methyl N2-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]-N5-(nitrocarbamimidoyl)ornithinate
Homo sapiens
-
-
0.0381
methyl N2-[[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetyl]lysinate
Homo sapiens
-
-
0.0634
methyl [(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetate
Homo sapiens
-
-
0.0234
N-(4-aminophenyl)-6-hydroxy-6-oxo-N2-[(3,4,5-trimethoxyphenyl)carbonyl]-L-norleucinamide
Homo sapiens
-
-
0.0243
N-(4-chlorophenyl)-6-hydroxy-6-oxo-N2-[(3,4,5-trimethoxyphenyl)carbonyl]-L-norleucinamide
Homo sapiens
-
-
0.0000023
N-[(2S)-2-(([(1R)-1-amino-2-phenylethyl](hydroxy)phosphoryl)methyl)-4-methylpentanoyl]-L-phenylalanine
Homo sapiens
-
IC50: 2.3 nM
0.0000053
N-[(2S)-3-([(1R)-1-amino-2-phenylethyl](hydroxy)phosphoryl)-2-(biphenyl-4-ylmethyl)propanoyl]-L-alanine
Homo sapiens
-
IC50: 5.3 nM
0.0000015
N-[(2S)-3-([(1R)-1-amino-2-phenylethyl](hydroxy)phosphoryl)-2-benzylpropanoyl]phenylalanine
Homo sapiens
-
IC50: 1.5 nM
0.0000019
N-[(2S)-3-([(1R)-1-aminoethyl](hydroxy)phosphoryl)-2-(4-bromobenzyl)propanoyl]-L-alanine
Homo sapiens
-
IC50: 1.9 nM
0.0000029
N-[(2S)-3-([(1R)-1-aminoethyl](hydroxy)phosphoryl)-2-(biphenyl-4-ylmethyl)propanoyl]alanine
Homo sapiens
-
IC50: 2.9 nM
0.0000048
N-[(2S)-3-([(R)-amino(phenyl)methyl](hydroxy)phosphoryl)-2-(biphenyl-4-ylmethyl)propanoyl]-L-alanine
Homo sapiens
-
IC50: 4.8 nM
0.0000049
N-[(2S)-3-([(R)-amino(phenyl)methyl](hydroxy)phosphoryl)-2-(biphenyl-4-ylmethyl)propanoyl]-L-serine
Homo sapiens
-
IC50: 4.9 nM
0.0000102
N-[(2S)-3-([(R)-amino(phenyl)methyl](hydroxy)phosphoryl)-2-(biphenyl-4-ylmethyl)propanoyl]-L-threonine
Homo sapiens
-
IC50: 10.2 nM
0.0000328
N-[(2S)-3-([(R)-amino(phenyl)methyl](hydroxy)phosphoryl)-2-(biphenyl-4-ylmethyl)propanoyl]glycine
Homo sapiens
-
IC50: 32.8 nM
0.0000042
N-[(2S)-3-([(R)-amino(phenyl)methyl](hydroxy)phosphoryl)-2-benzylpropanoyl]-L-phenylalanine
Homo sapiens
-
IC50: 4.2 nM
0.0031
N-[(3S)-1-[2-(hydroxyamino)-2-oxoethyl]-2,6-dioxopiperidin-3-yl]-3,4,5-trimethoxybenzamide
Homo sapiens
-
-
1.049
N1-[(2R)-2-amino-3-phenylpropyl]-N-(2,4-dichlorobenzoyl)-L-cysteinamide hydrochloride
Homo sapiens
-
-
2.263
N1-[(2R)-2-amino-3-phenylpropyl]-N-(2,4-dichlorobenzoyl)-L-phenylalaninamide hydrochloride
Homo sapiens
-
-
0.2772
N1-[(2R)-2-amino-3-phenylpropyl]-N-(3,5-dinitrobenzoyl)-L-phenylalaninamide hydrochloride
Homo sapiens
-
-
0.366
N1-[(2R)-2-amino-3-phenylpropyl]-N-(3-phenylpropanoyl)-L-phenylalaninamide hydrochloride
Homo sapiens
-
-
0.6928
N1-[(2R)-2-amino-3-phenylpropyl]-N-(4-chlorobutanoyl)-L-phenylalaninamide hydrochloride
Homo sapiens
-
-
0.1736
N1-[(2R)-2-amino-3-phenylpropyl]-N-(4-methoxybenzoyl)-L-phenylalaninamide hydrochloride
Homo sapiens
-
-
1.39
N1-[(2R)-2-amino-3-phenylpropyl]-N-(4-nitrobenzoyl)-Lphenylalaninamide hydrochloride
Homo sapiens
-
-
0.2024
N1-[(2R)-2-amino-3-phenylpropyl]-N-(6-aminohexanoyl)-L-cysteinamide hydrochloride
Homo sapiens
-
-
1.457
N1-[(2R)-2-amino-3-phenylpropyl]-N-(6-aminohexanoyl)-L-leucinamide hydrochloride
Homo sapiens
-
-
1.539
N1-[(2R)-2-amino-3-phenylpropyl]-N-(6-aminohexanoyl)-L-phenylalaninamide hydrochloride
Homo sapiens
-
-
0.097
N6-[(benzyloxy)carbonyl]-N-hydroxy-N2-(pyrazin-2-ylcarbonyl)-L-lysinamide
Homo sapiens
-
-
0.0912 - 0.0943
N6-[(benzyloxy)carbonyl]-N-hydroxy-N2-(pyridin-3-ylcarbonyl)-L-lysinamide
0.5696
N6-[(benzyloxy)carbonyl]-N-hydroxy-N2-[(2E)-3-phenylprop-2-enoyl]-L-lysinamide
Homo sapiens
-
-
0.0958
N6-[(benzyloxy)carbonyl]-N-hydroxy-N2-[(3-nitrophenyl)carbonyl]-L-lysinamide
Homo sapiens
-
-
0.1974
N6-[(benzyloxy)carbonyl]-N2-(pyrazin-2-ylcarbonyl)-L-lysine
Homo sapiens
-
-
0.1668 - 0.2196
N6-[(benzyloxy)carbonyl]-N2-(pyridin-3-ylcarbonyl)-L-lysine
0.1272
N6-[(benzyloxy)carbonyl]-N2-[(2,4-dichlorophenyl)carbonyl]-L-lysine
Homo sapiens
-
-
0.0132
N6-[(benzyloxy)carbonyl]-N2-[(2,4-dichlorophenyl)carbonyl]-N-hydroxy-L-lysinamide
Homo sapiens
-
-
0.2151
N6-[(benzyloxy)carbonyl]-N2-[(2E)-3-phenylprop-2-enoyl]-L-lysine
Homo sapiens
-
-
0.1108
N6-[(benzyloxy)carbonyl]-N2-[(3-nitrophenyl)carbonyl]-L-lysine
Homo sapiens
-
-
0.188
N6-[(benzyloxy)carbonyl]-N2-[(4-bromophenyl)carbonyl]-L-lysine
Homo sapiens
-
-
0.1119
N6-[(benzyloxy)carbonyl]-N2-[(4-bromophenyl)carbonyl]-N-hydroxy-L-lysinamide
Homo sapiens
-
-
0.00029
PAQ-22
Homo sapiens
-
IC50: 0.00029 mM, kidney enzyme
0.000015
phebestin
Homo sapiens
-
IC50: 0.000015 mM, kidney enzyme
0.000016 - 0.00005
probestin
0.007 - 0.018
psammaplin A
Homo sapiens
-
natural inhibitor isolated from a marine sponge, non-competitive, highly cytotoxic, IC50: 0.007-0.018 mM, overview
0.0031
puromycin
Homo sapiens
-
IC50: 0.0031 mM, kidney enzyme
0.000025
RB3014
Homo sapiens
-
IC50: 0.000025 mM, kidney enzyme
0.0498
[(3S)-2,6-dioxo-3-[[(3,4,5-trimethoxyphenyl)carbonyl]amino]piperidin-1-yl]acetic acid
Homo sapiens
-
-
0.025
[3-nitro-2-(2-nitrophenyl)-4-oxo-4H-chromen-8-yl]acetic acid
Homo sapiens
-
IC50: 0.025 mM
0.00071
[amino(phenyl)methyl](1-amino-3-phenylpropyl)phosphinic acid
Homo sapiens
-
-
0.0044 - 0.012
[amino(phenyl)methyl](1-hydroxy-3-methylbutyl)phosphinic acid
0.00024 - 0.00073
[amino(phenyl)methyl](1-hydroxy-3-phenylpropyl)phosphinic acid
0.0182 - 0.048
[amino(phenyl)methyl](1-hydroxyethyl)phosphinic acid
0.028
[amino(phenyl)methyl](1-hydroxypentyl)phosphinic acid
Homo sapiens
-
-
0.00055 - 0.0015
[amino(phenyl)methyl][hydroxy(phenyl)methyl]phosphinic acid
0.00025
(1-amino-2-methylpropyl)(1-hydroxy-3-phenylpropyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.0005
(1-amino-2-methylpropyl)(1-hydroxy-3-phenylpropyl)phosphinic acid
Homo sapiens
-
-
0.00042
(1-amino-3-methylbutyl)(1-hydroxy-3-phenylpropyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.001
(1-amino-3-methylbutyl)(1-hydroxy-3-phenylpropyl)phosphinic acid
Homo sapiens
-
-
0.0000077
(4R)-4-(hexanoylamino)-N-hydroxy-1-[(3,4,5-trimethoxyphenyl)carbonyl]-L-prolinamide
Homo sapiens
-
-
0.0000077
(4R)-4-(hexanoylamino)-N-hydroxy-1-[(3,4,5-trimethoxyphenyl)carbonyl]-L-prolinamide
Homo sapiens
-
IC50: 7.7 nM
0.012
1,10-phenanthroline
Homo sapiens
-
pH 7.4, 37°C, presence of 0.05 mM EDTA
0.027
1,10-phenanthroline
Homo sapiens
-
pH 7.4, 37°C, presence of 0.005 mM EDTA
0.179
1,10-phenanthroline
Homo sapiens
-
pH 7.4, 37°C
0.00118
1-amino-2-methylpropyl(hexylcarbamothioyl)phosphinic acid
Homo sapiens
-
-
0.0012
1-amino-2-methylpropyl(hexylcarbamothioyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.0019
1-amino-2-methylpropyl(isobutylcarbamothioyl)phosphinic acid
Homo sapiens
-
-
0.01535
1-amino-2-methylpropyl(isobutylcarbamothioyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.0005
1-amino-3-methylbutyl(hexylcarbamothioyl)phosphinic acid
Homo sapiens
-
-
0.00096
1-amino-3-methylbutyl(hexylcarbamothioyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.01056
1-amino-3-methylbutyl(methylcarbamothioyl)phosphinic acid
Homo sapiens
-
-
0.02
1-amino-3-methylbutyl(methylcarbamothioyl)phosphinic acid
Homo sapiens
-
IC50 above 0.02 mM, at 37°C in 100 mM Tris-HCl, pH 7.5
0.00038
1-amino-3-phenylpropyl(4-methoxybenzylcarbamothioyl)phosphinic acid
Homo sapiens
-
-
0.00064
1-amino-3-phenylpropyl(4-methoxybenzylcarbamothioyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.00228
1-aminobutyl(phenethylcarbamothioyl)phosphinic acid
Homo sapiens
-
-
0.0036
1-aminobutyl(phenethylcarbamothioyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.00112
1-aminoethyl(4-methoxybenzylcarbamothioyl)phosphinic acid
Homo sapiens
-
-
0.02
1-aminoethyl(4-methoxybenzylcarbamothioyl)phosphinic acid
Homo sapiens
-
IC50 above 0.02 mM, at 37°C in 100 mM Tris-HCl, pH 7.5
0.0042
1-aminoethyl(phenethylcarbamothioyl)phosphinic acid
Homo sapiens
-
-
0.0058
1-aminoethyl(phenethylcarbamothioyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.00025
1-aminopentyl(4-methoxybenzylcarbamothioyl)phosphinic acid
Homo sapiens
-
-
0.00064
1-aminopentyl(4-methoxybenzylcarbamothioyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.00071
1-aminopentyl(phenethylcarbamothioyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.00073
1-aminopentyl(phenethylcarbamothioyl)phosphinic acid
Homo sapiens
-
-
0.000075
actinonin
Homo sapiens
-
IC50: 0.000075 mM, kidney enzyme
0.0002
actinonin
Homo sapiens
-
natural competitive inhibitor, IC50: 0.0002 mM
0.0031
actinonin
Homo sapiens
-
IC50 is 0.0031 mM
0.0004
bestatin
Homo sapiens
-
inhibits enzyme activity and cell growth, e.g. of leukocytes, overview, IC50: 0.0004 mM, kidney enzyme
0.0031
bestatin
Homo sapiens
-
-
0.007 - 0.0169
bestatin
Homo sapiens
-
narural competitive inhibitor, inhibits enzyme activity, but not chemotactic activity, IC50: 0.007-0.0169 mM
0.0085
bestatin
Homo sapiens
-
in phosphate sodium buffer (pH 7.2, 50 mM), at 37°C
0.01
bestatin
Homo sapiens
-
IC50 is 0.01 mM
0.0169
bestatin
Homo sapiens
-
-
0.0912
N6-[(benzyloxy)carbonyl]-N-hydroxy-N2-(pyridin-3-ylcarbonyl)-L-lysinamide
Homo sapiens
-
-
0.0943
N6-[(benzyloxy)carbonyl]-N-hydroxy-N2-(pyridin-3-ylcarbonyl)-L-lysinamide
Homo sapiens
-
-
0.1668
N6-[(benzyloxy)carbonyl]-N2-(pyridin-3-ylcarbonyl)-L-lysine
Homo sapiens
-
-
0.2196
N6-[(benzyloxy)carbonyl]-N2-(pyridin-3-ylcarbonyl)-L-lysine
Homo sapiens
-
-
0.000016
probestin
Homo sapiens
-
IC50: 0.000016 mM, kidney enzyme
0.00005
probestin
Homo sapiens
-
-
0.00005
probestin
Homo sapiens
-
natural competitive inhibitor from Streptomyces sp., IC50: 0.00005 mM
0.0044
[amino(phenyl)methyl](1-hydroxy-3-methylbutyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.012
[amino(phenyl)methyl](1-hydroxy-3-methylbutyl)phosphinic acid
Homo sapiens
-
-
0.00024
[amino(phenyl)methyl](1-hydroxy-3-phenylpropyl)phosphinic acid
Homo sapiens
-
-
0.00073
[amino(phenyl)methyl](1-hydroxy-3-phenylpropyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.0182
[amino(phenyl)methyl](1-hydroxyethyl)phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
0.048
[amino(phenyl)methyl](1-hydroxyethyl)phosphinic acid
Homo sapiens
-
-
0.00055
[amino(phenyl)methyl][hydroxy(phenyl)methyl]phosphinic acid
Homo sapiens
-
-
0.0015
[amino(phenyl)methyl][hydroxy(phenyl)methyl]phosphinic acid
Homo sapiens
-
at 37°C in 100 mM Tris-HCl, pH 7.5
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Luciani, N.; Marie-Claire, C.; Ruffet, E.; Beaumont, A.; Roques, B.P.; Fournie-Zaluski, M.C.
Characterization of Glu350 as a critical residue involved in the N-terminal amine binding site of aminopeptidase N (EC 3.4.11.2): insights into its mechanism of action
Biochemistry
37
686-692
1998
Homo sapiens, Sus scrofa
brenda
Menrad, A.; Speicher, D.; Wacker, J.; Herlyn, M.
Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells
Cancer Res.
53
1450-1455
1993
Homo sapiens
brenda
Lalu, K.; Lampelo, S.; Vanha-Perttula, T.
Characterization of three aminopeptidases purified from maternal serum
Biochim. Biophys. Acta
873
190-197
1986
Homo sapiens
brenda
Huang, K.; Takahara, S.; Kinouchi, T.; Takeyama, M.; Ishida, T.; Ueyama, H.; Nishi, K.; Ohkubo, I.
Alanyl aminopeptidase from human seminal plasma: purification, characterization, and immunohistochemical localization in the male genital tract
J. Biochem.
122
779-787
1997
Homo sapiens
brenda
McClellan, J.B.; Garner, C.W.
Purification and properties of human intestine alanine aminopeptidase
Biochim. Biophys. Acta
613
160-167
1980
Homo sapiens
brenda
Olsen, J.; Cowell, G.M.; Konigshofer, E.; Danielsen, E.M.; Moller, J.; Laustsen, L.; Hansen, O.C.; Welinder, K.G.; Engberg, J.; Hunziker, W.; Spiess, M.; Sjstrm, H.; Noren, O.
Complete amino acid sequence of human intestinal aminopeptidase N as deduced from cloned cDNA
FEBS Lett.
238
307-314
1988
Homo sapiens
brenda
Tokioka-Terao, M.; Hiwada, K.; Kokubu, T.
Purification and characterization of aminopeptidase N from human plasma
Enzyme
32
65-75
1984
Homo sapiens
brenda
Bauvois, B.; Puiffe, M.L.; Bongui, J.B.; Paillat, S.; Monneret, C.; Dauzonne, D.
Synthesis and biological evaluation of novel flavone-8-acetic acid derivatives as reversible inhibitors of aminopeptidase N/CD13
J. Med. Chem.
46
3900-3913
2003
Homo sapiens
brenda
Acartuerk, F.; Parlatan, Z.I.; Saracoglu, O.F.
Comparison of vaginal aminopeptidase enzymatic activities in various animals and in humans
J. Pharm. Pharmacol.
53
1499-1504
2001
Cavia porcellus, Oryctolagus cuniculus, Ovis aries, Homo sapiens, Rattus norvegicus
brenda
Taracha, E.; Habrat, B.; Lehner, M.; Wislowska, A.; Woronowicz, B.T.; Bogulas, M.; Charewicz, J.; Markuszewski, C.; Plaznik, A.
Alanine aminopeptidase activity in urine: a new marker of chronic alcohol abuse?
Alcohol. Clin. Exp. Res.
28
729-735
2004
Homo sapiens
brenda
Lendeckel, U.; Bukowska, A.; Laettig, J.H.; Brandt, W.
Alanyl-aminopeptidases in human T cells. Structures and functions
Aminopeptidases in Biology and Disease (Hooper, N. M. ; Lendechel, U. , eds. )
2
201-227
2004
Homo sapiens
-
brenda
Iturrioz, X.; Reaux-Le Goazigo, A.; Llorens-Cortes, C.
Aminopeptidase inhibitors as anti-hypertensive drugs
Aminopeptidases in Biology and Disease (Hooper, N. M. ; Lendechel, U. , eds. )
2
229-250
2004
Homo sapiens
-
brenda
Thielitz, A.; Bukowska, A.; Wolke, C.; Vetter, R.; Lendeckel, U.; Wrenger, S.; Hashimoto, Y.; Ansorge, S.; Gollnick, H.; Reinhold, D.
Identification of extra- and intracellular alanyl aminopeptidases as new targets to modulate keratinocyte growth and differentiation
Biochem. Biophys. Res. Commun.
321
795-801
2004
Homo sapiens
brenda
Riemann, D.; Tcherkes, A.; Hansen, G.H.; Wulfaenger, J.; Blosz, T.; Danielsen, E.M.
Functional co-localization of monocytic aminopeptidase N/CD13 with the Fc gamma receptors CD32 and CD64
Biochem. Biophys. Res. Commun.
331
1408-1412
2005
Homo sapiens
brenda
Saitoh, Y.; Koizumi, K.; Minami, T.; Sekine, K.; Sakurai, H.; Saiki, I.
A derivative of aminopeptidase inhibitor (BE15) has a dual inhibitory effect of invasion and motility on tumor and endothelial cells
Biol. Pharm. Bull.
29
709-712
2006
Homo sapiens
brenda
Fontijn, D.; Duyndam, M.C.; van Berkel, M.P.; Yuana, Y.; Shapiro, L.H.; Pinedo, H.M.; Broxterman, H.J.; Boven, E.
CD13/Aminopeptidase N overexpression by basic fibroblast growth factor mediates enhanced invasiveness of 1F6 human melanoma cells
Br. J. Cancer
94
1627-1636
2006
Homo sapiens
brenda
Fukasawa, K.; Fujii, H.; Saitoh, Y.; Koizumi, K.; Aozuka, Y.; Sekine, K.; Yamada, M.; Saiki, I.; Nishikawa, K.
Aminopeptidase N (APN/CD13) is selectively expressed in vascular endothelial cells and plays multiple roles in angiogenesis
Cancer Lett.
243
135-143
2006
Homo sapiens (P15144), Homo sapiens
brenda
Xu, W.; Li, Q.
Progress in the development of aminopeptidase N (APN/CD13) inhibitors
Curr. Med. Chem.
5
281-301
2005
Homo sapiens
brenda
Turner, A.J.
Membrane alanyl aminopeptidase
Handbook of Proteolytic Enzymes (Barrett, J. ; Rawlings, N. D. ; Woessner, J. F. , eds. )
1
289-294
2004
Oryctolagus cuniculus, Homo sapiens, Lactococcus lactis, Lymantria dispar, Rattus norvegicus, Sus scrofa
-
brenda
Gabrilovac, J.; Cupic, B.; Breljak, D.; Zekusic, M.; Boranic, M.
Expression of CD13/aminopeptidase N and CD10/neutral endopeptidase on cultured human keratinocytes
Immunol. Lett.
91
39-47
2004
Homo sapiens
brenda
Chang, Y.W.; Chen, S.C.; Cheng, E.C.; Ko, Y.P.; Lin, Y.C.; Kao, Y.R.; Tsay, Y.G.; Yang, P.C.; Wu, C.W.; Roffler, S.R.
CD13 (aminopeptidase N) can associate with tumor-associated antigen L6 and enhance the motility of human lung cancer cells
Int. J. Cancer
116
243-252
2005
Homo sapiens
brenda
Vijgen, L.; Keyaerts, E.; Zlateva, K.; Van Ranst, M.
Identification of six new polymorphisms in the human coronavirus 229E receptor gene (aminopeptidase N/CD13)
Int. J. Infect. Dis.
8
217-222
2004
Homo sapiens (P15144), Homo sapiens
brenda
Kehlen, A.; Geisler, M.; Olsen, J.; Sablotzki, A.; Langner, J.; Riemann, D.
IL-10 and TGF-beta differ in their regulation of aminopeptidase N/CD13 expression in monocytes
Int. J. Mol. Med.
13
877-882
2004
Homo sapiens
brenda
Alfalah, M.; Krahn, M.P.; Wetzel, G.; von Horsten, S.; Wolke, C.; Hooper, N.; Kalinski, T.; Krueger, S.; Naim, H.Y.; Lendeckel, U.
A mutation in aminopeptidase N (CD13) isolated from a patient suffering from leukemia leads to an arrest in the endoplasmic reticulum
J. Biol. Chem.
281
11894-11900
2006
Homo sapiens
brenda
Cowburn, A.S.; Sobolewski, A.; Reed, B.J.; Deighton, J.; Murray, J.; Cadwallader, K.A.; Bradley, J.R.; Chilvers, E.R.
Aminopeptidase N (CD13) regulates tumor necrosis factor-alpha-induced apoptosis in human neutrophils
J. Biol. Chem.
281
12458-12467
2006
Homo sapiens
brenda
Roecken, C.; Licht, J.; Roessner, A.; Carl-McGrath, S.
Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma
J. Clin. Pathol.
58
1069-1075
2005
Homo sapiens
brenda
Mina-Osorio, P.; Ortega, E.
Aminopeptidase N (CD13) functionally interacts with FcgammaRs in human monocytes
J. Leukocyte Biol.
77
1008-1017
2005
Homo sapiens
brenda
Mina-Osorio, P.; Shapiro, L.H.; Ortega, E.
CD13 in cell adhesion: aminopeptidase N (CD13) mediates homotypic aggregation of monocytic cells
J. Leukocyte Biol.
79
719-730
2006
Homo sapiens
brenda
Kunii, R.; Nemoto, E.; Kanaya, S.; Tsubahara, T.; Shimauchi, H.
Expression of CD13/aminopeptidase N on human gingival fibroblasts and up-regulation upon stimulation with interleukin-4 and interleukin-13
J. Periodontal Res.
40
138-146
2005
Homo sapiens
brenda
Bauvois, B.; Dauzonne, D.
Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects
Med. Res. Rev.
26
88-130
2006
Homo sapiens
brenda
Ichimura, E.; Yamada, M.; Nishikawa, K.; Abe, F.; Nakajima, T.
Immunohistochemical expression of aminopeptidase N (CD13) in human lung squamous cell carcinomas, with special reference to bestatin adjuvant therapy
Pathol. Int.
56
296-300
2006
Homo sapiens
brenda
Kasman, L.M.
CD13/aminopeptidase N and murine cytomegalovirus infection
Virology
334
1-9
2005
Homo sapiens, Mus musculus
brenda
Wentworth, D.E.; Tresnan, D.B.; Turner, B.C.; Lerman, I.R.; Bullis, B.; Hemmila, E.M.; Levis, R.; Shapiro, L.H.; Holmes, K.V.
Cells of human aminopeptidase N (CD13) transgenic mice are infected by human coronavirus-229E in vitro, but not in vivo
Virology
335
185-197
2005
Homo sapiens (P15144), Homo sapiens
brenda
Reinhold, D.; Biton, A.; Goihl, A.; Pieper, S.; Lendeckel, U.; Faust, J.; Neubert, K.; Bank, U.; Taeger, M.; Ansorge, S.; Brocke, S.
Dual inhibition of dipeptidyl peptidase IV and aminopeptidase N suppresses inflammatory immune responses
Ann. N. Y. Acad. Sci.
1110
402-409
2007
Homo sapiens, Mus musculus
brenda
Thielitz, A.; Reinhold, D.; Vetter, R.; Bank, U.; Helmuth, M.; Hartig, R.; Wrenger, S.; Wiswedel, I.; Lendeckel, U.; Kaehne, T.; Neubert, K.; Faust, J.; Zouboulis, C.C.; Ansorge, S.; Gollnick, H.
Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation
J. Invest. Dermatol.
127
1042-1051
2007
Homo sapiens
brenda
Kotlo, K.; Shukla, S.; Tawar, U.; Skidgel, R.A.; Danziger, R.S.
Aminopeptidase N reduces basolateral Na+ -K+ -ATPase in proximal tubule cells
Am. J. Physiol. Renal Physiol.
293
F1047-F1053
2007
Homo sapiens (P15144)
brenda
Garde, S.V.; Forte, A.J.; Ge, M.; Lepekhin, E.A.; Panchal, C.J.; Rabbani, S.A.; Wu, J.J.
Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects
Anticancer Drugs
18
1189-1200
2007
Homo sapiens
brenda
Mina-Osorio, P.; Soto-Cruz, I.; Ortega, E.
A role for galectin-3 in CD13-mediated homotypic aggregation of monocytes
Biochem. Biophys. Res. Commun.
353
605-610
2007
Homo sapiens
brenda
Yang, E.; Shim, J.S.; Woo, H.J.; Kim, K.W.; Kwon, H.J.
Aminopeptidase N/CD13 induces angiogenesis through interaction with a pro-angiogenic protein, galectin-3
Biochem. Biophys. Res. Commun.
363
336-341
2007
Homo sapiens, Mus musculus
brenda
Petrovic, N.; Schacke, W.; Gahagan, J.R.; OConor, C.A.; Winnicka, B.; Conway, R.E.; Mina-Osorio, P.; Shapiro, L.H.
CD13/APN regulates endothelial invasion and filopodia formation
Blood
110
142-150
2007
Homo sapiens
brenda
Terauchi, M.; Kajiyama, H.; Shibata, K.; Ino, K.; Nawa, A.; Mizutani, S.; Kikkawa, F.
Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells
BMC Cancer
7
140
2007
Homo sapiens, Mus musculus
brenda
Tsukamoto, H.; Shibata, K.; Kajiyama, H.; Terauchi, M.; Nawa, A.; Kikkawa, F.
Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer
BMC Cancer
8
74
2008
Homo sapiens, Mus musculus
brenda
Tokuhara, T.; Hattori, N.; Ishida, H.; Hirai, T.; Higashiyama, M.; Kodama, K.; Miyake, M.
Clinical significance of aminopeptidase N in non-small cell lung cancer
Clin. Cancer Res.
12
3971-3978
2006
Homo sapiens
brenda
Demaegdt, H.; Lenaerts, P.J.; Swales, J.; De Backer, J.P.; Laeremans, H.; Le, M.T.; Kersemans, K.; Vogel, L.K.; Michotte, Y.; Vanderheyden, P.; Vauquelin, G.
Angiotensin AT4 receptor ligand interaction with cystinyl aminopeptidase and aminopeptidase N: [125I]angiotensin IV only binds to the cystinyl aminopeptidase apo-enzyme
Eur. J. Pharmacol.
546
19-27
2006
Homo sapiens
brenda
Vanderheyden, P.M.; Demaegdt, H.; Swales, J.; Lenaerts, P.J.; De Backer, J.P.; Vogel, L.K.; Vauquelin, G.
Synergistic inhibition of the enzymatic activity of aminopeptidase N by divalent metal ion chelators
Fundam. Clin. Pharmacol.
20
613-619
2006
Homo sapiens, Sus scrofa
brenda
Kawamura, J.; Shimada, Y.; Kitaichi, H.; Komoto, I.; Hashimoto, Y.; Kaganoi, J.; Miyake, M.; Yamasaki, S.; Kondo, K.; Imamura, M.
Clinicopathological significance of aminopeptidase N/CD13 expression in human gastric carcinoma
Hepatogastroenterology
54
36-40
2007
Homo sapiens
brenda
Yamashita, M.; Kajiyama, H.; Terauchi, M.; Shibata, K.; Ino, K.; Nawa, A.; Mizutani, S.; Kikkawa, F.
Involvement of aminopeptidase N in enhanced chemosensitivity to paclitaxel in ovarian carcinoma in vitro and in vivo
Int. J. Cancer
120
2243-2250
2007
Homo sapiens, Mus musculus
brenda
Surowiak, P.; Drag, M.; Materna, V.; Suchocki, S.; Grzywa, R.; Spaczy?ski, M.; Dietel, M.; Oleksyszyn, J.; Zabel, M.; Lage, H.
Expression of aminopeptidase N/CD13 in human ovarian cancers
Int. J. Gynecol. Cancer
16
1783-1788
2006
Homo sapiens
brenda
Sonneck, K.; Baumgartner, C.; Rebuzzi, L.; Marth, K.; Chen, K.W.; Hauswirth, A.W.; Florian, S.; Vrtala, S.; Buehring, H.J.; Valenta, R.; Valent, P.
Recombinant allergens promote expression of aminopeptidase-N (CD13) on basophils in allergic patients
Int. J. Immunopathol. Pharmacol.
21
11-21
2008
Homo sapiens
brenda
Miki, T.; Takegami, Y.; Okawa, K.; Muraguchi, T.; Noda, M.; Takahashi, C.
The reversion-inducing cysteine-rich protein with Kazal motifs (RECK) interacts with membrane type 1 matrix metalloproteinase and CD13/aminopeptidase N and modulates their endocytic pathways
J. Biol. Chem.
282
12341-12352
2007
Homo sapiens
brenda
von Wallbrunn, A.; Waldeck, J.; Hoeltke, C.; Zuehlsdorf, M.; Mesters, R.; Heindel, W.; Schaefers, M.; Bremer, C.
In vivo optical imaging of CD13/APN-expression in tumor xenografts
J. Biomed. Opt.
13
011007
2008
Homo sapiens
brenda
Mina-Osorio, P.; Shapiro, L.H.; Ortega, E.
CD13 in cell adhesion: aminopeptidase N (CD13) mediates homotypic aggregation of monocytic cells
J. Leukoc. Biol.
79
719-730
2006
Homo sapiens
brenda
Axen, A.; Andersson, H.; Lindeberg, G.; Roennholm, H.; Kortesmaa, J.; Demaegdt, H.; Vauquelin, G.; Karlen, A.; Hallberg, M.
Small potent ligands to the insulin-regulated aminopeptidase (IRAP)/AT(4) receptor
J. Pept. Sci.
13
434-444
2007
Homo sapiens
brenda
Gera, L.; Fortin, J.; Adam, A.; Stewart, J.M.; Marceau, F.
Discovery of a dual-function peptide that combines aminopeptidase N inhibition and kinin B1 receptor antagonism
J. Pharmacol. Exp. Ther.
317
300-308
2006
Oryctolagus cuniculus, Homo sapiens
brenda
Wulfaenger, J.; Niedling, S.; Riemann, D.; Seliger, B.
Aminopeptidase N (APN)/CD13-dependent CXCR4 downregulation is associated with diminished cell migration, proliferation and invasion
Mol. Membr. Biol.
25
72-82
2008
Homo sapiens
brenda
Uehara, N.; Fujita, M.; Shimizu, T.
Colorimetric assay of aminopeptidase N activity based on inhibition of the disassembly of gold nano-composites conjugated with a thermo-responsive copolymer
Anal. Sci.
25
267-273
2009
Homo sapiens
brenda
Shim, J.S.; Park, H.M.; Lee, J.; Kwon, H.J.
Global and focused transcriptional profiling of small molecule aminopeptidase N inhibitor reveals its mechanism of angiogenesis inhibition
Biochem. Biophys. Res. Commun.
371
99-103
2008
Homo sapiens
brenda
Shang, L.; Fang, H.; Zhu, H.; Wang, X.; Wang, Q.; Mu, J.; Wang, B.; Kishioka, S.; Xu, W.
Design, synthesis and SAR studies of tripeptide analogs with the scaffold 3-phenylpropane-1,2-diamine as aminopeptidase N/CD13 inhibitors
Bioorg. Med. Chem.
17
2775-2784
2009
Homo sapiens
brenda
Mawrin, C.; Wolke, C.; Haase, D.; Krueger, S.; Firsching, R.; Keilhoff, G.; Paulus, W.; Gutmann, D.H.; Lal, A.; Lendeckel, U.
Reduced activity of CD13/aminopeptidase N (APN) in aggressive meningiomas is associated with increased levels of SPARC
Brain Pathol.
20
200-210
2009
Homo sapiens
brenda
Morikawa, T.; Xie, H.; Wang, T.; Matsuda, H.; Yoshikawa, M.
Acylated flavonol bisdesmosides, sinocrassosides A3-A7 and B3, with aminopeptidase N inhibitory activity from Sinocrassula indica
Chem. Biodivers.
6
411-420
2009
Homo sapiens
brenda
Morikawa, T.; Xie, H.; Wang, T.; Matsuda, H.; Yoshikawa, M.
Bioactive constituents from Chinese natural medicines. XXXII. aminopeptidase N and aldose reductase inhibitors from Sinocrassula indica: structures of sinocrassosides B4, B5, C1, and D1-D3
Chem. Pharm. Bull.
56
1438-1444
2008
Homo sapiens
brenda
Morikawa, T.; Funakoshi, K.; Ninomiya, K.; Yasuda, D.; Miyagawa, K.; Matsuda, H.; Yoshikawa, M.
Medicinal foodstuffs. XXXIV. Structures of new prenylchalcones and prenylflavanones with TNF-alpha and aminopeptidase N inhibitory activities from Boesenbergia rotunda
Chem. Pharm. Bull.
56
956-962
2008
Homo sapiens
brenda
Holdt, B.; Peters, E.; Nagel, H.R.; Steiner, M.
An automated assay of urinary alanine aminopeptidase activity
Clin. Chem. Lab. Med.
46
537-540
2008
Homo sapiens
brenda
Ansorge, S.; Bank, U.; Heimburg, A.; Helmuth, M.; Koch, G.; Tadje, J.; Lendeckel, U.; Wolke, C.; Neubert, K.; Faust, J.; Fuchs, P.; Reinhold, D.; Thielitz, A.; Taeger, M.
Recent insights into the role of dipeptidyl aminopeptidase IV (DPIV) and aminopeptidase N (APN) families in immune functions
Clin. Chem. Lab. Med.
47
253-261
2009
Homo sapiens
brenda
Kawai, M.; Araragi, K.; Shimizu, Y.; Hara, Y.
Identification of placental leucine aminopeptidase and triton-slowed aminopeptidase N in serum of pregnant women
Clin. Chim. Acta
400
37-41
2009
Homo sapiens
brenda
Stankovic, M.; Vlahovic, P.; Avramovic, V.; Todorovic, M.
Distribution of dipeptidyl peptidase IV in patients with chronic tonsillitis
Clin. Vaccine Immunol.
15
794-798
2008
Homo sapiens
brenda
Zhang, X.; Xu, W.
Aminopeptidase N (APN/CD13) as a target for anti-cancer agent design
Curr. Med. Chem.
15
2850-2865
2008
Homo sapiens
brenda
Gabrilovac, J.; Breljak, D.; Cupic, B.
Regulation of aminopeptidase N (EC 3.4.11.2; APN; CD13) on the HL-60 cell line by TGF-beta1
Int. Immunopharmacol.
8
613-623
2008
Homo sapiens
brenda
Cai, J.; Kehoe, O.; Smith, G.M.; Hykin, P.; Boulton, M.E.
The angiopoietin/Tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy
Invest. Ophthalmol. Vis. Sci.
49
2163-2171
2008
Homo sapiens
brenda
Lukaszuk, A.; Demaegdt, H.; Szemenyei, E.; Toth, G.; Tymecka, D.; Misicka, A.; Karoyan, P.; Vanderheyden, P.; Vauquelin, G.; Tourwe, D.
Beta-homo-amino acid scan of angiotensin IV
J. Med. Chem.
51
2291-2296
2008
Homo sapiens
brenda
Kuehlmann, U.C.; Chwieralski, C.E.; van den Brule, S.; Roecken, C.; Reinhold, D.; Welte, T.; Buehling, F.
Modulation of cytokine production and silica-induced lung fibrosis by inhibitors of aminopeptidase N and of dipeptidyl peptidase-IV-related proteases
Life Sci.
84
1-11
2009
Homo sapiens
brenda
Li, S.H.; Li, G.; Huang, H.M.; Xiong, F.; Mai, X.; Kuang, B.H.; Liu, C.M.; Tu, G.G.
Synthesis of 1,3,4-thiadiazole derivatives as aminopeptidase N inhibitors
Pharmazie
64
67-70
2009
Homo sapiens
brenda
Teranishi, J.; Ishiguro, H.; Hoshino, K.; Noguchi, K.; Kubota, Y.; Uemura, H.
Evaluation of role of angiotensin III and aminopeptidases in prostate cancer cells
Prostate
68
1666-1673
2008
Homo sapiens
brenda
Mina-Osorio, P.
The moonlighting enzyme CD13: old and new functions to target
Trends Mol. Med.
14
361-371
2008
Homo sapiens
brenda
Grzywa, R.; Oleksyszyn, J.; Salvesen, G.S.; Drag, M.
Identification of very potent inhibitor of human aminopeptidase N (CD13)
Bioorg. Med. Chem. Lett.
20
2497-2499
2010
Homo sapiens, Rattus norvegicus, Sus scrofa
brenda
Inagaki, Y.; Tang, W.; Zhang, L.; Du, G.; Xu, W.; Kokudo, N.
Novel aminopeptidase N (APN/CD13) inhibitor 24F can suppress invasion of hepatocellular carcinoma cells as well as angiogenesis
Biosci. Trends
4
56-60
2010
Homo sapiens
brenda
Hausheer, F.H.; Parker, A.R.; Petluru, P.N.; Jair, K.W.; Chen, S.; Huang, Q.; Chen, X.; Ayala, P.Y.; Shanmugarajah, D.; Kochat, H.
Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of human aminopeptidase N
Cancer Chemother. Pharmacol.
67
381-391
2011
Homo sapiens
brenda
Saxena, A.; Rai, A.; Raina, V.; Seth, T.; Mitra, D.K.
Expression of CD13/aminopeptidase N in precursor B-cell leukemia: role in growth regulation of B cells
Cancer Immunol. Immunother.
59
125-135
2010
Homo sapiens
brenda
Cui, S.X.; Qu, X.J.; Gao, Z.H.; Zhang, Y.S.; Zhang, X.F.; Zhao, C.R.; Xu, W.F.; Li, Q.B.; Han, J.X.
Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells
Cancer Lett.
292
153-162
2010
Homo sapiens
brenda
Gong, Q.; Shi, W.; Li, L.; Ma, H.
Leucine aminopeptidase may contribute to the intrinsic resistance of cancer cells toward cisplatin as revealed by an ultrasensitive fluorescent probe
Chem. Sci.
7
788-792
2016
Homo sapiens (P28838)
brenda
Bizon, A.; Milnerowicz, H.
The effect of passive and active exposure to tobacco smoke on lipid profile parameters and the activity of certain membrane enzymes in the blood of women in the first trimester of pregnancy
Environ. Toxicol. Pharmacol.
53
74-80
2017
Homo sapiens (P15144), Homo sapiens
brenda
Weglarz-Tomczak, E.; Berlicki, L.; Pawelczak, M.; Nocek, B.; Joachimiak, A.; Mucha, A.
A structural insight into the P1S1 binding mode of diaminoethylphosphonic and phosphinic acids, selective inhibitors of alanine aminopeptidases
Eur. J. Med. Chem.
117
187-196
2016
Homo sapiens (P15144), Neisseria meningitidis serogroup B (Q9JYV4), Neisseria meningitidis serogroup B MC58 (Q9JYV4)
brenda
3.4.11.2 membrane alanyl aminopeptidase
more
top
The reliability class of the localization prediction ranges from 1 (very reliable) to 5 (not reliable). 
